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Abstract 
 
Laminitis is a debilitating and painful ailment of the equine foot. The 
pathophysiological mechanisms are diverse and still poorly understood. Disruption of cellular 
energy pathways may play a role in the different forms of laminitis including sepsis- and 
endocrine- associated laminitis and particularly supporting limb laminitis (SLL) where 
decreased perfusion of the lamellar tissue is suspected. The aim of this thesis was to 
characterize the normal bioenergetic profile of the lamellar tissue, and to establish if changes 
in metabolite patterns and microvascular perfusion occur as a result of modifications in limb 
load cycling activity and during the development of experimentally induced sepsis-associated 
laminitis. 
A tissue microdialysis technique was developed for serial measurement of lamellar 
energy metabolites and perfusion over a 24 hour period. Microdialysis probes were placed in 
the lamellar, sublamellar, and skin dermis of 14 healthy horses and glucose, lactate, pyruvate, 
urea and glycerol concentrations, lactate:glucose (L:G) and lactate:pyruvate (L:P) ratios were 
determined in microdialysis samples (dialysate). Dialysate volume and metabolite 
concentrations were stable for 24 hours and the technique was clinically well tolerated and 
resulted in minimal histological reaction at the probe site. There were key significant 
differences in dialysate composition between lamellar and skin dialysate (lower glucose and 
urea concentraitons and higher L:G in lamellar dialysates). Lamellar probe position 
(sublamellar dermis vs lamellar dermis) significantly affected the dialysate composition. 
In two subsequent studies, 9 horses instrumented with lamellar and skin microdialysis 
probes were subjected to sequential interventions designed to modify tissue perfusion (4 
interventions) and limb load cycling activity and weight bearing (4 interventions). Urea (20 
mmol/L) was added to the perfusion fluid to investigate if urea clearance (a microdialysis-
based method used to assess local blood flow) could identify lamellar perfusion changes. 
Energy metabolite concentrations (glucose, lactate, pyruvate), L:G, L:P and urea clearance 
were determined during each intervention and compared to baseline. 
A following study investigated changes in lamellar bioenergetic composition and 
perfusion during the development of experimentally induced, sepsis-associated laminitis. 
Microdialysis probes were placed in the lamellar tissue of one forelimb in 12 horses. 
Treatment (n=6) and control (n=6) horses received oligofructose (OF) and water via 
nasogastric tube. Bihourly sampling was performed. Lamellar metabolite composition, L:G, 
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L:P and urea clearance were determined and compared. Plasma glucose, lactate, pyruvate and 
urea were measured and compared; their correlation with dialysate composition was 
investigated. 
In another study using lamellar and skin dialysate and tissue sections from healthy 
horses (n=7), and lamellar dialysate and plasma samples from OFT (n=4) and CON (n=4) 
horses, targeted metabolomic analysis (i.e. 44 central carbon metabolites) was performed 
using liquid chromatography coupled with tandem mass spectrometry (LC-MS/MS). The 
differences between the lamellae and skin in healthy horses and the differences between OFT 
and CON horses were investigated. 
In the intervention studies, urea clearance was capable of detecting profound changes in 
lamellar perfusion, and, in combination with fluctuations in energy metabolite patterns, mild 
perfusion changes were also detected. Significant changes in lamellar energy metabolite 
composition and urea clearance were observed when limb load cycling activity was modified: 
significant increases in glucose and urea clearance, compatible with an increase in lamellar 
perfusion, were observed when limb activity increased. 
In the OF study, glucose decreased significantly in lamellar dialysate in the OFT group 
(OFT-L), and was consistently lower in OFT than in CON horses. Lactate was higher in OFT 
skin (OFT-S) compared with OFT-L and pyruvate decreased significantly from baseline in 
OFT-L and was also significantly less than CON-L. L:G and L:P increased significantly 
compared with baseline in OFT-L and OFT-S, but not CON-L or plasma from either group. 
Urea concentration in OFT-L decreased significantly compared with baseline (increased urea 
clearance); urea remained stable in CON-L. This study demonstrated that ischaemia does not 
occur during the developmental phase of laminitis in the OF model. There was evidence of 
lamellar hyperaemia, together with some bioenergetic disturbances. Despite increased 
perfusion, glucose concentrations in the lamellar interstitium were markedly reduced. There 
was no definitive evidence of lamellar bioenergetic failure, however it is still possible that 
reduced glucose availability could have compromised lamellar basal epithelial cell 
metabolism in particular. 
Metabolomic analysis of lamellar and skin dialysate showed no difference in metabolite 
composition in these two tissues in healthy horses, and the metabolome of dialysate and tissue 
samples was also found to be similar. A difference in central carbon metabolism (CCM) 
between plasma and lamellar dialysate, and between OFT and CON horses was observed. 
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Metabolomic analysis of lamellar CCM was capable of differentiating horses developing 
experimental laminitis from controls. Lamellar malate, pyruvate, aconitate and glycolate, and 
plasma malate alone, were identified as the source of differentiation between OFT and CON 
groups. 
The novel research described in this thesis demonstrated that lamellar microdialysis is 
well tolerated, and together with urea clearance it can be used for assessment of lamellar 
bioenergetic and perfusion changes. Microdialysis urea clearance demonstrated an increase in 
lamellar perfusion rather than ischaemia during the development of sepsis-associated laminitis 
(OF study). Results also suggest that lamellar perfusion and energy balance may be related to 
limb load cycling and are particularly affected by ambulation. The findings support the 
hypothesis that reduced limb load cycling activity, but not increased weight bearing, may be 
associated with reduced lamellar perfusion. Though further studies are required to determine 
if lamellar hypoperfusion and energy failure are key contributors to SLL, the development of 
strategies to increase limb load cycling in patients at risk of SLL may be important for 
prevention in horses at risk. 
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1. General Introduction 
 
A single digit is a unique characteristic of members of the genus Equus to which the 
domestic horse (Equus ferus caballus) and other equids belong. The presence of one toe in 
each of its four limbs confers speed and endurance to the horse, but a high price has come 
with this characteristic (Pollitt, 2010), especially after domestication. The toll to be paid by all 
equids is the susceptibility to the disease known as laminitis. 
 
Laminitis is a crippling condition of the equine digit.  It is a leading cause of lameness 
(13% of lameness cases), and a major cause of euthanasia (4.7% mortality) (USDA, 2000). 
Laminitis is characterized by a failure of the attachment between the internal surface of the 
hoof wall and the third phalanx. Weakening of this attachment combines with the mechanical 
distraction caused by weight bearing and locomotion, resulting in the key lesion of laminitis: 
failure of the suspensory apparatus of the distal phalanx (SADP) (Pollitt and Daradka, 1998). 
Alterations in the anatomy of the internal structures of the hoof follow as a result of 
separation of the lamellar epidermal cells from their basement membrane (BM) and 
underlying dermal tissue (Asplin et al., 2007; Pollitt, 1996b; van Eps et al., 2010a). The bone 
is driven down into the hoof capsule (sinking), and there is loss of the parallel conformation 
and an increased distance between the third phalanx and the inner surface of the hoof wall 
(rotation). Unfortunately, despite much research focusing on the identification of the 
mechanisms that lead to laminitis, the understanding of its pathophysiology remains 
incomplete (Budak et al., 2009). 
 
Identified contributors include activation of inflammatory mediators (Belknap et al., 
2007a; Black, 2009; Black et al., 2006b), and local enzymatic deregulation (Pollitt and 
Daradka, 1998). Recently, failure of energy metabolism has been suggested as an important 
contributor in the pathophysiologic events that result in some forms of laminitis (Belknap et 
al., 2009; van Eps et al., 2010a). The hoof lamellae have been shown to remove large amounts 
of glucose from the circulation compared to other tissues (Wattle and Pollitt, 2004). Because 
glycogen storage is not possible in the digit, glucose consumption is suggested to reflect the 
rate of glycolysis and energy utilization (van Eps et al., 2010a). Furthermore, glucose 
starvation in vitro causes lamellar failure (Pass et al., 1998). However, very little is known 
about the energy metabolism of the lamellar tissue. 
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One major reason for a lack of understanding of lamellar physiology is its anatomical 
location concealed within the hoof, rendering conventional techniques inappropriate for its 
study in vivo. A minimally invasive technique currently used to assess local metabolic and 
biochemical events in a range of organs is tissue microdialysis (Klaus et al., 2004; Nolting et 
al., 1996). It samples the extracellular environment without significant damage or disruption 
(Lonnroth et al., 1987), measuring local metabolic changes in real time (Klaus et al., 2004) 
and allowing for sample collection and storage (Wang et al., 2009). It also allows direct 
measurement of local perfusion, nutrient supply and cellular energy metabolism 
(bioenergetics), and it can assess local ischaemia or bioenergetic failure by quantification of 
local energy metabolites such as glucose, pyruvate and lactate (Goodman and Robertson, 
2009; Klaus et al., 2004). Tissue microdialysis has the potential to allow characterization of 
normal lamellar energy metabolism for the first time. Once standardized, a lamellar 
microdialysis technique combined with manipulations of digital perfusion and weight bearing, 
and with experimental laminitis induction models will enable documentation of the metabolic 
changes that take place within the lamellar tissue as a result of changes in blood flow and 
weight load, and during the development of laminitis. 
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2. Literature Review 
 
2.1. Anatomy and Physiology of the Equine Hoof 
 
2.1.1. General anatomy and physiology 
 
A single toe in each limb is a unique anatomic characteristic of the domestic horse 
(Eqqus ferus caballus), shared only with wild horses, asses and zebras (all members of the 
Eqqus genus). This is the sole genus in the family Equidae, which in turn is the solitary 
member of the Suborder Hippomorpha (single toed ungulate) in the Order Perissodactyla (odd 
toed ungulate) (Linnaeus, 1758). This unique phenotype of a single toe does a lot more than 
simply conferring the grounds for taxonomic classification. Its anatomic structure is a 
complex and imbricate system composed of a large number of tissues, including a keratinized 
epidermis, a dermis, bones, tendons, ligaments, cartilages, nerves, blood vessels, and a joint, 
all of which will be from here on referred to as the HOOF. The hoof is strong enough to 
support roughly 30% and 20% of the animal‟s body weight on a thoracic and a pelvic limb, 
respectively (equivalent to 150 Kg on the forelimb hoof of a 500 Kg horse at rest). 
Furthermore, it is easy to foresee a dramatic increment in the load to which each hoof is 
subjected, if only momentarily, when the horse is in motion. So the hoof must also be flexible 
and pliable to withstand and disperse acute forces that occur upon ground contact during 
locomotion. 
 
The complex equine hoof begins at an interface with the skin, where all three layers 
(subcutis, dermis and epidermis) suffer a remarkable modification, becoming hairless, 
cornified, and devoided of sebaceous and sweat glands. This margin, the perioplic segment or 
limbus, surrounds the entire circumference of the most proximal aspect of the hoof, just 
adjacent to the haired skin. It is underlined by a thick ring of subcutis known as the perioplic 
cushion, and is composed of an internal layer, the perioplic dermis, which has short dermal 
papillae covered by an unpigmented horny but soft external layer, the periople or epidermis 
limbi. The junction between the skin and the perioplic segment is known as the coronet. The 
perioplic segment is distally followed by a shallow groove that separates it from the coronary 
segment or corona. Tissues in the corona are organized in a similar fashion to those of the 
periople. However, this hoof segment is interrupted at the bulbs of the foot, where the 
periople merges into the frog (see frog/bulb segment below). The corona, together with the 
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lamellar segment that lies beneath it, reflects around the heels of the hoof, giving rise to the 
bars. Coronary tissue arrangements include: 1) a thicker subcutaneous coronary cushion that 
makes the corona bulge; 2) a coronary dermis or corium with a scaffold of downward directed 
papillae (orientated towards the ground as a result of the above-mentioned bulging); and 3) a 
coronary epidermis made of hard horn, which gives rise to the tough, usually pigmented 
middle layer of the hoof capsule, the stratum medium, as it is pushed distally by its dividing 
basal and spinous layers (Budras et al., 2003), which constantly replace cells (i.e. 
keratinocytes) that are worn off through friction against the ground (Pollitt, 1998). As 
keratinocytes migrate down and the distance from the basal cells increases, cytoskeletal 
keratin content also increases, the nucleus disappears, and the stratum medium becomes dense 
and hard (Pollitt, 1998). The proximal aspect of this coronary epidermal layer is rich in small 
perforations, the tubules, which extend 4 to 5 mm into the hoof wall, having the adequate size 
for single dermal papilla to fit in each one of them (Pollitt, 2004; Pollitt, 2010). As they 
mature, keratinocytes either arrange as tubular lining, or they turn into intertubular hoof wall 
that suffers further deposition of keratin, which is rich in disulphide bonds. When 
keratinisation is complete, the stratum medium acquires great strength (Pollitt, 1998), 
protecting the sensitive and softer structures within (Pollitt, 2010). 
 
Below the corona follows the lamellar segment that extends distally, beneath the thick 
stratum medium of the hoof capsule, becoming visible distally as the linea alba, and forming, 
together with the stratum medium, the surface of ground contact or sole border of the hoof. 
The wall segment is devoid of subcutis and lies directly over the third phalanx (P3) and the 
ungual cartilages (Budras et al., 2003). The dermis or corium of the wall is highly 
vascularized (Pollitt, 2010), and is composed of primary (PDL) and secondary (SDL) dermal 
lamellae, and a sub-lamellar dermis layer (Budras et al., 2003; Pollitt, 2010), which attaches 
to the underlying bone and cartilages through its dense connective tissue matrix (Pollitt, 
2010). At its most distal end, the parietal dermis gives rise to the terminal papillae, which fit 
into horn tubules present in the linea alba. Both PDL and SDL interdigitate with their 
epidermal counterparts, the primary (PEL) and secondary (SEL) epidermal lamellae  (Budras 
et al., 2003), which make the stratum internum of the hoof capsule (Pollitt, 1995). Each SEL 
is underlined by epidermal basal cells that form the basal cell layer or stratum germinativum 
(Pollitt, 2004; Pollitt, 2010). Attached and blended into the inner surface of the stratum 
medium, PELs proliferate from this germinal layer (Leach and Oliphant, 1983), although only 
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from the most proximal and most distal lamellae, but not from intermediate zones (Daradka 
and Pollitt, 2004). 
 
The blending and attachment of the stratum internum (PEL and SEL) with the stratum 
medium of the hoof capsule, while interdigitating with the corium (PDL and SDL) that is 
fixed through its connective tissue matrix to P3, generates a suspension system that ultimately 
supports the entire weight of the horse. This is made possible by a continuous sheet of 
extracellular matrix (ECM) which creates a very tough basement membrane (BM) that 
bridges the basal cells of the epidermal lamellae to the connective tissue of the dermal 
lamellae (Pollitt, 1998). This interaction at the interface between the dermal and epidermal 
layers will ultimately provide the weight baring strength to the Suspensory Apparatus of the 
Distal Phalanx (SADP). The SADP consists of a highly specialized dermo-epidermal 
interaction. Together, epidermal and dermal lamellae form the stratum lamellatum, which is 
composed of over 500 PEL, each holding 150 to 200 SEL. These SEL are folds that form 
along the length of each PEL as a result of cell proliferation. They provide an increased 
surface area and a high level of interlocking with the underlying, reciprocal SDL, which 
ultimately results in a strong attachment of all hoof structures to P3 (Pollitt and Daradka, 
1998). 
 
The connective tissue matrix attaching the corium to P3 spans across the dermal layer 
and tightly weaves into the overlying BM creating a solid link between the two. Collagen type 
IV is the structural backbone of the lamina densa of this BM and collagen type VII forms 
anchoring fibrils and plaques that attach the BM to the dermis (Pollitt and Daradka, 1998). On 
the other side of the BM, the resilient bringing of epidermal basal cells to the ECM is the 
result of ultramicroscopic anchoring points of cell-cell (desmosomes) and cell-substrate 
(hemidesmosomes) contact that generate a strong structural framework (Borradori and 
Sonnenberg, 1999; Green and Jones, 1996). Desmosomes (DMs) and hemidesmosomes 
(HDs) are transmembrane cell junction protein molecules with a cytoplasmic region attached 
to the cytoskeleton, and with an extracellular region anchoring the cell to its surroundings 
(Green and Jones, 1996). The extracellular region of one DM is firmly adhered to the 
extracellular region of a DM of a neighboring cell. In HDs, the extracellular region is firmly 
adhered to the underlying BM through anchoring filaments of laminin-332 (laminin-5) 
(Borradori and Sonnenberg, 1999; Green and Jones, 1996; Pollitt, 1994, 2010). The laminin-
332 filaments of epidermal basal cell HDs thus provide a stable attachment of the epidermis 
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to the dermis (Nishiyama et al., 2000). They meet the woven collagen in the lamina densa of 
the BM and directly bind the dermal collagen type VII of the anchoring fibrils (Rousselle et 
al., 1997), consolidating the solid bridging of the SADP (Figure 2.1). 
 
Within the dermal layers of the hoof (i.e. coronary, lamellar and solar corium), lies its 
vascular and nervous supply. Nerve endings provide sensory paths of which the epidermal 
layers are devoid, allowing, for example, to place nails for shoeing purposes. Vascular 
anatomy and hence its physiology is far more complex, with highly muscular and small lumen 
arterial and venous sides, thought to aid in withstanding severe pressure changes during 
locomotion, and with the coronary corium and the base of the lamellar corium being rich in 
arteriorvenous anastomoses (AVA), which provide a bypass of capillary beds. These blood 
shunts have been proposed as players in hoof tissue metabolism and also in thermoregulation 
(Molyneux et al., 1994). 
 
Two more hoof segments, the sole segment, and the frog and bulb segment seal the 
bottom and palmar/plantar aspect of the hoof (Budras et al., 2003). The sole segment also 
lacks a subcutis. It is composed of a dermal layer (solar corium) that attaches directly to the 
bottom of P3, and presents short papillae (sole papillae) that insert into a socket in the 
epidermal layer (Pollitt, 2004; Pollitt, 2010). The frog and bulb segment is merged with the 
perioplic segment in the palmar/plantar aspects. It presents an enlarged subcutis that conforms 
the digital cushion, and has a papillary dermal layer with their matching sockets in a horny 
but somewhat soft epidermal layer (Budras et al., 2003). 
 
Further anatomic detail of the other components of the hoof is beyond the scope of 
this review. The reader should refer to equine anatomy textbooks for a complete study of all 
other parts and segments of the horses hoof.  
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Figure 2.1: Diagrammatic representation of the internal structures of the equine hoof; (A) 
stratum lamellatum, and (B) suspensory apparatus of the distal phalanx (SADP). From Pollitt 
(2010). 
 
 
___________________________________________________________________________ 
 
 
2.1.2. Energy metabolism of tissues, including the skin and its appendages 
 
Tissue energy metabolism refers to the generation of adenosine tri-phosphate (ATP) 
through a sequence of enzymatic processes. In mammals, most of these ATP is synthesized 
out of glucose. However, the biochemical pathways can vary in different tissues and, more so, 
in different species. Overall, the metabolism of glucose to generate ATP has to do with 
transferring a phosphate (phosphorylating) from a high energy intermediate to adenosine 
diphosphate (ADP) (Decker, 1971). This process begins with glycolysis in the cellular 
cytosol, resulting in pyruvate production (see below). Depending on the availability of oxygen 
(O2), pyruvate is either anaerobically metabolized, also in the cytosol (anaerobic glycolysis), 
or transferred to the mitochondria, where it is aerobically oxidized, producing carbon dioxide 
(CO2) and one acetyl group that links to coenzyme A (CoA) resulting in the production of 
Acetyl-CoA. Acetyl-CoA is metabolized through aerobic cellular respiration in the 
tricarboxylic acid cycle (Krebs cycle or citric acid cycle) producing more CO2 and the transfer 
of electrons to intermediate electron acceptors that enter the electron transport chain (a 
sequence of electron transfers based on energy-releasing oxidation reactions that drive ADP 
oxidative phosphorylation, and thus, ATP production). 
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The skin and its appendages have been traditionally regarded as nothing more than a 
coating layer made of relatively inert tissues. However, it is now known that high levels of 
protein synthesis take place in these tissues (Davis et al., 1981; Preedy et al., 1983). Thus, the 
energy metabolism of the skin and its appendages is very active, as protein biosynthesis is a 
process with high energy requirements, where the formation of each peptide bond uses 3 
high-energy molecules (Alberts et al., 2008c). As such, the above-mentioned energy-
generating pathways are very active in the mutually dependant dermal and epidermal layers. 
Unfortunately, current understanding of the energy metabolism of these tissues is limited. 
Furthermore, the energy metabolism of the epidermal layer, which has been suggested to be 
predominantly anaerobic, still remains a subject of controversy (Ronquist et al., 2003). 
 
 
2.1.2.1. Glycolysis 
 
Meaning the lysis or breakdown of glycose (older name given to glucose), glycolysis 
is a sequence of 10 reactions, which correspond to the first stage of glucose metabolism for 
cellular energy production (Alberts et al., 2008a). In the process each molecule of glucose is 
degraded into two molecules of pyruvate. This results in the net production of two molecules 
of ATP, and two molecules of reduced nicotineamine adenine dinucleotide (NADH). 
Although there are variations leading to the existence of modified glycolytic pathways, the 
one path common to mammalian species and relevant when considering dermo-epidermal 
energy metabolism is the Embden-Meyerhof pathway (Figure 2.2). The 10 sequential 
reactions of this glycolytic pathway are: 
 
1. Glucose phosphorylation:  
Glucose + ATP  Glucose-6-phosphate (G-6-P) + ADP 
2. G-6-P isomerization: 
G-6-P  Fructose-6-phosphate (F-6-P) 
3. F-6-P phosphorylation: 
F-6-P + ATP  Fructose-1,6-biphosphate (FBP) + ADP 
4. FBP cleavage: 
FBP  Glyceraldehyde-3-phosphate (G-3-P) 
+ Dehydroxyacetone phosphate (DHAP) 
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5. DHAP isomerization: 
DHAP  G-3-P 
6. G-3-P oxidation (and phosphorylation) - x2: 
G-3-P + NAD
+
 + Pi  NADH + 1,3-biphosphoglycerate (BPG) + H
+
 
7. BPG transfer of phosphate group (ADP phosphorylation to ATP) - x2: 
BPG + ADP  3-phosphoglycerate (3-PG) + ATP  
8. 3-PG isomerization - x2: 
3-PG  2-phosphoglycerate (2-PG) 
9. 2-PG dehydration - x2: 
2-PG  phosphoenolpyruvate (PEP) + H2O  
10. PEP transfer of phosphate group (ADP phosphorylation to ATP) - x2: 
PEP + ADP  Pyruvate + ATP 
 
 The F-6-P phosphorylation step (reaction 3; transfer of a phosphate from ATP to 
fructose-6-phosphate) catalyzed by Phosphofructokinase (PFK), is the first irreversible 
glycolysis-specific step, and as such, is the reaction in which the sugar being degraded 
becomes committed to glycolysis (G-6-P and F-6-P can play roles in other pathways, while 
FBP cannot). In addition to catalyzing the reaction, PFK acts as a rate-limiting enzyme of the 
glycolytic pathway, and it plays a key role in its regulation (Callahan and Supinski, 2005; 
Campbell and Farrell, 2012). 
 
As mentioned previously, the pyruvate generated by glycolysis can then follow 
different additional energy generating paths: 1) anaerobic glycolysis, turning into lactate, or 2) 
aerobic oxidation, entering the citric acid cycle and eventually suffering oxidative 
phosphorylation. 
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Figure 2.2: The Embden-Meyerhof glycolytic pathway (free online source) 
 
 
 
___________________________________________________________________________ 
 
 
2.1.2.2. Tricarboxylic Acid Cycle 
 
The citric or tricarboxylic acid -TCA- cycle has been well described (Alberts et al., 
2008a). In the presence of O2, the pyruvate produced as a result of glycolysis (or from other 
sources such as fatty acid and amino acid breakdown) is sequentially oxidized. Once released, 
pyruvate is transported to the mitochondria, where it is processed by a five-enzyme system 
known as the pyruvate dehydrogenase complex. This first oxidation produces Acetyl-CoA 
and NADH, which can generate ATP via the electron transport chain (see below). 
 
Simplified pyruvate dehydrogenase complex: 
Pyruvate + CoA + NAD
+
  Acetyl-CoA + CO2 + H
+
 + NADH 
 
 Resultant acetyl-CoA (2 carbons) then enters the TCA-cycle through condensation 
with oxaloacetate (4 carbons) to produce citrate (6 carbons). A 3-reaction process of oxidative 
decarboxylation follows citrate formation; citrate is first isomerized to isocitrate, which is 
oxidized to α-Ketoglutarate (5 carbons), which is further oxidized with the aid of CoA to 
Succinyl-CoA (4 carbons). Each oxidation step generates NADH from NAD
+
, and one 
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molecule of CO2 is lost. Succinyl-CoA is then hydrolyzed to succinate and CoA, a reaction 
that is accompanied by the phosphorylation of guanosine diphosphate (GDP) to guanosine 
triphosphate (GTP). The GTP suffers a substrate level phosphorylation, where a phosphate is 
transferred to ADP to form GDP and ATP. Succinate is then oxidized to fumarate via a flavin 
adenine dinucleotide (FAD)-linked oxidation; rather than NAD
+
, the electron acceptor is 
FAD, which is reduced to FADH2. Same as NADH, FADH2 passes electrons on to the 
electron transport chain for ATP production. In the next reaction fumarate combines with 
water (hydration) to form L-Malate, which suffers a final oxidation step where another NAD
+
 
is reduced to NADH and oxaloacetate is regenerated. A specific enzyme catalyzes each of 
these reactions in the TCA-cycle (Figure 2.3). 
 
Figure 2.3. The tricarboxylic acid cycle (free online source)  
 
 
___________________________________________________________________________ 
 
Overall, during the TCA-cycle, starting from oxaloacetate and pyruvate (a 3-carbon 
compound), 3 carbons are lost as CO2 and eight reactions take place before regeneration of 
oxaloacetate. Energy is produced in the form of one ATP and of reduced electron equivalents 
(4 NADH and 1 FADH2) that enter the electron transport chain for further ATP production. A 
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total of 36 ATP molecules are generated from each glucose molecule that undergoes 
glycolysis followed by aerobic processing through the TCA-cycle and electron transfer in the 
electron transport chain. The latter is a series of reactions tightly coupled with oxidative 
phosphorylation of ADP, thus coupled to ATP production, in which NADH and FADH2 
produced during glycolysis and the TCA-cycle transfer electrons ultimately to oxygen, while 
protons (H
+
 ions) are pumped across the mitochondrial inner membrane. 
 
 
2.1.2.3. PyruvateLactate: lactate dehydrogenase (LDH) and anaerobic metabolism of 
pyruvate 
 
The process of anaerobic glycolysis has been well described (Alberts et al., 2008a). In 
the absence of O2, the two pyruvate molecules that are produced during glycolysis are 
processed anaerobically (anaerobic glycolysis) and converted to lactate by lactate 
dehydrogenase (LDH). This is an NADH-linked dehydrogenase that uses the NADH 
generated earlier in glycolysis during the oxidation of glyceraldehyde-3-phosphate (see 
glycolysis reaction 6: G-3-P oxidation to BPG). Regeneration of NAD
+
 from NADH occurs, 
and is essential for the continuity of glucose breakdown, and thus for the glycolytic pathway 
to continue generating pyruvate for further energy production in the cell. 
 
The overall anaerobic glycolysis reaction is: 
Pyruvate + NADH + H
+
  Lactate + NAD+ 
 
Production of lactate, primarily an energy-generating pathway utilized by muscle 
tissue, is the terminal process of glycolysis under anaerobic conditions (Figure 2.4). It can be 
considered a temporary mechanism for supplying ATP in the O2-deprived organ, shifting 
some of the metabolic load to the liver where lactate can be reconverted to pyruvate and 
glucose via gluconeogenesis (Alberts et al., 2008a). Interestingly, even in the presence of 
adequate O2 levels, anaerobic glycolysis is the main energy producing pathway of epidermal 
tissues (Ronquist et al., 2003). 
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Figure 2.4: Glycolytic pathway in the absence of O2 - anaerobic glycolysis 
 
___________________________________________________________________________ 
 
 
2.1.2.4. Pentose Phosphate Pathway 
 
An alternative to glycolysis, glucose metabolism through the pentose phosphate 
pathway is less concerned with ATP production and leads to the generation of 5-carbon 
sugars, one of which is ribose (Marks, 1956; Wolfe, 1958). Ribose and its derivate 
deoxyribose are important structural components of nucleic acids (Roth et al., 1986). In the 
pentose formation process nicotinamide adenine dinucleotide phosphate (NADPH) is 
produced, and this NADPH acts as a reducing agent in biosynthetic (anabolic) events 
(Beaconsfield et al., 1965). At the start of the pentose phosphate pathway a series of oxidation 
reactions take place. The first reaction is oxidation of G-6-P to 6-phosphogluconate yielding 
one NADPH. This is followed by oxidative decarboxylation of 6-phosphogluconate with 
production of a second molecule of NADPH, CO2, and ribulose-5-phosphate (Horecker and 
Mehler, 1955; Marks, 1956). The latter can follow a path into deoxyribose and hence nucleic 
acid production or via two different paths can be converted back into glycolytic intermediates 
Outline of the Glycolytic Pathway
Glucose
Glucose-6-Phosphate
Fructose-6-Phosphate
Fructose-1,6-Biphosphate
Glyceraldehyde-3-P DHAP
1,3-Biphosphoglycerate
Pyruvate
Lactate
PFK
NADHNAD+
NADH NAD+
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that ultimately result in the formation of G-3-P and eventually pyruvate for anaerobic 
glycolysis or TCA-cycle processing. The two NADPH molecules enter reductive anabolic 
pathways. Reactions of the pentose phosphate pathways occur according to immediate 
requirements. If NADPH is needed more than ribose-5-phosphate the complete pathway takes 
place. If there is a greater need for nucleic acids (ribose-5-phosphate) the oxidative portion of 
the pentose phosphate pathway can be bypassed. 
 
 
2.1.3. The extracellular matrix 
 
The extracellular matrix (ECM) is a network of organic matter found between the cells 
of living organisms (Dhugga, 2001). It corresponds to the non-cellular component of tissues 
present in body organs (Alberts et al., 2008b). In all tissues, the ECM can be divided into two 
domains: the basement membrane (BM) and the interstitial matrix (Bosman and Stamenkovic, 
2003). The basic structure of both of these domains is defined by collagen, which provides the 
scaffolding that keeps cells together in multicellular organisms, and creates a framework to 
give rise and maintain the shape of every organ (Alberts et al., 2008b). Beyond the provision 
and conservation of structure, the ECM is essential in the production of biochemical and 
biomechanical signals that regulate tissue homeostasis as well as morphogenesis and 
differentiation (Adams and Watt, 1993).  
 
Although ECMs vary in their specific composition in each tissue where they are 
present, all ECMs are essentially composed of water, proteins and polysaccharides (Frantz et 
al., 2010). The water content will differ greatly (e.g. eye vitreous ECM vs bone ECM) 
(Alberts et al., 2008b), as will do the proteins present. However, these proteins all share some 
characteristics including a large size, asymmetric shape and a high degree of glycosylation 
(Engel and Chiquet, 2011). If the macromolecular composition of the ECM is considered, its 
components are divided into two main classes of macromolecules: proteoglycans and fibrous 
proteins (Schaefer, 2010). Fibrous ECM proteins include glycoproteins (e.g. laminins, 
fibronectins, elastins) and collagens (Alberts et al., 2008b), with collagen being the main 
structural element of an ECM, and the most abundant (approximately 30% of the total protein 
mass of an animal) (Frantz et al., 2010). The glycoproteins and proteoglycans are adhesive 
components that adhere to the ECM collagen scaffold and to adjacent cells (Bosman and 
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Stamenkovic, 2003), providing a link between the two. The adhesive interaction with the cells 
occurs via specific receptors (i.e. integrins) (Bosman and Stamenkovic, 2003). 
 
This framework of complex molecular interactions that provides structural support to 
all cells, holding them together to give shape to body organs, has, in addition to many other 
characteristics, one more peculiarity: It is not a static network, meaning that the ECM is 
constantly being remodelled through a complex process of controlled breakdown. This 
constant remodelling confers the ECM the capability of allowing cell migration (Colognato 
and Yurchenco, 2000). Laminins are a family of cross-shaped glycoproteins that have a large 
size and many different isoforms (Aumailley et al., 2005). They are one of the main 
components of the BM, and have direct effects on adjacent cells. They play an important role 
in cell adhesion, migration and differentiation (Colognato and Yurchenco, 2000), and they 
also play a role as mediators of an interaction between the cells and their BM (Aumailley and 
Smyth, 1998). Of the various laminin isoforms, laminin-332 (laminin-5), which is present in 
the lamellar BM (Borradori and Sonnenberg, 1999; Jones et al., 1998), is involved in cell 
adhesion and migration, a function that relies on proteolytic processing of the laminin itself 
by the action of matrix metalloproteinases (MMPs) (Bosman and Stamenkovic, 2003). 
 
2.1.3.1. The basement membrane 
  
The basement membrane (BM) is a thin layer of ECM present in various tissues (e.g. 
endotheliums and muscles). Its composition is similar overall, but tissue specific variations 
exist (Ekblom et al., 1998). The BM serves as scaffolding for tissue structural support, it 
behaves as a barrier and offers selective permeability, and it regulates many other cellular 
functions and characteristics, including conformation, signaling and repair after the tissue is 
damaged (Timpl, 1996; Timpl and Brown, 1996). In epitheliums, the BM is in intimate 
contact with the basal cell layer and separates it from the underlying connective tissue. The 
equine hoof is an appendix of the skin, and as such, it is nothing more than highly specialized 
epithelium. Thus, a BM is present, which separates the epidermal from the dermal lamellae 
(Pollitt, 1994), while following the complex interdigitation of these two layers. 
 
 As stated above, despite tissue specific characteristics, all BMs share structural 
similarities including the presence of the same major components such as laminins, collagens 
and proteoglycans (Iozzo, 2005; LeBleu et al., 2007; Timpl, 1996). The many isoforms of 
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laminin are the result of different structural arrangements of the various subunits of the 
protein. Not surprisingly, laminins are also characterized by a variety of roles, including 
provision of structural support, and migration and adhesion functions (Colognato and 
Yurchenco, 2000).  
 
 
2.1.3.2. Hemidesmosomes 
 
Hemidesmosomes (HDs) are specialized structures, which function as points of cell-
substrate contact (Borradori and Sonnenberg, 1999; Green and Jones, 1996). In the hoof, HDs 
attach the basal epithelial keratinocyte layer of the SEL to its underlying BM, via the 
generation of a strong structural framework. These HDs are adhesive integrin-containing 
transmembrane cell junction protein molecules connecting the lamina densa of the BM to the 
cellular cytoskeleton (Tsuruta et al., 2003). As such, HDs possess a cytoplasmic region 
attached to the keratinocyte cytoskeleton, and an extracellular region anchoring the 
keratinocyte to its surroundings (Green and Jones, 1996). This connection is the key element 
of epithelial cell adhesion (Borradori and Sonnenberg, 1996, 1999), where HDs have a major 
role in keratinocyte attachment to the BM (Edlund et al., 2001). In the equine hoof, type I or 
classic HDs are present (French and Pollitt, 2004a, b). These type I HDs are composed of 
three classes of proteins: 1) cytoplasmic plaque proteins that link intermediate filaments to the 
plasma membrane [plectin (HD1) and Bullous Penphigoid Antigen I (BP230 or BPAG1)]; 2) 
transmembrane proteins that link the cell to the ECM [α6ß4 integrin and type XVII collagen 
(BP180 or BPAG2)]; and 3) BM associated proteins (Laminin-332 and collagens) (Borradori 
and Sonnenberg, 1999; Jones et al., 1998). Transmembrane proteins firmly adhere to the 
underlying BM through anchoring filaments of laminin-332 (Borradori and Sonnenberg, 
1999; Green and Jones, 1996; Pollitt, 1994, 2010). It is ultimately the laminin filaments of 
HDs that provide the stable dermo-epidermal junction attachment (Nishiyama et al., 2000). 
Thus, HDs are the  primary structures responsible for attachment of epithelial cells to their 
BM in various tissues, (Baker et al., 1996; Riddelle et al., 1991), including the epidermal 
layer of the equine hoof lamella (French and Pollitt, 2004a, b), where they are the key 
attachment point of the SADP. 
 
The interactions between HD components are complex, and a detailed description of 
all the mechanisms of HD attachment is beyond the scope of this review. Of relevance is the 
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recent suggestion of an energy requirement for HD formation and maintenance (Ozawa et al., 
2010). That study showed that HD-enriched protein complexes (HPCs), the in-vitro 
equivalents of HDs in cultured keratinocytes, have a complex interaction with keratinocyte 
Focal Contacts (FCs) that is dependent on myosin (Ozawa et al., 2010). Thus, the HD – FC 
interactions might require energy to be maintained. Keratinocyte FCs are assembly structures 
with components (integrins) that have an adhesion role (Nguyen et al., 2000a; Nguyen et al., 
2000b), which tether actin filaments to the cell surface (Yamada and Geiger, 1997), and 
which, thanks to a high degree of motility (Zlatanov et al., 2005), work as “dynamic” 
attachment devices (Ozawa et al., 2010); a dynamicity that relies on actinomyosin-dependent 
systems (Tsuruta et al., 2002). The major integrins that make up these FCs in epidermal 
keratinocytes are α3ß1 and α2ß1, whose ligands are laminin-332 and collagen I, respectively 
(Fleischmajer et al., 1998). Thus, the FC integrin, α3ß1, shares the same ligand (laminin-332) 
with the HD integrin, α6ß4, further emphasizing the complexity of interactions between HDs 
components (Ozawa et al., 2010). This α6ß4 integrin extracellular domain in HDs is the 
structure ultimately responsible for the stable epidermal layer anchorage to the underlying 
matrix through its bond to laminin-332 (Jones et al., 1998; Niessen et al., 1994). In turn, 
laminin-332 is the primary component of the HD anchoring filaments: it spans the lamina 
lucida of the BM and connects to its lamina densa (Rousselle et al., 1997), via binding to type 
VII collagen (Nakashima et al., 2005), the major component of BM anchoring fibrils (Chen et 
al., 1999; Rousselle et al., 1997). 
 
 
2.1.3.3. Cell adhesion energy 
 
The cell-substrate interaction occurs through families of receptor molecules. One of 
these families, the integrins, mediates cell adhesion to the ECM (Couchman and Woods, 
1999). As mentioned in the previous section, the anchor of the epidermal HDs to the 
underlying matrix is provided by its integrin domain, which binds laminin-332 (Jones et al., 
1998; Niessen et al., 1994), and a requirement of energy to maintain these HDs has been 
suggested (Ozawa et al., 2010). An earlier study had shown that energy depletion induced a 
disruption of HD protein clusters in vitro, indicating that maintenance of functional HDs 
requires energy (Tsuruta et al., 2003). Thus, the mechanics of cell adhesion must include 
provision of adequate energy for cells to remain attached to their surroundings (adhesion 
energy) (Maitre and Heisenberg, 2011), which has been estimated by measurements of de-
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adhesion forces (Palecek et al., 1997). However, despite the rapidly growing knowledge about 
the components of the cell adhesion machinery, the way in which this machinery functions to 
determine adhesion energy remains unclear (Maitre and Heisenberg, 2011). Overall, the 
energy required to maintain HD and other cellular adhesive interactions with the surrounding 
cells or ECM remains to be determined. It has been suggested that its study would be best 
performed via a deduction of the adhesion energy from the geometry of the cell contacts and 
tensions. Once determined, the adhesion energy will allow further characterization of de-
adhesion forces and adhesion molecule distribution. It should also allow for further 
characterization of the mechanisms of cell adhesion failure in disease states (Maitre and 
Heisenberg, 2011), including laminitis, where detachment of lamellar epidermal basal cells 
from their BM is a key feature (Pollitt, 1996b; Pollitt and Daradka, 1998). 
 
At present, it can only be emphasized that a lack of knowledge exists about the 
energy required for maintenance of HDs and cell adhesion to the ECM. It is also unclear 
whether maintenance of HDs and cell adhesion is a priority when cells are placed in a 
negative energy balance, or whether this function is sacrificed somewhat in favour of other 
cellular processes. 
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2.2. Laminitis – the clinical disease 
  
Clinically, laminitis in the horse can be divided into three distinct and sequential 
phases: developmental, acute and chronic. The developmental phase is characterized by the 
presence of an inciting insult (e.g. sepsis) causing damage to lamellar tissue, prior to any 
clinical manifestations of foot pain (Obel, 1948). Its duration is variable, being as short as 8 
hours in some cases of black walnut induced laminitis (Galey et al., 1990), and lasting 48 
hours or more in cases of carbohydrate overload (Garner et al., 1975). The appearance of 
clinical signs of foot pain marks the end of the developmental phase and the initiation of the 
acute phase. The acute phase has been further characterized clinically (i.e. the Obel grading 
system (Obel, 1948)) and microscopically (the histological grading system (Pollitt, 1996b; 
van Eps et al., 2014)). Clinically, the severity of foot pain, which is evidenced by varying 
degrees of a characteristic lameness, is the basis of the Obel grading system (Obel, 1948) (see 
below). The transition to the chronic phase occurs when extensive damage to the hoof 
lamellae, which results in failure of the SADP, leads to an altered position (displacement) of 
P3 within the hoof (Hood, 1999). In other words: a modification of the anatomical relation 
between P3 and the hoof capsule as determined by radiographic evaluation. The hallmark of 
these positional changes is rotation and/or sinking (distal displacement) of P3, with clinical 
manifestations including hoof wall deformity, and persistent foot pain and lameness (Hunt, 
1993). In the absence of positional changes, the transition from acute to chronic has been said 
to occur at 72 hours after the onset of clinical signs (Hood, 1999). 
 
 
2.2.1. The Obel grading system 
 
A four point grading system based on the clinical manifestations, hence the severity 
of foot pain was described in 1948 by Nils Obel (Obel, 1948): 
 
Obel Grade I: Weight shifting between the forelimbs, while still ambulating freely. 
 
Obel Grade II: More obvious lameness characterized by a shuffling, stilted gait, which is 
worse while turning. A foot can be easily lifted off the ground. 
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Obel Grade III: Severe foot pain makes the horse reluctant to move or lift one foot off the 
ground. 
 
Obel Grade IV: The horse refuses to walk and may be recumbent. 
 
 
2.2.2. Clinical signs 
 
Frequent weight shifting is regarded as the first manifestation of foot pain (Obel 
grade I) and as one of the earliest clinically detectable signs of laminitis, second only to the 
increase in digital pulses during the developmental phase. Hitherto, the identification of this 
early sign of laminitis has been subjective, introducing bias to the recognition of weight 
shifting as a result of observer interpretation, personal opinion and clinical experience (i.e. 
subtle weight shifting can be overlooked, or normal limb load cycling activity can be over-
interpreted). The use of digital pedometers placed on the forelimbs of research subjects has 
been suggested as a method to eliminate this bias (van Eps et al., 2012; van Eps et al., 2014). 
A significant increase in pedometer counts was apparent 2 to 4 h before weight shifting was 
identified visually; a finding that suggest that recording pedometer count frequencies on the 
forelimbs of laminitis-prone horses might be an alternative, objective method for the early 
detection of foot pain, before weight shifting is apparent even to the experienced clinician. 
However, the value of recording pedometer count frequencies as a diagnostic aid in high risk 
equine patients remains to be determined. If validated, it would allow earlier and more 
targeted initiation of prophylactic interventions such as digital cryotherapy (Van Eps and 
Pollitt, 2004), which has been shown to decrease lamellar damage if instituted prior to 
experimental laminitis induction (Van Eps and Pollitt, 2004) as well as after the onset of 
lameness (van Eps et al., 2014), and has been shown to ameliorate its devastating effects in 
clinical cases (Kullmann et al., 2013). 
 
 
2.2.3. The histological grading system 
 
A three point grading system (Grades 1 – 3) based on microscopic changes present in 
the lamellar tissues was described in 1996 (Pollitt, 1996b). This system was recently modified 
to include a fourth category (Grade 4) (van Eps et al., 2014): 
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Grade 1: blurred BM, which is often not attached to the epidermal basal cell at the tip of the 
SEL; the latter are elongated and pointy; the tips of SDL remain close to the keratinized axis 
of PEL (Figure 2.5 panel A). 
 
Grade 2: stretched and wavy SEL with tapered tips, some of them with a single basal cell 
round (instead of oval) nucleus; the BM is completely separated from the keratinized axis of 
the PEL; most SEL are depleted of connective tissue, more so at the tips (Figure 2.5 panel B). 
 
Grade 3: the tips of the SEL are completely devoid of epidermal cells and made only of 
collapsed tubes of BM; neutrophils infiltrate the surrounding dermis and some are even 
present in the epidermal compartment (Figure 2.5 panel C). 
 
Grade 4: complete physical separation of lamellar epidermis from dermis, with no association 
between epidermal and dermal tissues on the histological section (Figure 2.5 panel D). 
 
Figure 2.5: Laminitis histologic grading system; (A) grade 1, (B) grade 2, (C) grade 3 and (D) 
grade 4 laminitis. From Pollitt (1996b) panels A, B and C, and van Eps et al. (2014) panel D 
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2.3. Laminitis Aetiology 
 
Equine laminitis can be divided into three major forms based on aetiology (van Eps, 
2011): 1) laminitis as a result of diseases characterized by the Systemic Inflammatory 
Response Syndrome (SIRS), and in particular bacterial sepsis (Belknap et al., 2009; van Eps, 
2011); 2) laminitis associated with endocrine disorders (i.e. equine metabolic syndrome -
EMS-, and pituitary pars intermedia dysfunction -PPID-) (Johnson et al., 2010; McGowan, 
2010; Treiber et al., 2006a), and 3) laminitis that occurs as a result of excessive or continuous 
weight bearing (supporting limb laminitis -SLL-) or direct trauma (van Eps et al., 2010a). 
Laminitis in horses exposed to lush pastures appears to share a strong association with the 
endocrine-associated form of the disease, but may also share some pathophysiological traits 
with the sepsis-associated form (Geor, 2009). 
 
 
2.3.1. Sepsis-associated laminitis 
 
Diseases characterized by sepsis can lead to the occurrence of laminitis in the horse 
(van Eps, 2011). A correlation between this form of laminitis and multiple organ dysfunction 
syndrome (MODS) as it occurs in humans, secondary to SIRS during sepsis, has been 
suggested (Belknap et al., 2009). Why SIRS-induced damage to the hoof lamellae appears to 
be more severe than damage to other organs in the septic horse remains to be determined. A 
suggested contributor to the predilection for lamellar destruction and failure prior to failure of 
other organ(s) in the septic horse is the exposure of lamellae to mechanical forces imposed by 
weight bearing (van Eps, 2011). 
 
Clinical cases of carbohydrate (CHO) overload, such as occur due to purposeful or 
accidental overfeeding of certain dietary supplements or after engorgement when a horse 
gains access to feedstuffs, have a similar pathogenesis to that of sepsis-associated laminitis 
(van Eps, 2011). The CHOs present in dietary supplements (mainly starch) are readily 
fermentable substrate for certain bacteria (i.e. Streptococcus spp) present in the horse‟s colon 
(Milinovich et al., 2008; Milinovich et al., 2007). The starch content of the grain, the amount 
of CHO that reaches the colon undigested and the fermentation rate of these undigested 
CHOs, directly correlate with the likelihood of laminitis. Important determinants of the 
amount of undigested starch reaching the colon are the type of grain and the way it is initially 
23 
 
processed by the stomach and small intestine (Pollitt and Visser, 2010). Large amounts of 
CHO, in excess of the small intestinal digestive capacity, arrive into the colon and serve as a 
readily available substrate that promotes rapid proliferation of Gram-positive organisms 
including Streptococcus bovis and Lactobacillus spp (Garner et al., 1978). Fermentation of 
such substrates results in volatile fatty acid and lactic acid production, which cause a sudden 
acidification of the colonic content (Garner et al., 1977). This is followed by the death and 
lysis of the normal colonic flora, mainly composed by Gram-negative organisms, thus 
releasing endotoxin in the form of lypopolysaccharide (LPS) from the bacterial cell wall 
(Garner et al., 1975; Garner et al., 1977; Garner et al., 1978) into the colonic lumen (Moore et 
al., 1979). The altered populations of colonic bacteria lead to further modifications to the 
normal colonic environment, including further changes in pH (as low as 4) (Pollitt and Visser, 
2010), hyperosmolarity, hypersecretion and mucosal damage. The released bacterial 
components are readily absorbed through a highly permeable, disrupted mucosa. This leads to 
the presence of bacterial products in the bloodstream (including LPS) (Bailey et al., 2009; 
Milinovich et al., 2008), as was first demonstrated by Sprouse and co-workers (1987). 
 
As a result of the studies of Garner, Moore and Sprouse in the seventies and eighties, 
a causative role of endotoxin in the development of laminitis was suggested (Sprouse et al., 
1987). However, evaluation of this hypothesis through the administration of endotoxin to 
horses failed to induce laminitis (Clark and Moore, 1989). Thereafter, synergy of endotoxin 
with other effectors has been proposed (Menzies-Gow et al., 2004); an idea that is supported 
by the demonstration of changes in the expression of inflammatory (Rodgerson et al., 2001) 
and vasoactive mediators (Moore et al., 2004) during endotoxaemia in the horse. 
 
Because endotoxaemia is a major contributor to SIRS during sepsis (Hazinski, 1994), 
both CHO overload and other septic states in the horse share a common pathophysiologic path 
to the induction of laminitis. This is of the utmost importance for the study of equine laminitis 
using experimental models of CHO overload such as the oligofructose induction model (see 
section 2.5.1) (van Eps and Pollitt, 2006), because these experimental models result in SIRS, 
mirroring the events that take place during naturally occurring septic states in horses (e.g. 
metritis, colitis, pleuropneumonia, etc). Once sepsis occurs as a result of bacterial 
proliferation during CHO overload or infection, a complex interaction of inflammatory 
events, enzymatic deregulation, abnormalities in vascular function, and disruption of cellular 
energy metabolism takes place (van Eps, 2011) during the development of laminitis. 
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Exposure to Black Walnut (Juglans nigra) has resulted in naturally-occurring clinical 
cases of laminitis (Eaton et al., 1995). The presence of a toxin in Black Walnut has been 
suggested; however, no endotoxin has been identified (Eaton et al., 1995) and the exact cause 
of laminitis after exposure to this plant remains to be determined. Regardless of the cause, a 
severe inflammatory response and severe mucosal damage have been observed in the colon of 
exposed horses (McConnico et al., 2005). Furthermore, after Black Walnut Extract (BWE) 
administration, neutrophil infiltration and cytokine expression in the lamellar tissue (and other 
organs) have been consistently observed (Belknap et al., 2007a; Black et al., 2006b; Fontaine 
et al., 2001; Loftus et al., 2006; Loftus et al., 2007b). These findings suggest that the 
pathophysiology of this form of laminitis is also associated with a severe systemic and local 
inflammatory response (Belknap, 2010). However, naturally occurring laminitis after 
exposure to Black Walnut is rare and geographically limited to where this tree grows. Its 
relevance relates to the ongoing use of the BWE model in laminitis research (see section 
2.5.2). However, this model appears to have a unique pathophysiology (van Eps, 2011) and 
therefore, in the author‟s opinion, conclusions drawn from studies in which the BWE model is 
used should not be extrapolated to other causes of laminitis. In other words, knowledge built 
using the BWE experimental model should be considered relevant for the understanding of 
naturally occurring laminitis after exposure to Juglans nigra, but should be interpreted with 
caution when dealing with other forms of laminitis. 
 
 
2.3.2. Endocrinopathic and Pasture-associated laminitis 
 
Laminitis associated with endocrine dysfunction has been divided into two broad 
groups: 1) associated with glucocorticoids, and 2) associated with insulin resistance 
(McGowan, 2010). In both cases, laminitis happens as a result of hormonal abnormalities 
(Johnson et al., 2004a; Johnson et al., 2004b) with an apparent lack of inflammatory 
mediation (de Laat et al., 2010a). However, in the author‟s opinion, this separation is a mere 
technicality, since in both groups insulin resistance (and hyperinsulinaemia) appears to be the 
key event leading to laminitis.  
 
The equine metabolic syndrome (EMS) is characterized by obesity, insulin resistance 
and a predisposition to laminitis (Geor and Frank, 2009; Johnson et al., 2004a; Johnson, 2002; 
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Johnson et al., 2004b). After the name was coined, various studies have demonstrated a link 
between EMS-related laminitis and sustained hyperinsulinemia (Carter et al., 2009; Treiber et 
al., 2006b; Walsh et al., 2009), which ultimately reflects a state of insulin resistance. The 
EMS syndrome is linked to the most common form of naturally occurring laminitis: the 
pasture-associated form (Hinckley and Henderson, 1996; USDA, 2000), where affected 
horses develop the disease after consumption of lush, improved pastures rich in non-structural 
CHOs in the form of fructans (Longland and Byrd, 2006; Longland and Cairns, 2000). 
Moreover, horses affected by EMS have been suggested to be especially prone to the 
development of hoof pain if allowed to graze pastures during certain times of the year 
(Longland, 2007; Longland and Byrd, 2006). 
 
The fructans, which are indigestible in the small intestine (Hoffman et al., 2001), can 
accumulate and reach extremely high levels in certain grasses under specific climatic 
conditions (Cairns and Longland, 1998). The exact link between consumption of pasture rich 
in fructans and laminitis is still unclear, and it was long believed that pure CHO overload (and 
the resultant SIRS state) was responsible (Bailey, 2004). This hypothesis was further 
supported by the use of a commercial fructan (oligofructose) to induce laminitis; an induction 
model that is also characterized by acute sepsis (see section 2.5.1) (van Eps and Pollitt, 2006). 
But an inconsistency became apparent through the observation of a higher susceptibility to 
pasture-associated laminitis in a subset of horses, and this susceptibility has since been linked 
to insulin resistance (Geor and Frank, 2009; Treiber et al., 2006b) and obesity (Geor and 
Frank, 2009; Johnson, 2002), and thus to EMS. 
 
Glucocorticoid-associated laminitis can be iatrogenic or related to pituitary pars 
intermedia dysfunction (PPID). The former is the result of exogenous administration of 
corticosteroids, and the latter can be attributed to the effects of hyperadrenocortisism 
(McGowan, 2010). In both cases, laminitis can be linked to the ability of corticosteroids to 
induce insulin resistance (Johnson et al., 2004b), emphasizing the existence of a common path 
to the development of endocrinopathic-associated laminitis, regardless of the inciting primary 
disease. 
 
Overall, hyperinsulinaemia, which characterizes states of insulin resistance (Johnson 
et al., 2004b), may be the single event necessary for the development of laminitis in insulin 
resistant horses as evidenced by the studies of Asplin and coworkers (2007), and DeLaat and 
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Pollitt (2010a). In these studies the authors report the induction of laminitis in healthy ponies 
and healthy adult Standardbred horses, respectively, with the administration of a constant rate 
infusion of insulin to maintain hyperinsulinaemia for a prolonged period of time, whilst also 
sustaining euglycaemia through glucose administration (prolong Euglycaemic-
Hyperinsulinaemic Clamp – pEHC) (Asplin et al., 2007; de Laat et al., 2010a). The exact 
mechanisms by which hyperinsulinaemia leads to laminitis are still unclear. Asplin and 
coworkers (2011) demonstrated a complete insensitivity to insulin in the lamellar tissue; thus, 
glucose uptake in the lamellae must be considered insulin independent. An association 
between vascular dysfunction and/or an altered blood supply and the development of laminitis 
as a result of hyperinsulinaemia has been suggested (de Laat et al., 2010b). Based on the 
nitric-oxide-mediated vasodilator effect exerted by insulin on endothelial cells (Muniyappa et 
al., 2007), a potential increased delivery of laminitogenic substances to the hoof is 
hypothesized (de Laat et al., 2010b). This hypothesis appears somewhat flawed, in that a 
source of so called laminitogenic substances, as is seen in sepsis, does not appear to be 
present during naturally occurring and experimental hyperinsulinaemic states. A direct effect 
of excess insulin on lamellar physiology seems like a plausible alternative that remains to be 
determined and warrants further investigation. 
 
 
2.3.3. Weight bearing and Trauma-induced laminitis 
 
Chronic exposure to increased weight load in one digit (whilst pathology of the 
contralateral limb is present) leads to a form of laminitis known as supporting limb laminitis 
(SLL) (Parsons et al., 2007; Redden, 2003a). This form of laminitis is now recognized as a 
devastating, success-limiting complication during treatment of diseases that are otherwise 
manageable with the advent of new technologies in equine practice (e.g. fractures, septic 
arthritis, lymphangitis) (Parsons et al., 2007; Peloso et al., 1996; Richardson, 2008). The 
supporting limb is loaded with twice the normal amount of weight and, most importantly, in 
an uninterrupted fashion. Pathology of the lamellae has been demonstrated after as little as 
only 2 to 3 days of constant weight bearing in some cases (Cohen et al., 1994). The 
combination of excess weight and constant loading is thought to compromise blood flow 
through the hoof, eventually leading to the development of laminitis (van Eps et al., 2010a). 
However, the interruption or decrease in blood flow through an overloaded, uninterruptedly 
weight-bearing limb in vivo has hitherto not been determined.  
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Direct, repetitive trauma to the hoof such as occurs during excessive work on a hard 
surface or as a result of poor farriery (i.e. over-trimming) can also lead to laminitis (Eustace 
and Cripps, 1998). In these cases, lamellar damage is likely to be exclusively the result of 
mechanical tissue damage. 
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2.4. Pathophysiology of Laminitis 
 
As a multifactorial disease that results from diverse insults, the pathophysiological 
mechanisms that lead to laminitis are also diverse. Conventionally presented as “the theories 
of laminitis pathophysiology”, it is the author‟s opinion that these should not be referred to as 
separate and independent theories and instead should be referred to as a group of diverse 
events that in partial or total summation will result in a clinical presentation of laminitis (only 
some are required, and some or all can be present, for laminitis to develop). 
 
The diverse pathophysiological mechanisms that lead to laminitis are associated 
with: a) vascular events, b) enzymatic events, c) inflammatory events, and d) maybe, lamellar 
energy failure (with or without ischemia). One or more of these mechanisms may contribute 
to laminitis in a given case. 
 
 
2.4.1. Evidence for the occurrence of vascular events 
 
The earliest phenomenon studied in laminitis pathophysiology was that of vascular 
disturbances. It has also been a matter of great controversy, which is slowly being clarified in 
recent years. In the process, a variety of methodologies have been used to assess distal limb 
rheology during the different stages of laminitis. The study of rheology during the 
developmental stages of the disease was motivated by the detection of increased pulse 
strength over the palmar digital arteries, and higher hoof temperatures in clinical cases. 
Angiographic (Ackerman et al., 1975; Coffman et al., 1970), scintigraphic (Galey et al., 
1990), and arteriographic (Weiss et al., 1994, 1995a; Weiss et al., 1995b) studies suggested a 
decrease in blood flow to the stratum lamellatum of the hoof during laminitis development. A 
role for hypoperfusion and ischaemia was further supported by the detection of bypassing of 
capillary blood flow by radiolabeled particles, which appeared in the venous circulation after 
intra-arterial injection, without being detected in the capillary beds. The suggested bypassing 
route was through dilated AVA, which divert blood flow from the lamellae (Hood et al., 
1978). Contradictorily, a previous study, although with various confounders (i.e. anaesthesia, 
surgical intervention and vessel canulation), showed decreased vascular resistance and 
increased blood flow through the distal limb (Robinson et al., 1976). The contradictory results 
continued to appear in various other, more recent studies. Another scintigraphy-based study 
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showed increase blood flow to the hoof lamellae during the developmental phase of laminitis, 
but failed to demonstrate if the increase corresponded to capillary blood flow or to AVA flow 
bypassing the capillaries (Trout et al., 1990). Regardless, the authors considered their findings 
non-supportive of hypoperfusion and ischemia being implicated in laminitis development. 
Later work by Pollitt and Davies (Pollitt and Davies, 1998) demonstrated a significant 
increase in hoof wall temperature during the developmental phase of CHO overload induced 
laminitis. The increased temperature was assumed to correlate with increased blood flow 
through the hoof. Furthermore, low temperatures, which were interpreted as vasoconstriction, 
were suggested to have a protective effect (Pollitt and Davies, 1998). 
 
This was shortly followed by another CHO overload induced laminitis, hoof wall 
temperature-based study, in which a reduction in blood flow during the developmental phase, 
with a subsequent blood flow increase in the acute phase (after onset of lameness) were 
demonstrated (Hood et al., 2001). Laser Doppler flowmetry based work during BWE induced 
laminitis showed similar blood flow patterns of hypoperfusion/ischaemia during the 
developmental phase, followed by increased blood flow after lameness onset (Adair et al., 
2000). These two studies led to the suggestion of laminitis being a form of ischaemia-
reperfusion injury secondary to the generation of reactive oxygen species (ROS). 
Interestingly, the lamellae of the hoof lack superoxide dismutase (SOD) (Loftus et al., 2007a), 
an enzyme with anti-oxidant functions performed via neutralization of ROS. Thus, the 
lamellar tissue is allegedly susceptible to severe damage as a result of ROS production in the 
developmental phase of laminitis (Black et al., 2006b). However, the expected increase in 
xanthine oxidase that normally accompanies ischaemia-reperfusion injury and which is 
characteristic of, and essential for ROS production, was not present in the lamellae during the 
developmental phase of BWE-induced laminitis (Loftus et al., 2007a). It thus appears like 
reperfusion is not an important player in laminitis pathogenesis, or that at least the classic 
ROS production it induces is not a major contributor. 
 
Nuclear scintigraphy, was again used a decade after the report by Trout and 
coworkers (Trout et al., 1990). Investigation of blood flow changes in response to controlled 
exposure to heat and cold in normal horses was reported (Worster et al., 2000); hoof wall 
temperature was also assessed in that study with the use of a thermistor probe placed within 
the dorsal lamellae following insertion proximal to the coronary band. In response to bathing 
in ice water at 4ºC, a decrease to 80.5% of the resting soft tissue perfusion of the digit was 
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reported. Conversely, a 25.1% increase in perfusion was recorded in response to bathing in 
hot water at 47ºC (Worster et al., 2000). Later, Doppler sonograms of the palmar digital artery 
in clinical cases of laminitis with Obel-grades 3 and 4 were suggestive of increases in blood 
flow (Wongaumnuaykul et al., 2006). Unfortunately the authors do not specify if the horses 
were in the acute or chronic phase of the disease; however, the timeline of their repeated 
sonograms suggests that, except for the first examination they report, which was conducted at 
presentation, all other measurements at 3, 6 and 9 days after admission to the clinic, probably 
can be safely assumed to correspond to assessment of the chronic phase of laminitis. When 
compared to Doppler sonograms of healthy horses, arterial diameter, blood flow velocity, and 
blood volume were all significantly increased in the laminitic group (Wongaumnuaykul et al., 
2006). Although supportive of an increase in blow flow to the digit, the study assessed 
nothing more than circulatory changes proximal to the hoof, and if blood reached or bypassed 
the lamellar circulation was not determined. A first step towards determination of circulatory 
changes within the lamellae was performed using dynamic contrast-enhanced computed 
tomography (DCE-CT) on clinically healthy, non-lame horses (Kruger et al., 2008). This 
study demonstrated that, although cumbersome, DCE-CT can be used to assess lamellar blood 
flow and vascular permeability in the horse. Its application in laminitic horses or laminitis 
induction studies has not been reported. 
 
Another procedure used in laminitis studies, which has proven very useful in offering 
a new understanding of the vascular alterations that take place in the stratum lamellatum of 
the hoof, is retrograde venous angiography (venography) (Baldwin and Pollitt, 2010). The 
technique was first suggested as an aid in the diagnosis of laminitis (Redden, 1993). A 
method for retrograde angiographic assessment of the standing horse was subsequently 
described (Redden, 2001a) and eventually standardized (Rucker et al., 2006). Angiography 
has since been combined with experimental laminitis induction to evaluate changes in digital 
circulation leading to visualization of the rheologic alterations that occur during the acute and 
chronic phases of the disease (Baldwin and Pollitt, 2008; Baldwin and Pollitt, 2010). 
However, retrograde venous angiographic events during the developmental phase of laminitis 
remain to be determined. 
 
In addition to the experimental assessment of lamellar rheology, various studies have 
investigated the presence of biochemical mediators of vasoconstriction. The presence of 
endothelin-1, a potent vasoconstrictor, has been demonstrated in the digital circulation during 
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the developmental phase of CHO-induced laminitis (Eades et al., 2007), in the lamellae of 
horses in the acute and chronic phases of the disease (Katwa et al., 1999), and in the plasma 
of endotoxaemic horses with gastrointestinal disease (Ramaswamy et al., 2002). Thrombi in 
the microvasculature (Weiss et al., 1994) and aggregates of platelets, and platelets and 
neutrophils in blood samples have also been identified (Eades et al., 2007; Weiss et al., 1997). 
In association with LPS mediated platelet activation, the release of other potent digital 
vasoconstriction mediators such as serotonin, and thromboxane B2 (TxB2), has been 
documented (Bailey et al., 2000; Menzies-Gow et al., 2004). Furthermore, increased levels of 
isoprostanes, very potent vasoactive substances (Morrow and Roberts, 1997) produced 
through arachidonic acid ROS-catalyzed peroxidation (Morrow et al., 1990), has been 
documented in a BWE-induced laminitis study. Isoprostanes, in particular iso-prostaglandin 
PGF2α (iso-PGF2α) concentrations in the lamellar tissue of BWE treated horses at the time of 
euthanasia (Obel grade 1 laminitis), were significantly higher compared to iso-PGF2α in 
control, sham treated horses (Noschka et al., 2009). The study also evaluated the responses of 
isolated lamellar blood vessels to three commercially available vasocontriction receptor 
agonists. It found a significantly greater contractile response in the venous side of the lamellar 
circulation (Noschka et al., 2009), supporting the hypothesized predisposition of the equine 
digit to venoconstriction (Peroni et al., 2006). 
 
Also relevant is a disruption of the caecal flora known to occur in association with 
the onset of laminitis (Garner et al., 1978), and the identification of caecal production of 
monoamines that are structurally related to serotonin and mimic its actions (Elliott et al., 
2003). As a result, it has been hypothesized that vasoactive amines originating in the 
gastrointestinal tract may be at least partially responsible for the initiation of vascular events 
(i.e. vasoconstriction) in certain forms of laminitis (Elliott and Bailey, 2006). Of these amines, 
tryptamine is the most potent and has been shown to cause vasoconstriction in vitro (Elliott et 
al., 2003) and in vivo (Bailey et al., 2004); it causes vasoconstriction via direct activation of 
serotonin receptors, and has a high selectivity for digital veins, as well as a low threshold for 
causing digital venoconstriction (Elliott et al., 2003). Thus, tryptamine or other monoamines 
found in the equine caecum could be responsible for the induction of digital haemodynamic 
disturbances that lead to lamellar failure in cases of laminitis that develop in association with 
intestinal disturbances. 
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Overall, various research studies have strongly supported the occurrence of 
ischaemia due to vasoconstriction as well as vaso-occlusion in equine laminitis. Although 
certainty of the exact rheologic and vascular events involved in the pathogenesis of laminitis 
and their timeline has not been yet established, the bounding digital pulses and increased 
temperature of the hoof widely recognized as one of the early clinical signs of the disease, 
together with all the above mentioned studies which provide evidence of the release of 
various vasoconstrictors, and the formation of platelet aggregates and thrombi within the hoof 
vascular beds are undeniable. All these findings present themselves as strong evidence in 
support of the involvement of vascular derangements in the pathophysiology of equine 
laminitis. 
 
 
2.4.2. Evidence for the occurrence of enzymatic events 
 
2.4.2.1. Basement membrane breakdown 
 
Loss of the attachment of the epidermal basal cells to their BM, and BM degradation 
were demonstrated as the tissue disruption that characterizes equine laminitis (Pollitt, 1996a). 
The histological investigation of hoof lamellar sections obtained from horses with 
experimentally induced laminitis using a CHO overload induction model demonstrated that 
degradation of the BM was characterized by loss of BM laminin and collagens (Pollitt, 1996a; 
Pollitt and Daradka, 1998). The observed changes provided the basis for the histological 
grading system of laminitis (Pollitt, 1996a). These changes included evidence of separation of 
an intact BM that remained within the dermal tissue, a finding that was considered suggestive 
of an epidermal location or origin of the cause of BM detachment (Pollitt and Daradka, 1998). 
It was hypothesised that the pathogenesis of BM desadhesion and thus of laminitis, was 
associated with increased proteolytic activity within the lamellar tissue as a result of excessive 
metalloproteinase production or arrival in the circulation, with a concomitant reduction in the 
levels of tissue inhibitor of metalloproteinase (TIMP) (Pollitt, 1996a; Pollitt and Daradka, 
1998). A study of lamellar tissues obtained from 6 laminitic and 8 non-laminitic horses 
(Johnson et al., 1998), together with an ex-vivo study using explants of healthy and laminitic 
hoof tissues (Pollitt et al., 1998), both supported this hypothesis. Using gelatin zymography, 
the first of these studies identified a significantly higher activity of matrix metalloproteinase 
(MMP)-2 and MMP-9 in the homogenates of tissues obtained from laminitic horses, 
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compared to homogenates of tissues obtained from non-laminitic horses (Johnson et al., 
1998). Also with the aid of gelatin zymography, the second study confirmed the presence of 
inactive proenzyme forms (zymogens) of MMP-2 and MMP-9, as well as small amounts of 
active MMP-2 in the supernatant of tissue explants obtained from healthy horses. The 
zymograms of the supernatants from laminitic tissue explants demonstrated a dramatic 
increase in the levels of MMP-2 and MMP-9 proenzymes, as well as an increase in the active 
forms of both metalloproteinases (Pollitt et al., 1998). Simultaneous work combining 
immuhistochemisty (IHC), in-situ zymography and gelatinase inhibition, corroborated the 
presence of MMP-9 in healthy lamellar tissues, and demonstrated the presence of this enzyme 
to be confined to the SEL of the hoof (Mungall et al., 1998). 
 
The MMPs are a large family of proteolytic enzymes, the matrixins, with 25 
members (1 to 28; those initially classified as MMP-4, -5, and -6 turned out to be either 
MMP-2 or -3), 24 of which are found in mammals (MMP-18 has only been identified in frogs 
of the Genus Xenopus). Matrixins or matrix metalloproteinases, belong to the metzincin 
(zinc-bearing proteins) superfamily of metalloproteases (Ra and Parks, 2007). Another 
member of the metzincin superfamily is the adamalysin family, which includes the subfamily 
of ADAMTSs [A Disintegrins And Metalloproteinases (ADAMs) with Thrombospondin 
motifs type I (TSP-1)] (Killar et al., 1999). Matrixins were initially thought to be only 
involved in the turnover and degradation of ECM, hence the name MMP. However, many of 
these enzymes, as well as other metalloproteases including ADAMs, have now been shown to 
act on non-ECM proteins, including cytokines, chemokines and antimicrobial peptides (Parks 
et al., 2004). Thus, it is now known that metalloproteases are the main enzymes controlling 
the extracellular environment (Stamenkovic, 2003) and are involved in cell–cell and cell–
matrix signalling (Page-McCaw et al., 2007). 
 
Although the predominant function of the MMP family is no longer considered to be 
ECM degradation, some members are indeed involved in these processes under physiologic 
conditions. One of the four membrane-type MMPs (MT-MMPs), MT1-MMP or MMP-14, is 
a demonstrated physiologic collagenase (Holmbeck et al., 2004). This enzyme, as well as the 
gelatinase MMP-2, other MT-MMPs, and MMP-19 and -28 are all expressed in normal 
tissues, supporting their involvement in tissue homeostasis (Ra and Parks, 2007). The more 
recently identified ADAMTS subfamily, which consists of 19 members (1 to 20; there is no 
ADAMTS-11), is a group of secreted proteins with catalytic activities against various 
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substrates (Stanton et al., 2011). It includes several ECM-modifying enzymes, which, together 
with MMPs, are involved in physiologic processes of embryonic development and 
organogenesis, angiogenesis, maturation of proproteins, and tissue remodeling (i.e. bone) and 
repair (i.e. wound healing). Furthermore, both MMPs and ADAMTSs have also been 
identified as important players in diseases characterized by tissue destruction, as is the case 
for ADAMTS-4 and -5 in arthritis (Lin and Liu, 2010), as well as MMP-2 and -9 in tumor 
malignancy (Hua et al., 2011). 
 
As previously stated, the gelatinases, MMP-2 and -9 were the earliest MMPs to be 
incriminated as potential causes of laminitis ECM degradation and lamellar BM separation 
(Johnson et al., 1998; Pollitt et al., 1998). Involvement of MMP-2 was supported by 
demonstration of an enhanced transcription of this gelatinase in lamellar tissues of horses 
during the developmental phase of CHO overload induced laminitis (Kyaw-Tanner and 
Pollitt, 2004). Support for involvement of MMP-9, although of extra-lamellar origin, came 
from the observed positive correlation between the MMP-9 levels and neutrophil recruitment 
in the lamellae of BWE induced laminitis at the onset of Obel grade 1 lameness (Loftus et al., 
2006). Neutrophils are known to contain two matrix degrading enzymes, one of which is 
MMP-9 (Mollinedo et al., 1991a; Mollinedo et al., 1986; Mollinedo et al., 1991b) and, using 
in situ zymography, these polymorphonuclear cells have been shown to exhibit gelatinase 
activity (Mungall and Pollitt, 1999). Furthermore, a considerable influx of neutrophils into the 
lamellar tissue of laminitic horses has been recognized (Black et al., 2006b; Pollitt, 1996a). 
The combined data is in support of the idea that MMP-9 as has been identified in laminitic 
equine tissues is at least partially, and possible completely, of neutrophil granular origin. 
Another protease, neutrophil elastase, was recently showed to suffer a statistically significant 
elevation in plasma, hoof lamellae and skin of horses treated with BWE. The enzyme is 
proposed to act by both, activation of MMP-9, as well as direct digestion of laminin-332 
(laminin-5) in the lamellar BM (de la Rebiere de Pouyade et al., 2010). 
 
Recently, the presence of MT1-MMP (MMP-14) in the cytoplasm of lamellar basal 
cells in healthy horses has been confirmed with immunohistochemistry. In the same study, a 
statistically significant elevation in the transcription of MT1-MMP during the developmental 
phase of CHO overload induced laminitis was demonstrated (Kyaw-Tanner et al., 2008). 
Aggrecanase-1 (ADAMTS-4) was also recently shown to suffer enhanced gene expression 
during the developmental and acute phases of BWE and CHO-overload induced laminitis, 
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respectively. Similarly, horses afflicted by different forms (acute, chronic and chronic 
aggravated
1
) of naturally occurring clinical laminitis, also demonstrated elevations in the 
expression of the ADAMTS-4 gene (Coyne et al., 2009). These findings were corroborated by 
the identification of a 6.6-fold up-regulation in the expression of the ADAMTS-4 gene in 
horses with CHO (oligofructose -OF-) overload induced laminitis when compared to a control 
group (Budak et al., 2009). The substrate for ADAMTS-4 is aggrecan (Kashiwagi et al., 
2004), a cartilage proteoglycan that protects collagen from proteolytic cleavage (Pratta et al., 
2003). The authors of the Coyne study suggest ADAMTS-4 to be likely necessary for the 
development of laminitis. They go on to propose ADAMTS-4 as a laminitis primer, which 
would cleave aggrecan or another proteoglycan to allow access of MMPs to the structural 
components of the lamellar BM. However, the need to establish whether aggrecan is or is not 
present in equine hoof lamellae is also acknowledged (Coyne et al., 2009). 
 
2.4.2.2. Hemisdesmosome breakdown 
 
Hemidesmosomes (HDs) are the  primary structures responsible for the attachment of 
the lamellar epidermal basal cells (EBC) to their BM. Rounding of EBC nuclei, elongation of 
the tips of the SEL, and loss of attachment of EBC to their BM occurs as the BM disintegrates 
(Pollitt, 1996a; Pollitt and Daradka, 1998). At ultrastructural, subcellular level, HDs are 
disassembled and lost in a manner that correlates with the severity of laminitis, at least in 
experimental subjects (French and Pollitt, 2004b; Nourian et al., 2007). The separation of 
EBC from their BM is associated with this HD disassembly, and the rounding of EBC nuclei 
is the result of collapse of the cellular cytoskeleton. The transmembrane proteins that firmly 
adhere to the underlying BM do so through anchoring filaments of laminin-332 (Borradori 
and Sonnenberg, 1999; Green and Jones, 1996; Pollitt, 1994, 2010). It is ultimately these 
laminin filaments of HDs that provide the stable dermo-epidermal junction attachment 
(Nishiyama et al., 2000). During HD disassembly, the anchoring filaments that link the EBC 
to the lamina densa of the BM are lost (French and Pollitt, 2004b). Thus, the cause of HD 
disassembly appears to be the cleavage of its BM associated protein components (laminin-332 
and collagens) (Borradori and Sonnenberg, 1999; Jones et al., 1998) by MMPs, as has been 
suggested by French and Pollitt (2004a). 
 
                                                     
1
 Chronic aggravated cases as defined by the authors are horses that had a history of laminitis 
and were experiencing a debilitating episode. 
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It is a well-established fact that metalloproteases are capable of degrading the 
components of the BM (Holmbeck et al., 2004). Also well accepted is the unequivocal 
identification of BM desadhesion with loss of its collagen and laminin as the primary lesion 
of laminitis (Pollitt, 1996a; Pollitt and Daradka, 1998). Together with the scientific evidence 
of increased activity of MMP-2, -9, and -14, ADAMTS-4 and now neutrophil elastase, as well 
as the disruption to hemidesmosomal laminin anchoring filaments, these findings provide 
strong evidence for the occurrence of a variety of enzymatic events in the developmental, the 
acute and even the chronic phases of equine laminitis. 
 
 
2.4.3. Evidence for the occurrence of inflammatory events 
 
Despite the ending “-itis" (a suffix that originates from Greek and that, although 
meaning only pertaining to, is well accepted and understood as inflammation of), 
inflammation was long regarded as unimportant in the development of laminitis. A minor role 
for inflammation was first proposed base on the observation that lamellar tissues from 
laminitic horses in the early stages of disease were characterized by a lack of histopathologic 
evidence of leukocyte infiltration (Hunt, 1991). Furthermore, the inflammatory activity that 
was observed later in the disease course was attributed to secondary changes in response to 
metabolic or vascular laminitis triggering events (Hood, 1999). However, more recent work 
demonstrated a marked increase in interleukin (IL) -1β mRNA expression by perivascular 
cells in small lamellar venules and capillaries during the early stages of BWE induced 
laminitis. This enhanced genetic expression of IL-1β coincided with a severe neutropenia 
(Fontaine et al., 2001), which is characteristic of the early stages of the BWE induction model 
(Galey et al., 1991). Furthermore, the increased levels of IL-1β were suggestive of a primary 
role for inflammatory cytokines in laminitis, as potential inducers of the vascular and 
metabolic changes (Waguespack et al., 2004b), which were previously regarded as primary 
events (Hood, 1999; Pollitt, 1999). 
 
The suggested primary role for cytokines in laminitis resulted in a renewed interest in 
the investigation of the pathogenetic mechanisms of inflammation in association with this 
hoof pathology. One of the first studies investigating the role of inflammatory changes in 
experimentally induced laminitis reported the identification of the equine gene encoding for 
„Molecule possessing Ankyrin-repeats Induced by LPS‟ (MAIL) (Waguespack et al., 2004b), 
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a nuclear regulator of the expression of inflammatory cytokines, namely in LPS-induced 
inflammatory signalling and in the up-regulation of IL-6 (Kitamura et al., 2000). Using 
lamellar tissues from BWE-treated and control horses the differential expression of MAIL, 
IL-1β and IL-6 between the two groups was assessed. Results showed a near 3-fold, a 30-fold 
and a 160-fold increase in lamellar mRNA expression of MAIL, IL-1β and IL-6, respectively, 
2.5 to 3 hours (at the time of neutropenia) after BWE administration when compared to a 
sham treatment (Waguespack et al., 2004b). The findings not only agreed with the previously 
identified increase in IL-1β in the developmental phase of laminitis (Fontaine et al., 2001), 
but provided further support to the idea of inflammatory activation and involvement in 
laminitis pathogenesis. The three mediators with which the study was concerned exert early 
roles in the inflammatory cascade, including activation and regulation of the inflammatory 
responses (Tizard, 2012). In another study, this same group of researchers identified an 
approximate 11-fold increase in the mRNA expression levels of cyclooxygenase-2 (COX-2) 
in BWE treated horses compared to controls. Up-regulation of COX-2, an expected event 
during inflammatory processes, was considered to either precede or coincide with the time 
points at which the vascular and metabolic lamellar disturbances associated with laminitis 
have been reported. The study further suggests that the up-regulation of COX-2, with the 
subsequent downstream production of prostanoids are central components in the 
pathophysiology of laminitis, namely through the vasoactive effects of such COX-2 induced 
prostanoids (Waguespack et al., 2004a). Because a lack of correlation between COX mRNA 
and COX-2 protein concentrations has been reported (Wilson et al., 2004), a study evaluating 
both COX-2 mRNA levels as well as COX-2 protein levels in archived lamellar tissue 
samples obtained from BWE treated horses was subsequently conducted. A marked increase 
in the concentration of this enzyme during the developmental phase of laminitis, which 
paralleled the previously reported increase in mRNA expression (Waguespack et al., 2004a), 
was confirmed. Furthermore, at the onset of lameness, only a slight elevation in COX-2 
protein levels was detected by immunoblotting, whereas a statistically significant elevation in 
COX-2 mRNA expression was still present (Blikslager et al., 2006). 
 
After demonstration of the dramatic increase in cytokine expression, in particular the 
elevation of IL-1β (Fontaine et al., 2001; Waguespack et al., 2004b), a very important 
cytokine released by activated leukocytes (Newton, 1990), white blood cell diapedesis 
through the lamellar microvasculature during the early stages of BWE-induced laminitis was 
investigated. Leukocytes were not observed perivascularly in the lamellae of control horses, 
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indicating an absence of a marginal pool of white blood cells in the lamellar circulation; in the 
BWE treated horses, leukocyte emigration, although highly variable, was confirmed at two 
different time points (i.e. at the onset of leukopenia and at the onset of acute clinical signs of 
laminitis). Furthermore, the majority of these perivascularly located leukocytes were 
identified as neutrophils, indicating that activation of the innate immune response (i.e. 
neutrophil diapedesis) is a potential important player in the initiation of lamellar events such 
as increased cytokine, COX-2 and MMP expression, which result in lamellar failure in equine 
laminitis (Black et al., 2006a). 
 
Once evidence to support the idea of considerable inflammatory mediation in equine 
laminitis was produced by the above mentioned, BWE model-based studies, the lamellar 
mRNA expression of a larger number of cytokines (i.e. IL-1β, -2, -4, -6, -8, -10, -12, -18, 
TNF-α, and IFN-γ) was evaluated during the developmental and acute (at the onset of 
lameness) phases of BWE-induced laminitis, and during the acute (at the onset of lameness) 
phase of OF-induced laminitis. The targeted cytokines aimed to establish if, and which 
components of the innate and the adaptive immune responses could be involved in laminitis 
pathogenesis (Belknap et al., 2007a). Selected, statistically significant changes in cytokine 
concentrations identified in that study are presented in table 1. Interestingly, while a marked 
increase in the expression of IL-1β has been consistently identified in the lamellar tissues of 
BWE treated horses during the developmental and acute phases of laminitis, a statistically 
significant change in IL-1β was not detected in OF treated horses. Furthermore, there 
appeared to be a trend towards a reduction in IL-1β expression in the OF treated horses when 
compared to controls. The suggested explanation for this finding is a reduction in IL-1β levels 
to or below baseline values in the OF group at the time of lameness onset (delayed 20 hours 
when compared to the BWE model), giving enough time for levels to drop after a peak during 
the developmental phase, which was not assessed. Although the occurrence of an IL-1β peak 
early in the developmental phase of OF-induced laminitis is a reasonable expectation, as is 
suggested by the significantly higher levels of the potent neutrophil chemokine CXCL-8 
(formerly IL-8) (Baggiolini et al., 1989) in this group of horses, as well as in the BWE treated 
horses at developmental and acute time-points (Belknap et al., 2007a), IL-1β activity in OF-
induced laminitis remains to be determined. Other interesting shifts in cytokine levels 
identified in the study, which require further investigation are the decrease in the anti-
inflammatory cytokine IL-10 in the developmental phase of BWE-induced laminitis, the 
increase in IL-4 (a Th2 cytokine) and IL-12 (a Th1 cytokine) at the onset of lameness in the 
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BWE treated horses, and the increase in IL-2 and IFN-γ (both Th1 cytokines) in the acute 
phase of OF-induced laminitis. Overall, the reported findings are suggestive of a combined 
innate (IL-1β, IL-6 and CXCL-8) and adaptive (IL-4 and IL-12) immune response during 
BWE-induced laminitis, and of an adaptive (IL-2 and INF-γ, Th1 mediated) immune response 
during OF-induced laminitis (Belknap et al., 2007a). 
 
A similar study was performed to assess the lamellar inflammatory gene expression, 
adhesion molecule gene expression, leukocyte emigration, as well as MMP regulation at an 
earlier time point during BWE-induced laminitis development (i.e. 1.5 hours post-BWE 
administration). The study confirmed previously reported elevations in mRNA expression of 
IL-1β, IL-6, CXCL-8 and COX-2, and it identified a decrease in MMP-2 mRNA at the earlier 
time point after BWE administration. It also identified a transient, but statistically significant 
increase in the adhesion molecules E-selectin and intercellular adhesion molecule (ICAM)-1 
mRNA concentrations at the early time point (1.5 h), as well as at the more commonly 
evaluated developmental time point of BWE-induced laminitis (3 – 4 h). Adhesion molecule 
levels were either unchanged (E-selectin) or not significantly changed (ICAM-1) at the time 
of lameness onset (9 – 12 h). These findings suggest that activation of the lamellar 
endothelium occurs very early in the disease process, and could contribute to leukocyte 
activation, adhesion and diapedesis. Furthermore, the authors propose that MMP synthesis 
and accumulation are downstream events, secondary to the early endothelial activation, pro-
inflammatory cytokine release and neutrophil influx (Loftus et al., 2007b). A separate study 
reported the detection of systemic markers of leukocyte activation as early as one hour after 
BWE dosing; it showed a statistically significant increase in ROS production capacity in 
leukocytes from BWE treated horses that developed laminitis (responders), when compared to 
controls and to BWE treated horses that did not develop laminitis (non-responders). 
Moreover, leukocyte ROS production capacity was significantly higher in the baseline sample 
(before BWE administration) in the responders, when compared to non-responders (Hurley et 
al., 2006). Putting together the results of both of these studies, it seems likely that early 
leukocyte emigration is the result of a combined endothelial and leukocyte activation early in 
the course of BWE-induced laminitis. The finding of an increase in ROS production capacity 
in leukocytes recovered from responders to BWE treatment support the idea of systemic 
inflammatory activation early in laminitis pathogenesis. Furthermore, confirmation of a 
higher ROS production capacity in the baseline sample of the responders versus non-
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responders is strongly suggestive of a predisposition to laminitis in horses with a higher basal 
level of inflammatory activity (Hurley et al., 2006). 
 
With the application of microarray technology, lamellar gene expression has been 
assessed during the developmental phase of OF-induced (Budak et al., 2009), and BWE-
induced (Noschka et al., 2009) laminitis. Both of these studies demonstrated, among other 
changes, the up-regulation of various pro-inflammatory and chemotactic genes. Recently, 
similar to what has been observed in the BWE model, although at a different time point in the 
course of laminitis, statistically significant elevations in the concentration of IL-1β, IL-6, 
COX-2, E-selectin and ICAM-1 were detected in the lamellae of CHO-overload treated 
horses at the time of lameness onset (Leise et al., 2011; Leise et al., 2010). The authors of that 
study indicate that although evidently different in its temporal patterns of cytokine expression 
when compared to the BWE model, CHO overload is also characterized by the presence of 
lamellar inflammation as evidenced by the robust pro-inflammatory cytokine response they 
identified (Leise et al., 2011). Furthermore, although studies assessing lamellar cytokine 
expression in hyperinsulinaemic induced laminitis are lacking, a recent study reported on 
circulating concentrations of TNF-α, IL-6 and serum amyloid A (SAA), as well as on gene 
expression of IL-1β, IL-6 and TNF-α in adipose tissue, skeletal muscle and leukocytes of 
horses with acute hyperinsulinaemia of 6 hours duration (Suagee et al., 2011). The study 
identified a statistically significant increase in circulating levels of TNF-α and IL-6 in insulin 
treated horse when compared to controls, with no difference in SAA concentrations between 
groups. Statistically significant changes included a decrease in TNF-α mRNA in adipose 
tissue, and an increase in IL-6 mRNA in leukocytes. In skeletal muscle, TNF-α and IL-1β 
mRNA increased slightly, but not significantly, and IL-6 had a tendency to decrease. Together 
with the findings of two other studies which showed an association between an increased 
expression of inflammatory cytokine (TNF-α, IL-1 and IL-6) with obesity and insulin 
resistance in mares (Vick et al., 2007), and an apparent priming of circulating neutrophils in 
obese horses (Holbrook et al., 2012), it seems reasonable to suggest that inflammatory 
changes are also likely involved in the pathophysiology of endocrinopathic and insulin 
induced laminitis. Furthermore, extravasation of neutrophils and localization around the tips 
of primary epidermal lamellae has been reported to occur in insulin treated (de Laat et al., 
2011) and glucose treated (de Laat et al., 2012) horses but not in controls. 
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Inflammation was initially regarded as a potential initiating factor and not only as a 
secondary event in the pathogenesis of laminitis about a decade ago (Fontaine et al., 2001; 
Waguespack et al., 2004b). Since then, laminitis research has intensified and numerous 
studies have accumulated. The currently available work of many researchers now provides 
robust evidence for the occurrence of various inflammatory events in the developmental phase 
of equine laminitis during BWE, CHO overload and hyperinsulinaemia -induced laminitis, as 
well as in a limited number of naturally occurring disease. 
 
 
2.4.4. Evidence for the occurrence of lamellar energy failure 
 
Upon improvement of therapeutic interventions which resulted in survival of human 
patients that would otherwise have succumbed to cardiopulmonary collapse, the syndrome of 
multiple system organ failure (MSOF), now known as multiple organ dysfunction syndrome 
(MODS), was identified in the 1970s (Baue, 1975; Fry et al., 1980; Mizock, 1984). However, 
the pathophysiology of this sepsis induced phenomenon remained unclear, despite the 
suggested impairment of cellular oxidative substrate utilization independent of O2 delivery 
found throughout the literature (Astiz et al., 1988; Hotchkiss and Karl, 1992; Mizock, 1984; 
Siegel et al., 1979; Taylor and Piantadosi, 1995). 
 
More recently, an alteration in cellular O2 utilization as a result of sepsis has been 
demonstrated (Crouser et al., 1997). The existence of an alteration in cellular aerobic 
metabolism in the phase of disease, a condition termed “cytopathic hypoxia”, was 
simultaneously suggested (Fink, 1997). The term denotes an impaired cellular ATP 
production in the presence of normal O2 levels within the cells. It is defined as: “sepsis-
induced alterations in cellular energy metabolism caused by acquired intrinsic derangements 
in cellular respiration” (Fink, 1997), a concept that has rapidly become accepted in the last 
decade (Loiacono and Shapiro, 2010).  Cytopathic hypoxia has also been the focus of various 
research studies from which mitochondrial dysfunction has been established as the 
intracellular culprit of this cellular energetic catastrophe (Brealey et al., 2002; Crouser et al., 
1999; Fink, 2001, 2002; Loiacono and Shapiro, 2010). As a result, organ dysfunction in septic 
human patients is now linked to a relationship between tissue dysoxia and inflammation 
(Loiacono and Shapiro, 2010). 
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Although the concept of cytopathic hypoxia (i.e. failure to utilize oxygen for ATP 
production in cells during sepsis) was only introduced 15 years ago (Crouser et al., 1997; 
Fink, 1997), the idea of a defect or defects in cellular energy-producing metabolic pathways 
came about long before (Siegel et al., 1979), following the initial observation of abnormal O2 
consumption in septic shock (Duff et al., 1969). The end result is cellular energetic failure 
(bioenergetic failure), a reduction in the availability of high-energy phosphates, as a 
consequence of a cellular inability to effectively use existing metabolic substrate due to 
defective cellular energy metabolism (Hotchkiss and Karl, 1992). Thus, cytopathic hypoxia is 
a form of bioenergetic failure. 
 
An association between pathologies of the horse characterized by the potential for 
absorption of bacterial toxins and an increased risk for laminitis development has long been 
suspected (Baxter, 1992; Cripps and Eustace, 1999; Hood, 1999; Moore and Allen, 1996). As 
a consequence of the renewed interest in the association between inflammation and equine 
laminitis, as well as the identification of various local and systemic pro-inflammatories during 
laminitis development, it has been recently pointed out that the changes that take place within 
the lamellae represent a local manifestation of systemic inflammation (Belknap et al., 2009). 
 
Because leukocyte emigration is considered an important trigger factor for organ 
failure in human sepsis (Cohen, 2002; Strassheim et al., 2002), based on the observation of 
significant leukocyte emigration during the early stages of laminitis, lamellar failure in the 
horse was proposed to result from similar pathophysiologic mechanisms as those described 
for MODS in humans (Black et al., 2006b). Furthermore, an analogy between clinical signs 
manifested by horses suffering from diseases characterized by bacterial toxaemia and thus at a 
high risk for developing laminitis, and the clinical signs defining SIRS in humans has also 
been suggested (Belknap et al., 2007a). Why SIRS-induced damage to the hoof lamellae 
appears to be more severe than damage to other organs in the septic horse remains to be 
determined. A suggested contributor to the predilection for lamellar destruction and failure 
prior to failure of other organ(s) in the septic horse is the exposure to mechanical forces 
imposed by weight bearing (van Eps, 2011). Regardless of the reason, the suggestion of 
shared pathophysiologic mechanisms between equine lamellar failure and human organ 
failure in sepsis (Belknap et al., 2009; Black et al., 2006b) has led to considering the SADP as 
an additional shock “organ” in horses. Thus, inflammation can be considered a major player 
in MODS as well as SADP failure (Annane et al., 2005; Belknap et al., 2007a; Cohen, 2002; 
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de la Rebiere de Pouyade and Serteyn, 2011; Leise et al., 2011). As a result, in the case of 
laminitis, the term “metastatic” inflammatory process has been coined (Belknap et al., 2009). 
 
Mitochondrial dysfunction is accepted as the cause of cytopathic hypoxia (Brealey et 
al., 2002; Crouser et al., 1999; Fink, 2001, 2002; Loiacono and Shapiro, 2010), which is in 
turn accepted to explain the mechanisms by which sepsis leads to MODS in humans (Crouser, 
2004; Struck et al., 2005). In the horse, MODS-like events appear to be responsible for SADP 
failure, at least in the sepsis-associated form of laminitis (Belknap et al., 2009; van Eps, 
2011). Thus, it seems reasonable to consider mitochondrial dysfunction leading to cytopathic 
hypoxia, a form of bioenergetic failure, as a plausible explanation for the pathogenesis of 
laminitis in horses afflicted by septic states. 
 
However, very little is known about the energy metabolism of the SADP. To the 
authors‟ best knowledge, the energy requirements of equine hoof lamellae have only been 
reported in one study. A requirement for large amounts of energy in the form of glucose was 
shown, particularly when compared to other tissues (Wattle and Pollitt, 2004). Since glycogen 
storage is not possible in the hoof, glucose consumption is suggested to reflect the rate of 
glycolysis and energy utilization (van Eps et al., 2010a). It is failure of this poorly studied 
lamellar energy metabolism that is suggested as an important contributor in the pathogenesis 
of SIRS/sepsis-related laminitis (Belknap et al., 2009). Moreover, the potential for the 
involvement of lamellar energy failure in trauma-associated laminitis (i.e. supporting limb 
laminitis -SLL-) has also been suggested. The proposed mechanisms include the presence of 
low-grade systemic inflammation, which will weaken the lamellae of the unaffected limb in 
the case of SLL, and the fact that trauma alone, in the absence of sepsis, can result in SIRS in 
human patients (van Eps et al., 2010a). Similarly, since insulin is concerned with regulation of 
glycaemia, a disruption of the lamellar energy metabolism secondary to endocrinopathy 
instead of SIRS, inflammation and/or trauma could potentially be involved in the 
pathophysiology of this other distinct form of laminitis in the horse (i.e. endocrinophatic 
laminitis).   
 
Furthermore, phosphofructokinase (PFK) is the enzyme that catalyzes the first 
irreversible glycolysis-specific step. It also acts as a rate-limiting enzyme of the glycolytic 
pathway, and it plays a key role in its regulation (Callahan and Supinski, 2005; Campbell and 
Farrell, 2012). It thus seems reasonable to consider that down-regulation of PFK resulting in 
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glycolysis impairment and a generalized failure of energy pathways within the hoof could be 
a potential inciter of cytopathic hypoxia in a tissue that is assumed to rely on anaerobic 
glycolysis for energy production, as does the epidermis of human skin (Ronquist et al., 2003). 
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2.5. Models of Laminitis 
 
As was described in chapters 4 and 5, equine laminitis has been characterized into 
various clinical presentations, with their correspondingly diverse inciting causes. This 
diversity of events that lead to laminitis makes its study challenging and complex. 
Researchers have developed experimental models in an attempt to re-create naturally-
occurring forms of the disease. Three models for experimental laminitis induction are 
currently available to researchers: 1) the CHO overload model which includes the starch 
(Garner et al., 1975) and OF models (van Eps and Pollitt, 2006), 2) the BWE model (Minnick 
et al., 1987), and 3) the hyperinsulinaemic model (Asplin et al., 2007; de Laat et al., 2010a). 
 
 
2.5.1. Carbohydrate overload 
 
Until recently, the CHO overload laminitis induction model using corn starch gruel 
(Garner et al., 1975) had become the most common used for laminitis experimentation (Eades 
et al., 2006; Garner et al., 1975; Harkema et al., 1978; Hood et al., 2001; Moore et al., 1981; 
Pollitt and Davies, 1998; Prasse et al., 1990; Sprouse et al., 1987). In 2006 van Eps and Pollitt 
introduced a new model for experimental induction of laminitis in horses (van Eps and Pollitt, 
2006). The OF model, which in the author‟s opinion, is the best way to study the forms of 
naturally occurring laminitis associated with sepsis and SIRS (i.e. grain overload and severe 
infections such as metritis, colitis, pleuropneumonia, etc.), was initially sought as a way to 
reproduce and study pasture associated laminitis as it occurs after consumption of lush 
pastures rich in nonstructural carbohydrates such as fructan (van Eps 2012, personal 
communication). Oligofructose is a commercially available fructan (van Eps and Pollitt, 
2006). For laminitis induction, OF is administered to the horse at a single dose of 10 g/Kg via 
nasogastric tube.  The horses are precondition with a standard diet (hay/chaff and a small 
amount of concentrate), which is fed for four weeks immediately prior to the induction. 
During the last 3 days of preconditioning, 10% of the OF bolus dose is administered each day 
by nasogastric tube (Van Eps and Pollitt, 2009). 
 
An advantage of the OF model compared to the starch gruel is the consistency in the 
timeline of events that follow the inductions, with only slight variation between horses. 
Laminitis induced by OF is first observed between 18 and 24 hours after administration (van 
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Eps 2011, personal communication), compared to 20 to 44 hours with starch gruel (Morgan et 
al., 2003).  In addition, a greater than 90% response, and usually 100% if preconditioning is 
adequate, can be expected with OF (van Eps 2012, personal communication). A percentage 
that largely surpasses the approximate 70% response obtained with starch gruel (Belknap 
2012, personal communication) and the 80% response with the BWE (Belknap, 2010; 
Minnick et al., 1987). Furthermore, the histopathologic lamellar changes observed after OF 
dosing are identical to those seen after starch gruel administration (van Eps and Pollitt, 2006). 
 
After dosing, the corn starch or OF overwhelm the digestive capacity of the small 
intestine. The arrival of these highly fermentable substrates into the colon results in a series of 
events that ultimately lead to endotoxemia (Sprouse et al., 1987) and SIRS (Belknap et al., 
2009; van Eps, 2011) (see chapter 4: CHO overload). Supporting the link between SIRS and 
CHO overload, and thus sepsis associated laminitis, is the identification of clinical signs of 
systemic inflammation (Kalck et al., 2009; van Eps and Pollitt, 2006), the presence of 
endotoxin in the blood (Bailey et al., 2009), and the expression of inflammatory cytokines in 
the lamellae (Leise et al., 2011) of OF and corn starch-treated horses. 
 
 
2.5.2. Black Walnut Extract (Juglans nigra) model 
 
Juglans nigra, commonly known as Black Walnut, is a North American tree that 
grows in the United States, Canada and, after its introduction to the old continent, in certain 
parts of Europe where it is cultivated. An extract obtained from its wood has been used for 
over two decades for the experimental induction of laminitis in horses (Eaton et al., 1995; 
Galey et al., 1991; Loftus et al., 2007b; Minnick et al., 1987; Peroni et al., 2005; Stewart et 
al., 2009; Thomsen et al., 2000). 
 
Despite an approximate non-response rate of 20% (Belknap, 2010), the BWE model 
has been regarded as a very reliable and efficient induction model for laminitis 
experimentation, with a fast onset of clinical signs (Eaton et al., 1995), and a “high level of 
responsiveness in treated horses” (Minnick et al., 1987). However, induction with BWE is 
cumbersome; it uses only the heartwood of the Juglans nigra tree, which must be harvested in 
the autumn and prepared in the form of shavings (Belknap, 2010). A dose of shavings at a rate 
of 2 g/Kg of body weight is then calculated for each horse, and the shavings are soaked in 7 or 
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8 litres of water for 12 hours. This is then filtered and administered to the horse via a 
nasogastric tube (Minnick et al., 1987). The onset of clinical signs of laminitis, which 
typically occurs at 8 hours post BWE administration (Galey et al., 1990), is preceded by a 
severe generalized systemic inflammatory response (Black et al., 2006b; Galey et al., 1991). 
The white blood cell count values in these horses are characterized by a severe neutropenic 
leukopenia (Galey et al., 1991), which is apparent as early as 4 hours after BWE dosing 
(Eaton et al., 1995). The mechanisms by which BWE induces laminitis are unclear; endotoxin 
in the form of lipopolysaccharide (LPS) originated from Gram-negative bacteria has been 
suggested as a possible cause based on the clinical signs, which are characteristic of 
endotoxaemia in the horse (Bailey, 2004). However, demonstration of the presence of LPS in 
the plasma of affected horses has been unsuccessful (Eaton et al., 1995). Oxidative stress as a 
result of production of reactive oxygen species has also been suggested as a potential trigger 
of laminitis in the BWE model (Yin et al., 2009). 
 
Recently, the use of the BWE model and the demonstration of the severe inflammatory 
changes associated with it, provided the grounds for correlating the events that result in 
lamellar damage and SADP failure secondary to SIRS in septic horses, with the events that 
result in MODS in septic human patients (Belknap et al., 2009). Interestingly, in the BWE 
model, the inflammatory response identified in the hoof lamellae is more severe than in the 
lungs and liver (Stewart et al., 2009). These findings could indicate that the degree of 
inflammation in the hoof lamellae may be at least partially responsible for the predominating 
signs of laminitis, when compared to other signs of MODS in horses.  
 
Overall, the BWE model has been amply used for the study of laminitis, with the idea 
that it resembles the pathophysiologic events that occur during the developmental stages of 
other forms of the disease (i.e. sepsis associated and alimentary/grain overload laminitis). In 
the author‟s opinion the BWE model with its characteristic overwhelming inflammatory 
response, although in itself useful and fascinating, only really resembles the naturally 
occurring form of laminitis associated with accidental exposure to Black Walnut. Although 
somewhat of a similar pathophysiology to sepsis-associated laminitis, BWE does not offer an 
adequate model for the study of other clinical forms of the disease in horses. Hence, caution 
should be exercised when extrapolating and cross correlating current available information 
between the different models. 
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2.5.3. Prolonged Euglycaemic-Hyperinsulinaemic Clamp 
 
Recently, a new model for the experimental induction of laminitis has been described. 
Its use was first reported in a laminitis induction trial with healthy ponies (Asplin et al., 
2007). An induction in healthy adult Standardbred horses closely followed (de Laat et al., 
2010a). The model involves maintaining blood insulin levels well above normal 
(hyperinsulinaemia – HI), whilst simultaneously providing glucose to maintain a steady state 
in the blood (euglycaemia) for a prolonged period of time. It was given the descriptive name 
of prolonged Euglycaemic-Hyperinsulinaemic Clamp (p-EHC). Unfortunately, the 
mechanisms by which hyperinsulenaemia (HI) results in laminitis remain to be determined. 
Thus far, a direct role for insulin in laminitis pathogenesis (Asplin et al., 2007), and an 
association between endocrinopathic laminitis and vascular dysfunction (e.g. blood supply 
alterations) secondary to HI have been suggested (de Laat et al., 2010b). Regardless of 
pathophysiological mechanisms, the data convincingly demonstrate that HI, independent of 
hyperglycaemia or gastrointestinal derangements, can and does result in clinical laminitis. 
 
In the p-EHC, an initial insulin bolus of 45 mIU/Kg given over 1 minute is 
immediately followed by a constant rate infusion (CRI) of 6 mIU/Kg/minute. Concurrently, a 
CRI of 50% glucose is initiated at 10 µmol/Kg/minute. The rate of glucose CRI is adjusted 
throughout the experiment to maintain euglycaemia at 5 ± 1 mmol/L as previously defined 
(Asplin et al., 2007).  Blood glucose must be initially measured every 5 minutes and the rate 
of 50% glucose infusion adjusted accordingly, until a steady state is reached. The steady state 
is defined as a 30-minute period in which euglycaemia (5 ± 1 mmol/L) is maintained without 
altering the 50% glucose infusion rate. Once a steady state is achieved, blood glucose 
measurements can be performed every 30 minutes (de Laat et al., 2010a). This study reported 
initiation of the clinical signs of laminitis after 48 hours of sustained HI (de Laat et al., 
2010a). Furthermore, lamellar BM disintegration was histologically apparent (Asplin et al., 
2007), and lamellar pathology was also confirmed on electron  microscopy in HI induced 
laminitis (Nourian et al., 2009). However, lamellar changes in HI induced laminitis showed 
no evidence of BM separation (Nourian et al., 2009), which supports the idea that HI affected 
lamella have a different ultrastructural morphology to that observed in the OF induction 
model (Nourian et al., 2007), and after CHO induced laminitis (Nourian et al., 2009). 
Furthermore, a recent study concludes that although similar, the microscopic lesions of 
laminitis in different forms of the disease do differ (de Laat et al., 2011). 
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The p-EHC has quickly proven to be a valuable model for the study of 
endocrinopathic laminitis. In their studies, both groups reporting the use of the p-EHC model 
were able to induce laminitis in 100% of treated horses after 48 to 72 hours of sustained HI 
(Asplin et al., 2007; de Laat et al., 2010a). As mentioned in chapter 4, endocrinopathies such 
as EMS and PPID, result in clinical laminitis as a consequence of HI (Johnson et al., 2004a), 
apparently with a total absence of inflammatory mediation (de Laat et al., 2010a).  Naturally 
occurring HI has been proposed to occur as a consequence of insulin resistance (IR) (Frank, 
2009). The IR state is characterized by the absence of tissue glucose uptake in response to 
insulin. The lack of glucose utilization leads to hyperglycaemia, which further stimulates 
pancreatic insulin release ultimately leading to HI (Kronfeld, 2005; Shanik et al., 2008). In 
equine endocrinopathy, IR is one of the hallmarks of EMS (Geor and Frank, 2009; Treiber et 
al., 2006b), and it also occurs secondary to corticosteroid stimulation in horses afflicted by 
PPID (Johnson et al., 2004b). Furthermore, IR is now well accepted as a factor predisposing 
horses and ponies to laminitis (Frank, 2009; Geor, 2008; Johnson, 2002; Treiber et al., 
2006b). 
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2.6. Cellular Energy Failure in Sepsis 
 
Using a LPS administration model in the rat, Crouser and coworkers (1997) suggested 
the occurrence of an alteration in cellular O2 utilization as a result of sepsis. Simultaneously, 
Fink (1997) suggested the existence of an alteration in cellular aerobic metabolism in the face 
of disease; a condition he termed “cytopathic hypoxia”. The term denotes an impaired cellular 
ATP production in the presence of normal O2 levels within the cells. It is defined as: “sepsis-
induced alterations in cellular energy metabolism caused by acquired intrinsic derangements 
in cellular respiration” (Fink, 1997). 
 
As indicated in section 2.4.4 the concept of cytopathic hypoxia has rapidly become 
accepted in the last decade (Loiacono and Shapiro, 2010).  It has been the focus of various 
research studies that have demonstrated mitochondrial dysfunction as the cause(Brealey et al., 
2002; Crouser et al., 1999; Fink, 2001, 2002; Loiacono and Shapiro, 2010). As a result, organ 
dysfunction in septic patients is now linked to a relationship between tissue dysoxia and 
inflammation (Loiacono and Shapiro, 2010). 
 
As was mentioned in section 2.1.2.2 (see figure 2.3), the enzyme phosphofructokinase 
(PFK) catalyzes an irreversible reaction. This is the first glycolysis-specific step (transfer of a 
phosphate from ATP to fructose-6-phosphate), which means that it is in this reaction where 
the sugar being degraded becomes committed to glycolysis (glucose-6-phosphate and 
fructose-6-phosphate can be diverted into other pathways, whereas fructose-1,6-biphosphate, 
the product of the reaction catalysed by PFK, cannot). Furthermore, this reaction is a rate-
limiting step, making PFK a rate limiting and regulatory enzyme of the glycolytic pathway. In 
an elegant study, Callahan and Supinski (2005) demonstrated a sepsis-induced down-
regulation in PFK gene expression, protein levels and functional activity, together with a 
reduction in five electron transport chain proteins in rat muscle. Results of their study indicate 
that sepsis could be associated with a generalized reduction in cellular ATP generation 
capacity (Callahan and Supinski, 2005). It thus appears plausible that if PFK is a regulatory 
step in glycolysis and PFK expression is down-regulated during sepsis, all other ATP 
generating paths such as anaerobic glycolysis, the citric acid cycle and the electron transport 
chain will be compromised during sepsis.  
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2.6.1. Bioenergetic failure 
 
 As stated in section 2.4.4, improvements in patient management and treatment options 
in the 1970s resulted in decreased deaths secondary to cardiopulmonary collapse. As a result, 
MODS was first recognised (Baue, 1975; Fry et al., 1980; Mizock, 1984). Interestingly, 
despite the early and frequent suggestion of impairment of cellular oxidative substrate 
utilization independent of O2 delivery during MODS (Astiz et al., 1988; Hotchkiss and Karl, 
1992; Mizock, 1984; Siegel et al., 1979; Taylor and Piantadosi, 1995), the pathophysiology of 
this sepsis-induced phenomenon remained unclear for decades. 
Although the concept of cytopathic hypoxia (i.e. failure to utilize oxygen for ATP 
production in cells during sepsis) was only introduced 15 years ago (Crouser et al., 1997; 
Fink, 1997), the idea of a defect or defects in cellular energy-producing metabolic pathways 
came about long before (Siegel et al., 1979), following the initial observation of abnormal O2 
consumption in septic shock (Duff et al., 1969). The end result is bioenergetic failure, a 
reduction in the availability of high-energy phosphates, as a consequence of a cellular 
inability to effectively use existing metabolic substrate due to defective cellular energy 
metabolism (Hotchkiss and Karl, 1992). Thus, cytopathic hypoxia is a form of bioenergetic 
failure. 
 
 
2.6.2. Lamellar mitochondrial dysfunction and glycolytic failure due to “metastatic 
inflammation” 
 
Lamellar failure in sepsis-associated laminitis has been suggested to occur as a result 
of similar pathophysiologic mechanisms as those that have been described for organ failure in 
human sepsis (Belknap et al., 2009; Black et al., 2006b). This has led to the consideration 
of the equine lamellae as an additional shock “organ” that can be affected by MODS.  In 
MODS as well as laminitis, evidence suggests that inflammation is a key factor (Annane et 
al., 2005; Belknap et al., 2007a; Cohen, 2002; de la Rebiere de Pouyade and Serteyn, 2011; 
Leise et al., 2011).  
 
Mitochondrial dysfunction is accepted as the cause of cytopathic hypoxia (Brealey et 
al., 2002; Crouser et al., 1999; Fink, 2001, 2002; Loiacono and Shapiro, 2010), which is in 
turn accepted to explain the mechanisms by which sepsis leads to MODS (Crouser, 2004; 
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Struck et al., 2005). In the horse, MODS-like events appear to be responsible for lamellar 
failure in sepsis-associated laminitis (Belknap et al., 2009; van Eps, 2011). It thus seems 
reasonable to consider cytopathic hypoxia as a plausible explanation for the pathogenesis of 
laminitis in horses afflicted by septic states. However, the role of mitochondria in the equine 
lamellae remains to be determined. At best, it could presently be speculated that mitochondria 
might be irrelevant players in lamellar bioenergetics, based on the assumption of a major role 
for anaerobic energy-generating pathways in this tissue.  If this is true, PFK down-regulation 
resulting in glycolysis impairment and a generalized failure of energy pathways within the 
hoof could be considered as an alternative potential inciter of glycolytic failure in a tissue that 
is assumed to rely on anaerobic glycolysis for energy production, as does the epidermis of 
human skin (Ronquist et al., 2003). 
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2.7. Tissue Microdialysis 
 
 Tissue microdialysis is a minimally invasive technique used to sample the 
extracellular environment (interstitial fluid) (Lonnroth et al., 1987). It can be used to measure 
local metabolite changes in real time (Klaus et al., 2004), whilst simultaneously allowing for 
sample storage and future analysis (Wang et al., 2011). 
 
 
2.7.1. Origins, principles, procedures and pitfalls 
 
Tissue microdialysis, one of many methods suitable for in vivo interstitial fluid sample 
collection (Benveniste, 1989) was first described in association with the study of 
neurochemical events in the brain (Bito et al., 1966). Since then, the technique has undergone 
many refinements (Butcher et al., 1987; Delgado et al., 1972; Johnson and Justice, 1983; 
Lonnroth et al., 1987; Sandberg and Lindstrom, 1983; Ungerstedt et al., 1982), transforming it 
into a useful tool for research and clinical bioanalysis (Benveniste and Huttemeier, 1990). At 
present microdialysis developments are such that they have led to the creation of company 
branches specialized in microdialysis product design and commercialization for pre-clinical 
research (©CMA Microdialysis AB) and clinical applications (©M-dialysis AB). Moreover, 
microdialysis can theoretically be used for collection of any substance present in the 
interstitium, with what appears to be a limitless array of applications (Benveniste, 1989; 
Benveniste and Huttemeier, 1990), whilst causing a minimal amount of damage to the tissue 
where it is performed (Benveniste, 1989; Lonnroth et al., 1987). This very low degree of 
tissue disruption is a unique characteristic of microdialysis, which confers it superiority when 
compared to other available methods for interstitial fluid sampling (Benveniste and 
Huttemeier, 1990). 
 
The principle of microdialysis is based on the placement of a semi-permeable 
membrane in the tissue of interest (Bito et al., 1966; de Lange et al., 2000; Guihen and 
O'Connor, 2010). The membrane allows water and solutes to diffuse between the interstitial 
fluid (IF) and the perfusate (which is usually free of the substances to be analyzed) 
(Benveniste, 1989). The system exploits the principles of Fick‟s laws of diffusion. The first 
Fick‟s law states that a substance will flow in response to the difference in concentration 
between solutions (concentration gradient). The second of Fick‟s laws states that the rate of 
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change in the concentration (flow speed) will be proportional to the rate of change in the 
concentration gradient, hence it varies in time (Fick, 1855), unless the source of the substance 
is endless or constantly renewed (Figure 2.6). 
 
Figure 2.6: Diagrammatic representation of Fick‟s laws of diffusion showing flow of a solute 
across a semi-permeable membrane from a higher to a lower concentration (a), and the 
variation of this flow in time (b). The black arrows point in the direction of flow of the 
particle in solution. 
 
___________________________________________________________________________ 
 
 
The semi-permeable membrane is housed in a microdialysis probe and can have a 
variable pore size (most commonly available in the 5 to 100 kiloDalton (kDa) range). In 
essence, the procedure is a diffusion-based sampling technique for the collection of freely 
available, low molecular weight molecules (Guihen and O'Connor, 2010). The probe is a 
tubular structure with a lumen. It is composed of the semi-permeable membrane, which is 
connected to inlet and outlet tubing (Figure 2.7). The probe is inserted into the tissue, 
ensuring the segment housing the membrane is embedded within the area to be sampled. The 
insertion procedure might involve surgical implantation for placement in deep organs/tissue, 
or simply feeding the probe into more superficial tissues with the aid of a hypodermic guide 
needle that is then removed. Once correctly positioned, the lumen of the probe is perfused 
through the inlet at a slow but constant rate with a physiologic solution, the perfusate. 
Ideally, the perfusate should closely resemble the ionic composition of the IF surrounding the 
probe (de Lange et al., 2000). As the fluid circulates beneath the membrane, molecules 
present on the outside (within the IF) that can pass through the membrane, diffuse into the 
lumen down a concentration gradient (Bito et al., 1966). The continuous flow carries the fluid 
together with its newly acquired molecules, the dialysate, into the outlet tubing segment, 
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from which the sample is collected for analysis (Benveniste and Huttemeier, 1990) (Figure 
2.8). For recovery of certain substances the use of membranes of large pore size is required. In 
this case the inclusion of a colloid in the perfusate can prevent fluid loss into the interstitium. 
The use of dextran has been well described and is frequently used for such purpose (Rosdahl  
et. al., 1997). 
 
Figure 2.7: Diagrammatic representation of a commercial coaxial microdialysis probe (from 
Huang et. al., 2013 and Barbe et. al., 2001) 
 
 
___________________________________________________________________________ 
 
 
Figure 2.8: Diagrammatic representation of a tissue microdialysis system. 
 
 
___________________________________________________________________________ 
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The outflow concentration in the dialysate represents the diffusion from the IF, 
through the membrane and into the perfusate (Benveniste et al., 1989). The actual relation 
between the concentration of a molecule in the IF outside the probe and its concentration in 
the dialysate is termed relative recovery or extraction efficiency (Benveniste, 1989; de Lange 
et al., 2000; Zetterstrom et al., 1982). It is determined by temperature, the characteristics of 
the membrane (e.g. surface area and pore size), the flow rate and composition of the perfusate, 
the time after start of perfusion, and the concentration, molecular weight, quaternary structure 
and hydrophilicity of the substance being recovered (Benveniste and Huttemeier, 1990; de 
Lange et al., 2000; Waelgaard et al., 2006), as well as its interaction with the membrane 
(Benveniste, 1989). Of these the perfusion flow rate is determined by the operator; at higher 
perfusion rates less solute (i.e. substance of interest) is recovered because it allows less time 
for diffusion through the membrane. In other words, higher flow rate and thus larger volumes 
of perfusate result in dilution of the sample (Benveniste, 1989). However, higher flow rate 
also signifies larger dialysate volumes, which are sometimes required to meet minimal sample 
volume requirement for sample analysis. The absolute recovery refers to the amount present 
in the dialysate per unit of time (Benveniste, 1989). Figure 2.9 shows a typical curve of 
relative recovery as a function of time. As can be seen, the percentage of relative recovery 
initially drops very quickly. However, although it continues to drop gradually and never 
reaches a steady state, the change is negligible after the initial 60 minutes of perfusion (< 1%). 
Consequently, a high concentration of the substance(s) of interest is to be expected during the 
initial hour of microdialysis, which is followed by a dramatic drop after the second hour. To 
circumvent this excessive initial fluctuation, commencement of sample collection is usually 
delayed for one or two hours after probe placement (Benveniste, 1989). 
 
Figure 2.9: Typical curve for microdialysis relative recovery of a substance as a function of 
time. Note the rapid decline in relative recovery after high levels are initially observed. 
(Adapted from Benveniste, H. 1989). 
__________________________________________________________________________ 
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This poses another problem, however. The recovery of a given substance 
(concentration in the dialysate) although proportional to the concentration outside the probe 
(concentration in the IF), is not identical to it. The issue brings about the question of how to 
relate the tissue concentrations with the dialysate concentration (de Lange et al., 2000) or in 
other words, how to establish the real concentration of a given substance of interest in the 
tissue being studied. A commonly used method for the quantification of absolute IF substance 
concentrations from microdialysis data is the no-net-flux method developed by Lonnroth et al. 
(1987). The method involves consecutive perfusions of the microdialysis probe with different 
concentrations of the substance being studied. The known concentration in the perfusate 
(Cperfusate) is compared to the concentration of the substance in the dialysate (Cdialysate), and for 
each Cperfusate the difference between Cperfusate and Cdialysate is calculated and plotted as a 
function of Cperfusate. The value on the x-axis where it is intersected by the plotted function 
corresponds to the value where Cperfusate equals the concentration of the substance outside the 
probe, or the IF concentration when performing in vivo microdialysis (Lonnroth et al., 1987). 
A depiction of a no-net-flux plot is presented in figure 2.10. 
 
Figure 2.10: Plotted calculation for determination of no-net-flux using microdialysis. 
 
 
___________________________________________________________________________ 
 
Although the no-net-flux method can be used to establish the real concentration of a 
substance of interest in the IF, the procedure cannot always be performed during experimental 
or clinical microdialysis applications. Regardless, it is not the amount of substance recovered 
or the exact amount present in the IF that is most important (Waelgaard et al., 2006). Instead, 
it is the relative change in the amount of substance present or the variations in the ratio 
between different substances that is most valuable during research and clinical microdialysis 
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use, particularly over time or in response to an event or intervention (de Lange et al., 2000; 
Waelgaard et al., 2006). 
 
One of the most frequent applications of microdialysis is in the study of tissue 
ischaemia (see below) (Waelgaard et al., 2006), which implies utilization of the microdialysis 
technique in the evaluation of local blood flow. Ischaemia is a phenomenon that is deleterious 
to tissues as they rely on arrival of nutrients and O2 in the blood, as well as on the removal of 
the end products of cellular metabolism such as CO2. Hence, the understanding of the effects 
of an ischaemic insult and also of reperfusion (i.e. ischaemia-reperfusion injury), which have 
a demonstrated impact on local tissue metabolism (Grace and Mathie, 1999), can be improved 
with microdialysis. In addition, evidence supporting the idea of the need to monitor local 
blood flow whilst performing microdialysis is building, as it has become apparent that the 
concentration of any substance in the interstitium of a tissue, as assessed by microdialysis, is 
constantly influenced by the supply and removal of that substance via local blood flow 
(Newman et al., 2001; Newman et al., 2002; Rosdahl et al., 1993). 
 
The first technique developed to establish tissue blood flow using microdialysis was 
the ethanol clearance method (Hickner et al., 1991). It is based on the free diffusion of ethanol 
through the microdialysis membrane. Ethanol added to the perfusate will diffuse into the 
interstitium and it will be removed from the ECF at a rate that is directly proportional to blood 
flow. Thus, the difference between the concentration of ethanol in the perfusate and that of the 
dialysate (Cperfusate – Cdialysate) will be inversely proportional to blood flow through the tissue. 
At present, microdialysis ethanol clearance is regarded as the standard for assessing blood 
flow in a tissue in which microdialysis is being performed (Farnebo et al., 2010). Although 
simple and straightforward, ethanol clearance is not without problems: with ethanol being 
easily diffusible and very common in hospital environments, sample contamination and 
altered results are likely. Also, determination of its concentration in a sample requires 
specialized techniques. Most importantly, ethanol clearance cannot be used at low perfusion 
velocities that are desirable for the measurement of bioenergetic metabolites such as glucose 
and lactate (< 1 µL/min). At the low flow required for these measurements, most if not all of 
the ethanol will be removed from the interstitium via blood flow, which precludes its 
measurement in the dialysate and its use for blood flow assessment (Farnebo et al., 2010).  
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A second method for the assessment of blood flow, which overcomes the limitation of 
microdialysis ethanol clearance is the urea clearance method validated by Farnebo and co-
workers (2010). It is based on exactly the same principle of ethanol clearance; it uses the net 
loss of urea added to the perfusate at a known concentration, to semi-quantitatively determine 
tissue blood flow. The validation study for the urea clearance method concluded that the ideal 
perfusate urea concentration is 20 mmol/L, that urea clearance can be used to monitor blood 
flow in parallel to metabolic monitoring, and that the urea clearance method works well at the 
low perfusion rates (< 1 µL/min) necessary for bioenergetic metabolite determination 
(Farnebo et al., 2010). 
 
Although simple and straightforward, tissue microdialysis and its applications are not 
without pitfalls. These include: 
 
a. Recovery of very small sample volumes, which limits the analysis to processing with 
sophisticated low-volume analytical methods. 
b. Tissue reactions due to implantation of the probe, which have the potential to interfere 
with sample collection and to affect the local environment within the evaluated tissue 
(Clark et al., 2000). 
c. The presence of very low concentrations of the substance being studied as a result of the 
diluting effect of microdialysis, which requires very sensitive analytical methods (de 
Lange et al., 2000). 
d. Difficulty in the determination of exact in-vivo IF concentrations of a substance, which 
might be desirable under particular circumstances, such as during pharmacokinetic 
studies. 
e. The membrane pore size (cutoff) limits the size of molecules recovered from the IF, and 
molecules that are only marginally smaller than the membrane cutoff are often poorly 
recovered (de Lange et al., 2000). 
 
 
2.7.2. Current applications 
 
Tissue microdialysis has been traditionally applied mainly to the study of ischaemia 
(Waelgaard et al., 2006). It is currently being used to study local metabolic and biochemical 
events in medical research and intensive care monitoring (Klaus et al., 2004; Nolting et al., 
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1996). In addition to assessment of changes in local metabolism in real time (Klaus et al., 
2004), tissue microdialysis can be used for direct determination of local perfusion, nutrient 
supply and cellular energy metabolism (bioenergetics), and it can assess local ischaemia or 
bioenergetic failure through quantification of local energy metabolites such as glucose, 
pyruvate and lactate (Goodman and Robertson, 2009; Klaus et al., 2004). In addition to what 
could be defined as its traditional uses, microdialysis has now been tested for the recovery of 
cytokines, chemokines and anaphylotoxins (Waelgaard et al., 2006), as well as proteinases 
(Wang et al., 2009), growth factors (Waelgaard et al., 2006)  and pharmaceuticals (Hocht et 
al., 2006; Patsalos et al., 1995).  
 
 
2.7.3. Microdialysis in horses 
 
Only recently has microdialysis made its debut in veterinary clinical monitoring 
(Affenzeller et al., 2011). However, it was first used in equine research 20 years ago, where 
assessment of the pharmacokinetics of theophylline in the lungs of eight horses was 
attempted; the microdialysis procedures were satisfactory only in two of these (Ingvastlarsson 
et al., 1992). After nearly a decade, a second report that used microdialysis in horses was 
published. In that study, Chou and co-workers (2001) assessed the pharmacokinetics of 
caffeine and two of its metabolites (theophylline and theobromine) in the Splenius muscle and 
the blood of two mares (one Thoroughbred and one Quarter Horse) (Chou et al., 2001). More 
frequent utilization of microdialysis is apparent since 2005, but reports continue to be 
sporadic. The microdialysis based assessment of muscle metabolic changes in healthy 
Standarbred trotters during inhalation anaesthesia maintained with halothane (n=7) and 
isoflurane (n=6) was reported (Edner et al., 2005). This same group assessed muscle 
metabolism during and after (recovery phase) isoflurane-maintained anaesthesia with 
microdialysis in 10 client owned colic cases and 10 healthy horses that belonged to a 
university teaching herd (Edner et al., 2009). Lactate, glucose, urea and glycerol levels were 
successfully determined. However, microdialysis membrane damage or probe removal by the 
horses prevented the collection of data in most horses before 20 hours of the recovery phase 
were completed. Other interesting uses of tissue microdialysis in the horse include 
concentration assessment and pharmacokinetic comparisons after single dose intravenous 
administration of penicillin G and gentamicin in the allantoic fluid of five late gestational 
pony mares for a 24 hour period (Murchie et al., 2006). Also, microdialysis determination of 
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the concentration of caffeine and its metabolites in blood and cerebrospinal fluid (CSF) of six 
healthy horses, combined with simultaneous behavioural evaluation based on spontaneous 
motor activity was reported for assessment of the potential performance enhancing effects of 
caffeine (Vickroy et al., 2008). 
 
Recently, the development of an intra-lamellar microdialysis method for continuous 
monitoring of the ECF in the hoof lamellae, and evaluation of the pharmacokinetics of 
gentamicin in the lamellar tissue has been reported (Nourian et al., 2010a). Successful 
determination of gentamicin concentration in lamellar ECF after intravenous (Nourian et al., 
2010a) and intraosseous infusion of the distal phalanx (IOIDP) (Nourian et al., 2010b) was 
achieved. 
 
 
2.7.4. Potential for microdialysis in laminitis research and also clinical use 
  
As was previously mentioned, microdialysis causes minimal tissue damage 
(Benveniste, 1989; Lonnroth et al., 1987), and in theory can be used for collection of any 
substance present in the IF, with an apparent endless potential (Benveniste, 1989; Benveniste 
and Huttemeier, 1990). The reports of successful microdialysis application for continuous 
monitoring of the IF in the hoof lamellae (Nourian et al., 2010a, b), combined with its proven 
efficacy in the study of ischaemia (Waelgaard et al., 2006), local metabolism and 
biochemistry (Klaus et al., 2004; Nolting et al., 1996) including bioenergetics, (Goodman and 
Robertson, 2009; Klaus et al., 2004), cytokines, chemokines and anaphylotoxins (Waelgaard 
et al., 2006), proteinases (Wang et al., 2009), growth factors (Waelgaard et al., 2006),  and 
pharmaceuticals (Hocht et al., 2006; Patsalos et al., 1995), are an almost certain indication of 
the vast array of applications for tissue microdialysis  in the study of equine lamellar 
physiology and of laminitis pathophysiology. Circulatory abnormalities, derangements of 
local metabolism including biochemistry and bioenergetics, inflammatory changes mediated 
by cytokines and chemokines, and matrix metalloproteinase deregulation, have all been 
implicated in the pathophysiology of equine laminitis (see chapter 7). Combined with the 
experimental induction models (OF and p-EHC), and with transient unilateral weight bearing, 
tissue microdialysis can potentially evaluate the changes in lamellar bioenergetics, energy 
failure and blood flow associated with the developmental stage of laminitis in real time. 
Furthermore, microdialysis samples analysed by means of advanced molecular- and 
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immunoassay- based procedures (e.g. quantitative “omic” analysis and multiplex ELISA, 
respectively) could also determine the sequence of metabolic, inflammatory and enzymatic 
events during laminitis development. As a result, tissue microdialysis has the potential to 
allow for complete elucidation and description of the pathophysiologic changes that 
characterize each of the clinical presentations of equine laminitis (i.e. sepsis-associated, 
endocrinopathic and weight bearing/trauma-induced). 
  
Once the applicability of microdialysis in laminitis research is tested, and 
microdialysis markers in the developmental stages of disease are identified, the following 
natural step is its introduction to clinical monitoring. As a simple technique causing minimal 
tissue damage, microdialysis has the potential to be used in equine patients at risk of 
developing laminitis during hospitalization (i.e. horses afflicted by septic and orthopaedic 
diseases), as well as in horses already suffering from laminitis. Its use in these situations will 
allow for target directed early pre-emptive intervention or for institution and modification of 
therapeutic plans, respectively. Overall, microdialysis use in the hospital setting may lead to 
early disease recognition. This could in turn reduce the impact of equine laminitis and 
decrease its deleterious effects on health, wellbeing and performance, as well as the costs 
associated with treatment and negative patient outcome. 
 
2.7.4.1. Metabolomic analysis of lamellar microdialysis samples 
 
Metabolomic analysis refers to the comprehensive study of the metabolite composition 
of a tissue or biofluid. It is concerned with the chemical processes and the unique chemical 
(i.e. metabolic) fingerprint left behind by specific physiologic or pathologic events (Goodacre 
et al., 2004; Oliver et. al., 1998). The goal of metabolomic analysis is the comprehensive 
measurement of metabolite concentrations associated with a biological system at the cellular, 
tissue or whole organism level (Goodacre et al., 2004). Metabolomic analysis results in the 
systematic profiling of multiple metabolites and their temporal (or population) changes in 
biofluids and tissues (Oliver et al., 1998) - the metabolome. 
 
The most frequently used samples in metabolomic studies include biofluids and cell or 
tissue extracts which can provide a systematic and integrated overview for biomedical 
assessment. Urine or blood constituents such as plasma, which can be obtained non-
invasively, as well as various other sample types including cerebrospinal, peritoneal, amniotic 
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and synovial fluid, semen constituents, digestive juices and other samples such as the content 
of cysts and blisters, or pleural or lung aspirates and dialysis fluids (Lindon et. al., 1999). In 
other life science applications such as plant biology and environmental sciences, whole 
tissues and tissue extracts are used (Nicholson et. al., 2007). 
 
For determination of the metabolome of a sample a frequently used analytical method 
is based on mass spectrometry (MS). For MS a prior separation step of the metabolic 
components using, for example, chromatographic methods is required (Gamache et. al., 
2004). Metabolomic studies generate large data sets that require multivariate analysis and 
specialised software for interpretation (Nicholson et. al., 2007). The ultimate goal of this type 
of analysis is the generation of biochemical fingerprints of diagnostic or other classification 
value (Nicholson et. al., 2007). This is generally followed by the identification of the specific 
substance or substances leading to a diagnosis or classification, i.e. the combination of 
biomarkers that define a biological process (Nicholson et. al., 2007). Mass spectrometry is 
widely used in metabolic fingerprinting and metabolite identification. It is one of the main 
methods used for molecular identification purposes, especially through the use of tandem MS 
procedures. For metabolomic applications on biofluids, a high pressure liquid 
chromatography (HPLC) chromatogram is generated with MS detection, usually using 
electrospray ionisation, and both positive and negative ion chromatograms can be measured. 
At each sampling point in the chromatogram, there is a full mass spectrum and so the data is 
threedimensional in nature, i.e. retention time, mass and intensity. For biomarker 
identification, it is also possible to separate out substances of interest on a larger scale from a 
complex biofluid sample using techniques such as solid-phase-extraction or HPLC. A major 
advantage of MS over other methods is that it has a high sensitivity with very low detection 
limits as long as the analyte of interest can be ionised (Nicholson et. al., 2007). Overall, the 
aim of metabolomic analysis is the identification of metabolic differences between subjects, 
cohorts or populations in response to inherent and external factors (Bollard et. al., 2005). It is 
mainly used for assessment of phenotypic and physiological effects of experimental 
manipulations or disease processes, for pre-clinical drug candidate safety assessment, for 
disease diagnosis and therapeutic efficacy, and for pharmacologic studies (i.e. 
pharmacometabolomics). Other applications already exist and new ones are continuously 
emerging, including studies of environmental toxicity, functional genomics, epidemiological 
studies, and various other research areas (Nicholson et. al., 2007). 
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Metabolomic analysis of the lamellar microdialysate (or extract thereof) could be 
undertaken using two broadly different approaches, namely open profiling metabolomics or 
targeted (quantitative) metabolomics (Goodacre et al., 2004. The open approach attempts to 
capture as many endogenous metabolites (known or unknown) as possible and use this 
information to determine which of these metabolites best describes the underlying 
biochemical processes relating to the biological question, in this case a time course of 
laminitis. Targeted metabolomics can be regarded as an extension of a clinical chemistry 
battery whereby several predetermined analytes are quantitatively measured to assess their 
role in the same underlying processes. An example of this is a recent open metabolomics 
study of serum from horses before and after experimentally-induced laminitis revealed 
evidence of dysregulation of fatty acid metabolism, accumulation of organic acids (lactate) 
and identified the amino acid citrulline to be decreased in serum prior to the onset of clinical 
laminitis (foot pain) (Steelman et al., 2014). 
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3. Hypotheses 
 
3.1. (H1) Tissue microdialysis can be used as a non-invasive, clinically applicable technique 
to detect changes in microvascular perfusion as well as bioenergetic dysfunction of the 
lamellar tissue. 
 
3.2. (H2) Lamellar perfusion and therefore lamellar bioenergetic homeostasis relies upon 
regular cyclic limb loading; excessive weight bearing and/or a lack of limb load cycling 
can cause a reduction in lamellar perfusion and lamellar bioenergetic dysfunction/failure. 
 
3.3. (H3) Protocols of physical therapy and/or walking exercise and/or orthotic manipulation 
can be used to prevent reduced lamellar perfusion associated with excessive weight 
bearing and reduced limb load cycling. 
 
3.4. (H4) Laminitis development secondary to sepsis is associated with lamellar bioenergetic 
failure/deregulation that may contribute to dermo-epidermal separation. 
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4. Aims and Objectives 
  
4.1. Determine the normal pattern of energy metabolites in the lamellar interstitial fluid (IF) 
using microdialysis over a 24 hour period. 
 
4.2. Determine the changes in lamellar IF major energy metabolite patterns associated with 
induced vasoconstriction, vasodilation and ischemia. 
 
4.3. Establish if the microdialysis urea clearance method (Farnebo et al., 2010) can be used to 
assess lamellar microvascular perfusion. 
 
4.4. Determine the effect of walking, static limb load cycling, reduced limb load cycling 
activity and unilateral weight bearing on lamellar microvascular perfusion and 
bioenergetics. 
 
4.5. Examine the presence of bioenergetic failure in experimental sepsis-associated (OF- 
induced) laminitis. 
 
4.6. Examine changes in lamellar microvascular perfusion during OF-induced laminitis using 
microdialysis urea clearance. 
 
4.7. Document normal limb load cycling activity patterns in the horse and assess if these 
patterns can be quantified using digital pedometers. 
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5. Experiments 
 
5.1. Experiment 1 
 
Equine lamellar energy metabolism studied using tissue microdialysis 
 
C.E. Medina-Torres, C.C. Pollitt, C. Underwood, S. Collins, R.E. Allavena, D.W. Richardson, 
A.W. van Eps. (2014) The Veterinary Journal 201, 275 – 282.  
  
68 
 
 
69 
 
 
70 
 
 
 
71 
 
 
72 
 
 
73 
 
 
74 
 
 
75 
 
 
 
 
 
  
76 
 
5.2. Experiment 2 
 
Microdialysis measurements of equine lamellar perfusion and energy metabolism in 
response to physical and pharmacological manipulations of blood flow 
 
C.E. Medina-Torres
1
, C. Underwood
1
, C.C. Pollitt
1
, E.M. Castro-Olivera
1
, M.P. Hodson
2
, 
D.W. Richardson
3
, A.W. van Eps
1*
. 
 
1. Australian Equine Laminitis Research Unit, School of Veterinary Science, The University 
of Queensland, Gatton, QLD, Australia. 
2. Metabolomics Australia - Queensland Node, Australian Institute for Bioengineering and 
Nanotechnology, The University of Queensland, St Lucia, QLD, Australia. 
3. New Bolton Center, Department of Clinical Studies, School of Veterinary Medicine, 
University of Pennsylvania, Kennett Square, PA, USA. 
 
*Corresponding author. Email: a.vaneps@uq.edu.au   
 
Keywords: Bioenergetic; Horse; Laminitis; Metabolite; Microdialysis 
Word Count: 5120 
Ethical Considerations: The project was approved by the University of Queensland Animal 
Ethics Committee (AEC) that monitors compliance with the Animal Welfare Act (2001) and 
the Code of Practice for the care and use of animals for scientific purposes (current edition). 
All animals were monitored continuously by the investigators. 
Competing Interests: The authors have no competing interests to declare 
Source of Funding: The project was supported by the Grayson Jockey Club Research 
Foundation  
Acknowledgements: Supported by a Grayson Jockey Club Research Foundation Grant 
  
77 
 
Reasons for performing study: A suitable method for evaluating lamellar perfusion changes 
as well as their metabolic consequences is currently lacking. 
Objective: To examine perfusion changes in lamellar tissue using serial microdialysis 
measurements of urea clearance and energy metabolites. 
Study Design: Randomised, controlled (within subject), experimental trial. 
Methods: Nine Standardbred horses were instrumented with microdialysis probes in the foot 
lamellar tissue and skin (over the tail base). Urea (20 mmol/l) was added to the perfusate: its 
clearance used to estimate local perfusion. Samples were collected every 15 min for a 1-h 
control period, then during application of a distal limb tourniquet, during periods when 
norepinephrine (NE) or potassium chloride (KCl) were included in both skin and lamellar 
perfusates, and after systemic (intravenous) acetylpromazine (ACP). Dialysate concentrations 
of glucose, lactate, pyruvate and urea were measured and lactate:glucose (L:G) and 
lactate:pyruvate (L:P) ratios calculated. Values were compared to pre-intervention baseline 
and also between simultaneous skin and lamellar samples using non-parametric statistical 
testing. 
Results: Lamellar glucose decreased and lactate, urea, L:G and L:P increased significantly 
with tourniquet application, without significant changes in skin dialysate values. Lamellar and 
skin glucose decreased and L:G increased significantly during NE infusion, but the mild 
increases in urea were not significant at either site. KCl caused significant decreases in 
lamellar and skin L:G, and an increase in skin glucose, but did not significantly affect urea 
clearance. ACP administration caused profound decreases in lamellar glucose and L:P, with 
increased L:G and pyruvate, but did not affect urea clearance or any skin dialysate values.  
Conclusions: Microdialysis urea clearance detected only severe lamellar hypoperfusion, but 
changes in the dialysate metabolite patterns also reflected less profound perfusion changes. 
This method may be useful for examining lamellar perfusion and energy balance during 
laminitis development, as well as for evaluation of vasoactive therapeutics. 
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Introduction 
The role of altered lamellar perfusion in the pathophysiology of laminitis remains 
controversial. Findings from studies using the carbohydrate (CHO) overload [1-4] and Black 
Walnut extract (BWE) [5] models suggested a decrease in lamellar perfusion during laminitis 
development. Other studies have shown decreased vascular resistance and increased blood 
flow through the distal limb [6], and increased lamellar perfusion (scintigraphically) during 
laminitis development [7]. Also using a CHO overload model, an increase in hoof wall 
temperature [8] was suggested to correlate with increased digital blood flow, whilst a similar 
study showed a reduction in blood flow during the developmental phase, followed by an 
increase during acute laminitis [9]. These experimental models are most applicable to the 
sepsis-associated form of naturally occurring laminitis, however vascular derangement and 
perfusion changes have also been suggested as contributors to laminitis associated with 
hyperinsulinaemia [10] and supporting limb laminitis [11]. 
Blood perfusion within the equine foot has been studied using a variety of methods 
including laser Doppler flowmetry in healthy horses [12] and during BWE laminitis induction 
[13]; near infrared spectroscopy in normal horses and horses with laminitis [14]; and 
retrograde venous angiography in clinically normal horses [15-17] and during the progression 
to chronic laminitis [17]. A major confounding factor precluding accurate measurement of 
actual lamellar capillary (nutrient) blood flow is the rich presence of arteriovenous 
anastomoses (AVAs) in this tissue [18], as blood flowing to the digit may shunt through the 
AVAs without necessarily increasing flow through the capillary beds [18]. In addition, none 
of the previously used methods of measuring alterations in lamellar perfusion can assess the 
biological significance of perfusion changes in terms of energy metabolism, and most are not 
suitable for continuous monitoring in the horse.  
Tissue microdialysis is a minimally invasive technique that can be used to assess local 
energy metabolism through quantification of interstitial fluid metabolites (glucose, lactate, 
pyruvate, urea) in real time [19-24]. It is considered a sensitive tool for documenting tissue 
ischaemia and bioenergetic failure in different tissues [21; 25]. Microdialysis measurements 
of local glucose concentrations closely correlate with local tissue perfusion in the brain and 
can therefore estimate perfusion [26], however the recently described microdialysis urea 
clearance technique [27] can be used to measure perfusion changes more accurately, by 
removing the influence of variations in local tissue metabolism and cellular glucose uptake. 
A technique for lamellar microdialysis in the horse has previously been described [28], 
and with the use of a modified technique [29] energy metabolites were measured in lamellar 
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dialysate samples and remained relatively stable over a 24 h study period in normal horses. 
We hypothesized that the microdialysis technique, with urea clearance, would be capable of 
detecting transient changes in local perfusion and resultant energy balance within the lamellar 
tissue in response to interventions expected to cause hyper- or hypo-perfusion of the equine 
digit. 
 
Materials and Methods 
Animals 
Nine clinically normal Standardbred horses (7 geldings and 2 mares; age 6.7 ±2.3 years; 
bwt 480 ±54 kg) were enrolled. Horses were kept in stocks for the duration of the study with 
ad libitum access to hay and water, and monitored continuously by the investigators. They 
had no lameness, normal hooves on visual inspection and no radiographic abnormalities of the 
fore feet.  
 
Microdialysis probe placement 
Coaxial microdialysis probes with a 10 × 0.5 mm, 100 kDa cut-off membrane 
(CMA20
a
) were placed in the lamellar tissue of one randomly selected forelimb as well as the 
skin dermis over the tail base in each horse as previously described [29]. Briefly, for lamellar 
placement, a 1.5 x 1.0 cm hole was created by resecting keratinized tissue from the white line 
region (on midline, dorsal to the point of the frog). After abaxial, sesamoid perineural 
anaesthesia and aseptic preparation, an 18G × 15 cm long spinal needle with a pre-loosened 
grip-hub (Lochimed
b
) was introduced through the white line and advanced proximally (at a 
~5º angle toward the third phalanx) until the tip appeared through the skin above the coronet. 
This introduction technique results in positioning of the lamellar probes in the sublamellar 
dermis, close to the primary epidermal lamellar tips [29]. The stylet was removed and a 
microdialysis probe was inserted through the needle. The needle was withdrawn leaving the 
probe in place. The outlet tubing was connected to a custom made microdialysis vial holder 
secured to the dorsal hoof wall. The inlet tubing was connected to a precision pump 
(CMA107
c
) housed in a custom made limb boot. The defect at the toe was filled with silicone 
putty (Ortho-Pak Putty
d
). For insertion in the skin dermis of the tail base, after hair clipping, 
aseptic preparation and subcutaneous infiltration with 2% lignocaine HCl (Ilium Lignocaine 
20
e
), an 18G, 38 mm needle was used to introduce the probes. The inlet tubing was connected 
to a precision pump and the outlet tubing to a microdialysis vial (Microvial
f
), both secured to 
the tail. Both probes were perfused continuously at a rate of 1 µL·min
-1
 with an isotonic, 
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polyionic sterile perfusion fluid (T1
g
). The perfusate contained 40 g/L Dextran 70
h
, to prevent 
fluid loss [30], and 20 mmol/L of urea for determination of urea clearance [27; 31].  
 
Sample collection and analysis 
After probe insertion, a 2 h stabilization period was allowed before commencement of 
sample collection. Dialysate samples were then simultaneously collected every 15 min from 
the lamellar and skin probes for the duration of the experimental period. The collected 
dialysate samples were weighed and fluid recovery calculated as a percentage of the perfused 
volume during the sampling period (15 µL). Glucose, lactate, pyruvate, urea and glycerol 
concentrations were determined immediately (analysed within 3 min of sample collection) 
using a commercially available, dedicated microdialysis analyser (CMA IscusFlex
i
). Standard 
indices of energy metabolism (lactate:glucose [L:G] and lactate:pyruvate [L:P]) were 
calculated. 
 
Experimental protocol 
A 1 h (control) recording period was followed by a series of 4 consecutive interventions, 
arranged in random order for each horse, during a 24 h total experimental period. A minimum 
washout period of 45 minutes or until three successive samples showed measured metabolites 
had returned to within 10% of pre-intervention concentrations was allowed after each 
intervention to ensure analyte concentrations had returned to baseline values. Three resting 
samples were collected prior to each intervention and the mean metabolite concentration in 
these resting samples was used as a pre-intervention baseline value. The interventions were: 
1) Manual application of a tourniquet (rubber Esmarch‟s bandage) applied tightly over the 
fetlock region for 30 min after perineural anaesthesia with 2% lignocaine HCl; 2) Addition of 
0.5 mg/L norepinephrine (NE)
j
 in the perfusate of both the lamellar and skin probes for 45 
min [31]; 3) Addition of 15 mmol/L potassium chloride (KCl)
k
 in the perfusate of both the 
lamellar and skin probes for 45 min [32]; and 4) Intravenous administration of 0.05 mg/kg 
acetylpromazine (ACP)
l
. Digital pedometers (Digiwalker sw700
m
) were taped to the distal 
antebrachium of both forelimbs to record weight shifting frequency (counts recorded and reset 
for each sampling period) [33]. 
 
Statistical analysis 
The data failed normality tests (Shapiro-Wilk) and were therefore analysed non-
parametrically. The concentrations of dialysate analytes and ratios (L:G and L:P), fluid 
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recovery and pedometer counts were compared over time using Friedman analysis with 
Dunn‟s post-tests. The analyte concentrations and ratios were compared between skin and 
lamellar samples at each time point using Wilcoxon signed-rank tests. Statistical significance 
was set at P<0.05. Data are presented as median and interquartile range [IQR]. For graphical 
presentation and to eliminate the potential effects of between-subjects variability, all data 
were expressed as a percentage of the mean pre-intervention baseline value as previously 
described [31]. Statistical analyses were performed using GraphPad Prism v6.00 for 
Windows
n
. 
 
Results 
Control period 
The median [IQR] control period analyte concentrations, calculated ratios and fluid 
recovery from the lamellar and skin probes (over the entire 1 h period) are presented in Table 
1. There were no significant differences in any of the analyte values, fluid recovery or the 
pedometer counts between individual time points during the control period. Glucose 
concentration was significantly higher in skin compared with lamellar dialysate during the 
control period. 
 
Distal limb tourniquet 
Application of the tourniquet to the instrumented limb caused a rapid, significant 
decrease in lamellar dialysate glucose and an increase in lactate, urea, L:G and L:P (Fig. 1). 
Glucose was lowest after 30 min during tourniquet application (21.74 [3.47-36.99] % of 
baseline; 0.14 [0.11-0.23] mmol/L) and L:G peaked at the same time (343.4 [226.8-378.9] % 
of baseline; 8.63 [6.03-14,65]); whereas L:P peaked 15 minutes after removal of the 
tourniquet (227.0 [194.3-345.9] % of baseline; 36.13 [31.36-53.91]). There were no 
significant changes in simultaneous tail skin dialysate concentrations or ratios compared with 
the pre-intervention baseline value (data not shown). Glucose concentration was lower and 
urea, L:G and lactate higher in lamellar dialysate compared with skin during and after 
tourniquet application (Fig. 1). Pedometer count frequencies (Supplementary Fig. S1) and 
fluid recovery (Supplementary Fig. S2) were not significantly different from the pre-
intervention baseline value at any time point for tourniquet application. 
 
Local norepinephrine infusion 
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After inclusion of NE in the perfusate of both probes, there were rapid, significant 
decreases in glucose concentrations in both the lamellar and skin dialysates (Fig. 2). Glucose 
decreased to less than 20 % of pre-intervention baseline values after 45 min (19.09 [10.26-
86.19] %; 0.12 [0.07-0.43] mmol/L for lamellar, and 7.32 [4.08-55.22] %; 0.11 [0.06-0.82] 
mmol/L for skin). Lamellar and skin L:G also increased significantly. Significant increases in 
lactate and L:P occurred in skin but not lamellar dialysate, and there were also significant 
differences between skin and lamellar lactate concentrations and L:P during the infusion 
period (Fig. 2). Although there were apparent increases in dialysate urea concentration in both 
the skin and lamellar dialysates, this was only significant for skin at 45 min (Fig. 2C). 
Pedometer count frequencies (Supplementary Fig. S1) and fluid recovery (Supplementary Fig. 
S2) did not vary significantly from baseline during the NE infusion period.  
 
Local potassium chloride infusion 
With inclusion of KCl in the perfusate, a decrease in L:G was the only significant change 
compared with baseline in lamellar dialysate (Fig. 3B). In the skin, glucose increased (Fig. 
3A) and L:G decreased (Fig. 3B) significantly compared to baseline. Glucose, lactate and L:G 
differed significantly between lamellar and skin dialysates during the infusion period (Fig. 3). 
A decrease in urea concentration was apparent in both lamellar and skin dialysate, but the 
change did not reach statistical significance in either (Fig. 3C). Pedometer count frequencies 
(Supplementary Fig. S1) and fluid recovery (Supplementary Fig. S2) did not vary 
significantly from baseline. 
 
Intravenous acepromazine 
Lamellar dialysate glucose significantly decreased and L:G significantly increased from 
30 min post IV injection of ACP (Fig. 4A&B). Lamellar glucose was lowest at 60 min post 
injection 20.86 [10.61-41.24] % of baseline). The lamellar pyruvate was significantly 
increased at 60, 75 and 90 min and L:P significantly decreased at 75 and 90 min post injection 
(Fig. 4A&B). There was no significant change in urea concentration in either lamellar or skin 
dialysate compared with baseline (Fig. 4C). In skin, no significant difference compared with 
baseline was identified for any analyte (Fig. 4A&B). When compared with skin, lamellar 
dialysate glucose was significantly lower at all time points except 75 min after ACP injection 
(Fig. 4A). Lamellar dialysate urea was significantly lower than skin at 15 min and 75 min, 
and lamellar pyruvate was significantly higher than skin at 15 min, 75 min and 90 min post 
ACP injection. There was no significant change in fluid recovery compared to baseline 
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(Supplementary Fig. S2). Pedometer count frequency decreased significantly from baseline 
values after IV ACP and overall was significantly different from the control period 
(Supplementary Fig. S3). 
 
Discussion 
Tissue microdialysis was capable of detecting rapid transient perfusion and metabolite 
changes in equine lamellar tissue. The dramatic decrease in glucose, and increase in lactate, 
L:G and L:P recorded in lamellar samples during tourniquet application is a typical metabolic 
pattern attributed to ischaemia in other tissues [19]. This was also reflected in the significant 
increase in dialysate urea concentration (decreased urea clearance), which demonstrates that 
the urea clearance method can detect lamellar hypoperfusion during an ischaemic episode 
[27]. The L:P increase (227.0 [194.3-345.9] % of baseline; 36.13 [31.36-53.91] mmol/l) was 
consistent with initial transient ischaemia in other tissues such as brain, where it is the most 
useful indicator of energy failure [19; 34]. The absence of similar changes in the dialysate 
from the remote skin probe confirms that there was no systemic effect of limb tourniquet 
application. The method of tourniquet application used in the current study (Esmarch‟s 
bandage applied tightly; > 5 wraps with maximum stretch before each wrap) exceeds the 
pressure required for arterial occlusion in humans [35; 36] and is therefore expected to cause 
both arterial and venous occlusion when applied to the fetlock region in the horse [17], 
however this has not been directly evaluated and was not evaluated in the current study. 
Although there were profound metabolite changes, urea clearance did not significantly 
reflect expected perfusion changes with other interventions, and overall only tourniquet 
application (lamellar) and perfusion with NE (skin) caused significant changes in urea 
clearance. Since microdialysis perfusion rate can affect the sensitivity and resolution of the 
urea clearance technique [27], the use of a relatively high perfusion rate (1 µL·min
-1
) in this 
study may have reduced the likelihood of significant changes. The use of a lower perfusion 
rate (≤ 0.5 µL·min-1) may be appropriate for future studies, but must be balanced with the 
requirement for adequate sample volume to enable analysis, which dictates sampling 
intervals. 
Inclusion of NE in the perfusate caused significant changes in metabolite concentrations 
that were consistent with a reduction in perfusion due to vasoconstriction, but there were key 
differences between the skin and lamellar response. A similar profound decrease in glucose 
was observed in both skin and lamellar dialysate, which is consistent with decreased perfusion 
[26]. In skin, lactate, L:P and L:G increased significantly, whereas only a mild significant 
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increase in L:G occurred in lamellar dialysate. The relative lack of lactate accumulation in 
lamellar tissue under these circumstances compared with skin may be due to its utilisation as 
an energy source by lamellae (via lactate dehydrogenase, richly present in lamellar epidermis 
[37]) or efficient removal via a lactate shuttle [38] as previously suggested [29]. The changes 
in urea clearance with NE infusion were only significant in skin dialysate, suggesting that any 
relative decrease in perfusion compared with baseline was less profound or consistent in the 
lamellar tissue. The higher baseline concentration of urea in lamellar compared with skin 
dialysate (Table 1), although not significant, suggests relatively lower lamellar urea clearance 
(and therefore perfusion) [27] and the significantly lower baseline lamellar glucose 
concentration in this and a previous study [29] further supports this. Therefore any induced 
decreases in perfusion may have been less apparent in lamellar dialysate due to the 
comparatively lower baseline perfusion. There was also a lack of significant lamellar 
metabolite or urea clearance changes in response to the addition of KCl to the perfusate, 
which at these concentrations is expected to cause local vasodilation [32]. Although mild, a 
change in metabolite profile compatible with increased perfusion (increased glucose, 
decreased L:G) was apparent in skin dialysate. The use of KCl for induction of vasodilation 
has not been validated in microdialysis models, and although electrolytes would be expected 
to equalise rapidly across the microdialysis membrane [39], the tissue concentrations of KCl 
achieved in this study during the 45 minute infusion period were not measured. 
Previous studies have demonstrated an increase in palmar digital arterial blood flow [12; 
40] and lamellar microvascular perfusion (measured using laser Doppler flowmetry) [12] 
beginning 15-20 minutes after intravenous ACP administration. In the current study, there 
was no significant change in urea clearance and therefore no apparent change in perfusion; 
however, ACP administration did result in a marked decrease in glucose concentrations in the 
lamellar (but not skin) dialysate. Such a marked decrease in dialysate glucose would be 
expected with hypoperfusion rather than hyperaemia; however, in the absence of apparent 
perfusion changes the alternative explanation for the decreased lamellar dialysate glucose 
noted after ACP administration is a marked increase in cellular glucose uptake [41]. 
Phenothiazine derivatives have been shown to have direct effects on glucose uptake in vitro, 
but in the published studies they actually caused reduced cellular glucose uptake in 
mammalian tissues [42] and protozoa [43]. In the horse digit ACP, through its α-adrenergic 
inhibitory effects [44], is likely to cause opening of arterio-venous anastomoses (AVAs), 
richly present in lamellar tissue [18; 38; 45] but not necessarily the skin over the tail. The 
AVAs have a temperature-regulating function [46], rapidly increasing local tissue temperature 
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on opening in order to increase heat dissipation [47; 48]. Any increase in lamellar tissue 
temperature would be expected to increase metabolic rate [49] and therefore cellular glucose 
uptake, which could account for the marked significant decrease in dialysate (interstitial) 
glucose concentrations after ACP noted in the current study. Furthermore, opening of AVAs 
would increase net blood flow to lamellar tissue, as observed previously with laser Doppler 
flowmetry [12], but may not affect capillary flow [45] and therefore would not affect 
measurements of urea clearance or nutrient delivery in particular. Unfortunately lamellar 
temperature was not measured in this study nor was ambient temperature controlled. Further 
studies are needed to assess the effects of tissue temperature on lamellar metabolism: 
monitoring lamellar temperature and controlling ambient temperature is suggested for future 
lamellar microdialysis studies. The sedative effect of ACP also produced a significant 
decrease in limb load cycling activity (pedometer count frequency) (Supplementary Figure 
S3). Since limb load cycling/weight shifting is thought to enhance lamellar perfusion [11; 15; 
50], any reduction could reduce perfusion and therefore lamellar dialysate glucose 
concentration, although, as stated above, the pattern of the other metabolites does not support 
this as a reason for the observed changes in the current study. Nevertheless, it was recently 
reported that lamellar perfusion appears to be mostly dependent on limb load cycling/weight 
shifting [51], so the influence of a decrease in limb load cycling frequency after ACP 
administration perhaps overrides any attempts at pharmacologic manipulation of lamellar 
perfusion (particular vasodilation) in the standing static horses in this study.  
A major limitation of this study is that microdialysis was not compared to an established 
standard technique for measuring perfusion; however in the case of hoof lamellar tissue the 
rich presence of AVAs precludes accurate measurement of capillary perfusion using 
previously published techniques [12; 14-17]. In addition, the simultaneous measurement of 
energy metabolite patterns is unique to the microdialysis technique. The sequential order of 
interventions used in this study could have potentially affected results. To reduce potential 
bias, the order in which the interventions were performed was randomized. Furthermore, a 
washout period, combined with real time sample analysis enabled the investigators to ensure 
metabolite concentrations in the dialysates had returned to approximately pre-intervention 
baseline values before commencement of the subsequent intervention. Unfortunately, the 
random order of interventions precluded the evaluation of time effects on metabolites across 
the duration of the study, however the stability of the measured metabolites over a 24 h period 
in horses under similar conditions (but not subjected to any interventions) using this technique 
has been previously demonstrated [29].  
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Conclusion 
Using microdialysis with urea clearance we were able to detect a decrease in perfusion 
associated with transient severe lamellar hypoperfusion (tourniquet application), and the 
consequences of reduced perfusion and nutrient delivery were reflected in the dialysate 
energy metabolite concentrations. Other interventions expected to alter lamellar perfusion in 
this study did not significantly alter urea clearance, but did cause marked metabolite changes 
that reflected alterations in local tissue energy balance. The ability to document the effects of 
any detected perfusion changes on lamellar energy balance may prove useful when studying 
the role of perfusion changes in the development of laminitis. Measurement of lamellar 
microcirculatory perfusion is complicated by the presence of AVAs, and in this study ACP 
did not have an expected positive effect on lamellar microvascular perfusion and interstitial 
glucose availability. Instead, the profound effect of ACP on lamellar energy metabolites was 
suggestive of an increase in metabolic rate, probably due to increased tissue temperature as a 
consequence of opened AVAs. Changes in metabolic rate, modulated by the thermoregulatory 
effects of AVAs, may have a profound influence on lamellar energy metabolism and this 
requires further study. 
 
Manufacturers 
a,c,f,g,i CMA Microdialysis, Sweden 
b Shanghai Alifun Medical Technology, Shanghai, China 
d Hoof-Life, Baltimore, MD, USA 
e Troy Laboratories, Glendenning, NSW, Australia 
h Sigma-Aldrich, Castle Hill, NSW, Australia 
j,l Boehringer Ingelheim, North Ryde, NSW, Australia 
k BRAUN, Bella Vista, NSW, Australia 
m Yamax, Tokyo, Japan 
n GraphPad Software, La Jolla, California, USA  
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Table 5.2.1: Median ± [IQR] metabolite concentrations, calculated ratios and fluid recovery 
(% of infused volume) for lamellar and skin dialysate during the 1 hour control period. 
*Statistically significant difference between lamellar and skin dialysate. 
 
Analyte Lamellar dialysate Skin dialysate unit 
Glucose 0.51 [0.17-0.72]* 1.47 [0.92-2.33] mmol/L 
Lactate 0.97 [0.83-1.96] 1.85 [1.53-2.30] mmol/L 
Pyruvate 62.4 [38.75-73.5] 103.6 [75.28-118.1] µmol/L 
Urea 14.93 [12.16-16.06] 12.04 [9.04-13.78] mmol/L 
L:G 2.22 [1.0-12.25] 1.07 [0.87-2.07] ratio 
L:P 15.49 [13.58-31.54] 15.87 [14.49-21.20] ratio 
Recovery 100 [98-106] 103 [93-108] % 
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Figure 5.2.1: Median ± [IQR] changes in lamellar dialysate metabolite concentrations in 
response to application of a tourniquet over the fetlock region for 30 min (shaded area). The 
tourniquet was applied at the 0 min time point and removed after 30 min. A rapid and 
significant decrease in glucose (A), with an increase in lactate, L:G and L:P (B) was observed 
after tourniquet application. The urea concentration increased significantly (a decrease in urea 
clearance) confirming reduced lamellar perfusion (C). There were no significant changes in 
simultaneously measured skin parameters compared with baseline (data not shown). 
*Significantly different (P<0.05) from pre-intervention baseline. # Significant difference 
(P<0.05) between lamellar and skin dermis at that time point. Results are expressed as a 
percentage of the pre-intervention baseline value. 
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Figure 5.2.2: Lamellar (left column) and skin (right column) median ± [IQR] changes in 
dialysate metabolite concentrations in response to the addition of norepinephrine (0.5 mg/L) 
to the perfusate for 45 min (shaded area). There was a significant decrease in glucose in both 
lamellar and skin dialysates which was lowest at 45 min, and lactate was significantly 
increased after 30 min in skin but not lamellar dialysate (A). L:G was significantly increased 
in lamellar dialysate at 45 min but L:P did not increase significantly, whereas in skin there 
were significant increases in L:G and L:P (B). Although NE was associated with a gradual 
increase in urea concentration (decreased urea clearance) in both lamellar and skin dialysates, 
this was only significant in the skin (C). *Significantly different (P<0.05) from pre-
intervention baseline. # Significant difference (P<0.05) between lamellar and skin dermis at 
that time point. Results are expressed as a percentage of the pre-intervention baseline value. 
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Figure 5.2.3: Lamellar (left column) and skin (right column) median ± [IQR] changes in 
dialysate metabolite concentrations in response to the addition of potassium chloride (15 
mmol/L) to the perfusate for 45 min (shaded area). Glucose, lactate and pyruvate did not 
change significantly in lamellar dialysate , but in the skin, glucose increased significantly and 
was higher compared to lamellar dialysate from 15-45 min (A). There was a significant 
decrease in lamellar L:G which was also present in skin dialysate (B). KCl was associated 
with a gradual decrease in urea concentration (increased urea clearance) in both lamellar and 
skin dialysates but the changes were not significant (C). *Significantly different (P<0.05) 
from pre-intervention baseline. # Significant difference (P<0.05) between lamellar and skin 
dermis at that time point. Results are expressed as a percentage of the pre-intervention 
baseline value. 
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Figure 5.2.4: Lamellar (left column) and skin (right column) median ± [IQR] changes in 
dialysate metabolite concentrations after intravenous administration of acepromazine (ACP). 
There was a marked and significant decrease in lamellar dialysate glucose (A) and increase in 
L:G (B) which was not present in skin dialysate. This was accompanied by an increase in 
pyruvate and L:P in lamellar dialysate. There was no significant change compared with 
baseline in urea concentration in either lamellar or skin dialysate (C). The metabolite pattern 
in lamellar dialysate after ACP administration was most consistent with increased glucose 
uptake and utilisation, rather than decreased glucose delivery (hypoperfusion). *Significantly 
different (P<0.05) from pre-intervention baseline (time 0). # Significant difference (P<0.05) 
between lamellar and skin dermis at that time point. Results are expressed as a percentage of 
the pre-intervention baseline value. 
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Supplementary Figure 5.2.1: Median ± [IQR] pedometer count frequency in each forelimb 
(instrumented -INS- and non-instrumented -Not INS-) during tourniquet application (A), and 
during local delivery of NE (B) and KCl (C) in the perfusate. Pedometer count frequencies 
did not differ significantly between INS and Not INS.  
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Supplementary Figure 5.2.2: Median ± [IQR] fluid recovery during tourniquet application 
(A), during local delivery of NE (B) and KCl (C) in the perfusate, and after intravenous 
administration of ACP (D). Fluid recovery remained stable during each intervention and 
measured volumes did not differ significantly from recovery during the pre-intervention 
baseline period. 
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Supplementary Figure 5.2.3: Median ± [IQR] pedometer count frequency after ACP 
administration. Pedometer count frequencies decreased significantly in both the instrumented 
and non-instrumented limbs for 60 min after ACP administration. Although reduced limb load 
cycling is thought to impair lamellar perfusion, the pattern of dialysate metabolites after ACP 
administration reflected an increase in glucose uptake and utilisation, rather than decreased 
glucose availability. *Significantly different (P<0.05) from pre-intervention baseline value.  
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5.4. Experiment 4 
 
Microdialysis measurements of lamellar perfusion and energy metabolism during the 
development of laminitis in the oligofructose model. 
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Supplementary Table 5.4.1: Spearman‟s rank correlation coefficients (rs) between lamellar 
and skin (OFT only) dialysate and plasma metabolite concentrations, lactate:glucose (L:G) 
and lactate:pyruvate (L:P) ratios in control (CON) and oligofructose-treated (OFT) horses, 
and between lamellar microdialysis urea clearance and pedometer count frequencies in the 
instrumented limb in each group (OFT and CON). For n=12, the magnitude of the correlation 
coefficient deemed to be significant at α=0.05 and β=0.8 is rs≥0.68. *: significant correlation. 
 
 
  SPEARMAN’S RANK CORRELATION COEFFICIENTS (rs) 
  Glucose Lactate Pyruvate L:G L:P Urea 
CON 
Lamellae 
vs 
Plasma 
0.498 
(P=0.086) 
0.093 
(P=0.765) 
-0.599 
(P=0.034) 
0.703 
(P=0.009)* 
-0.390 
(P=0.189) 
0.357 
(P=0.232) 
OFT 
Lamellae 
vs 
Plasma 
-0.137 
(P=0.656) 
0.307 
(P=0.306) 
-0.022 
(P=0.949) 
0.313 
(P=0.297) 
-0.110 
(P=0.723) 
0.368 
(P=0.217) 
Skin 
vs 
Plasma 
0.022 
(P=0.949) 
0.253 
(P=0.401) 
0.258 
(P=0.349) 
-0.011 
(P=0.978) 
0.187 
(P=0.541) 
-0.264 
(P=0.383) 
  
Pedometer count frequency vs lamellar dialysate urea concentration 
INTRUMENTED 
LIMB 
CON  
-0.698 
(P=0.010)* 
OFT  
-0.162 
(P=0.587) 
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Supplementary Figure 5.4.1: Median ± interquartile range [IQR] temporal variations in 
clinical parameters (temperature (A), heart rate (B) and respiratory rate (C)) throughout the 
study. Significant differences (P≤0.05) compared to baseline (time 0) were observed only in 
oligofructose-treated horses (OFT, green) and are marked with #. Significant difference 
(P≤0.05) between OFT and control horses (CON, blue) are marked with an asterisk. 
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5.5. Experiment 5 
 
A liquid chromatography–tandem mass spectrometry-based investigation of the 
lamellar interstitial metabolome in healthy horses and during experimental laminitis 
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Abstract 
Lamellar bioenergetic failure is thought to contribute to laminitis pathogenesis. 
However, current knowledge of lamellar bioenergetic physiology is limited. Metabolomic 
analysis can systematically profile multiple metabolites. Applied to lamellar microdialysis 
samples (dialysate), lamellar bioenergetic changes during laminitis (the laminitis 
metabolome) could be characterised. The objectives of this study were to develop a technique 
for targeted metabolomic analysis of lamellar and skin dialysate in normal horses, and to 
compare the lamellar and plasma metabolomic profiles of normal horses to those from horses 
developing experimentally induced laminitis. Archived lamellar and skin dialysate (n=7) and 
tissue (n=6) from normal horses, and lamellar dialysate and plasma from horses given either 
10 g/kg oligofructose [treatment group (OFT); n=4] or sham [control group (CON); n=4] 
were analysed. The concentrations of 44 intermediates of central carbon metabolism (CCM) 
were determined using liquid chromatography – tandem mass spectrometry. Data were 
analysed using multivariate (MVA) and univariate (UVA) analysis methods. 
 
The plasma metabolome appeared to be more variable than the lamellar metabolome 
by MVA, driven by malate, pyruvate, aconitate and glycolate. In lamellar dialysate, these 
metabolites decreased in OFT horses at the later time points. Plasma malate was markedly 
increased after 6 hours in OFT horses. Plasma malate concentrations between OFT and CON 
at this time point were significantly different by UVA. Metabolomic analysis of lamellar 
CCM was capable of differentiating horses developing experimental laminitis from controls. 
Lamellar malate, pyruvate, aconitate and glycolate, and plasma malate alone, were identified 
as the source of differentiation between OFT and CON groups. These results highlighted clear 
discriminators between OFT and CON horses, suggesting that changes in energy metabolism 
occur locally in the lamellar tissue during laminitis development. The biological significance 
of these alterations requires further investigation. 
 
 
 
Keywords: Bioenergetic; Chromatography; Energy metabolism; Metabolomic; Sepsis   
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Introduction 
Failure of lamellar energy metabolism (bioenergetic failure) is thought to be involved in 
the pathophysiology of sepsis-related (Belknap et al., 2009), endocrinopathic (French and 
Pollitt, 2004; Pass et al., 1998) and supporting limb (van Eps et al., 2010) laminitis in the 
horse. High lamellar glucose consumption has been demonstrated both in vitro (Pass et al., 
1998) and in vivo (Wattle and Pollitt, 2004). Lamellar hemidesmosomes, specialised 
multiprotein complexes that participate in the attachment of epithelial cells to their underlying 
basement membrane (Borradori and Sunnenberg, 1999), are lost in the absence of glucose and 
the dermo-epidermal attachment becomes weak (French and Pollitt, 2004; Pass et al., 1998). 
It has recently been proposed that sepsis-related laminitis may also occur secondary to 
inappropriate utilisation of energy substrates (i.e. glucose) (Belknap et al., 2009), as is thought 
to occur in sepsis-related organ dysfunction in humans (Callahan and Supinski, 2005; 
Fullerton and Singer, 2011; Leverve, 2007; Singer, 2008).  Despite the purported role of 
energy failure in laminitis pathogenesis, current knowledge about lamellar bioenergetic 
physiology is limited. 
 
The goal of metabolomic analysis is the comprehensive measurement of metabolite 
concentrations associated with a biological system at the cellular, tissue or whole organism 
level (Goodacre et al., 2004). Metabolomic analysis results in the systematic profiling of 
multiple metabolites and their temporal (or population) changes in biofluids and tissues 
(Oliver et al., 1998). It can be undertaken using two broadly different approaches, namely 
open (or untargeted) profiling metabolomics or targeted (quantitative) metabolomics 
(Goodacre et al., 2004). Targeted metabolomics in veterinary science can be regarded as an 
extension of a clinical chemistry panel whereby several predetermined analytes are 
quantitatively measured to assess their role in an underlying process. A recent open 
metabolomics study of serum from horses before and after experimentally-induced laminitis 
revealed evidence of dysregulation of fatty acid metabolism, accumulation of organic acids 
(lactate) and identified the amino acid citrulline to be decreased in serum prior to the onset of 
clinical laminitis (foot pain) (Steelman et al., 2014). 
 
Using tissue microdialysis, our laboratory has examined the major energy metabolites 
(glucose, lactate and pyruvate) in the interstitium of the lamellar and skin dermis in normal 
horses over 24 h (Medina-Torres et al., 2014).  In the current study we sought to combine 
tissue microdialysis and metabolomics to examine the changes in lamellar energy central 
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carbon metabolism that occur locally during the development of laminitis. The analysis of the 
three major energy metabolites previously described (Medina-Torres et al., 2014) was 
considerably extended in this study by measuring the major energy metabolite pathway 
intermediates of glycolysis, the pentose phosphate pathway and the Krebs cycle, as well as 
nucleotides and co-factors. The primary aim of this metabolomic analysis was to determine 
the source and/or metabolic sequelae of any perturbation caused by experimental induction of 
laminitis and subsequent bioenergetic failure. Our objectives were: 1) to develop a reliable 
and reproducible technique for metabolomic analysis of equine lamellar and skin 
microdialysis samples (dialysates) and tissue samples using high performance liquid 
chromatography (HPLC) coupled to tandem mass spectrometry (MS/MS), 2) to compare 
dialysate and tissue extracts of lamellar tissue with the skin using targeted (quantitative) 
metabolomic analysis, and 3) to use targeted metabolomics to compare serial lamellar and 
plasma samples from normal horses with those of horses undergoing laminitis induction using 
the oligofructose (OF) model. 
 
Materials and Methods 
Samples  
Archived (< 1 year at -80°C) samples from adult Standardbred horses were used for 
analysis. Samples were collected during a previous study approved by The University of 
Queensland Animal Ethics Committee (AEC) that monitors compliance with the Animal 
Welfare Act (2001) and the Code of Practice for the care and use of animals for scientific 
purposes (current edition). Lamellar and skin microdialysis samples obtained every two hours 
over a 24-hour study period from seven healthy horses, skin and lamellar tissue blocks 
obtained from six healthy horses immediately after euthanasia, and lamellar microdialysis and 
plasma samples obtained from eight horses at 0, 6, 12 and 24 hours after nasogastric 
administration of either a bolus dose of 10 g/kg OF (Invita) [treatment group (OFT); n=4] as 
previously described (van Eps and Pollitt, 2006), or sham treatment [control group (CON); 
n=4] were analysed. The OFT horses had developed Obel grade 1 lameness (Obel, 1948) at 
18 to 22 hours after OF dosing and had histological evidence of acute laminitis at 48 h. 
Dialysate was collected with coaxial microdialysis probes with a 0.5 x 10 mm, 100 kDa cut-
off membrane (CMA20, CMA-Microdialysis), inserted into the lamellar tissue of one 
forelimb and into the skin dermis at the tail base as previously described (Medina-Torres et 
al., 2014). All probes were perfused with isotonic, polyionic sterile perfusion fluid (T1, CMA-
Microdialysis) containing 40 g/L dextran-70 (Sigma-Aldrich) to prevent perfusate loss as 
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previously described (Rosdahl et al., 1997). Plasma was separated by immediate 
centrifugation (15,000 × g, 10 min) of whole blood samples collected into heparinised tubes 
(Vacuette, Greiner Bio-One GmbH) in OFT and CON horses via a 16G indwelling catheter 
(Mila International Inc) placed aseptically in the right jugular vein. 
 
Development and optimization of LC-MS/MS 
In each sample, central carbon metabolism (CCM) was assessed by liquid 
chromatography - tandem mass spectrometry (LC-MS/MS) using a targeted method briefly as 
follows: 
 
For lamellar and skin microdialysis samples, assessment of the perfusion fluid 
(perfusate) was performed to determine its suitability as a calibration matrix. The performance 
of a perfusate-based calibration was measured and compared against an aqueous “blank” 
calibration through standard addition of the metabolite panel (reference standards; Sigma-
Aldrich) to the perfusate matrix. Thereafter lamellar and skin microdialysis samples were 
measured to assess the need for further optimization based upon sample-related effects on the 
analytical system. 
 
To analyse the metabolite composition of lamellar and skin dermis tissue sections, 
metabolites were extracted using a procedure adapted from Want et al (2013). In brief, 50 mg 
of each sample were sliced with a scalpel, suspended in 2 mL of 1:1 methanol:purified water 
plus 2 µL 1 mM azidothymidine (AZT) as an internal quantitative standard, and homogenised 
for 5 min at 20,000 rpm using an Omni TH Homogenizer (Omni International Inc). Purified 
water was generated using a water purification unit (Elga Purelab Classic; Veolia Water 
Solutions and Technologies). The fluid fraction/supernatant was collected and centrifuged for 
15 min at 13,000 × g at 4°C. The supernatant (800 µL) was retrieved and chloroform (800 
µL) added before vortexing for 15 s. Samples were then centrifuged for 10 min at 13,000 × g 
at 4°C and the supernatant (upper polar phase; 600 µL) was collected. Addition of chloroform 
(600 µL), vortexing and centrifugation were repeated. The upper polar phase was collected 
and dried down in a vacuum centrifuge (Eppendorf Concentrator Plus; Eppendorf) for 180 
min at 45°C using the V-AQ program. The dried sample was resuspended immediately in 100 
µL of purified water for LC/MS-MS analysis. Plasma (50 μL) was processed using the same 
extraction procedures, without the need for the initial tissue homogenization step. 
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LC-MS/MS data were acquired using a Dionex UltiMate 3000 LC system (Dionex) 
coupled to an ABSciex 4000 QTRAP mass spectrometer (ABSciex) as described by Dietmair 
et al (2012), with the following modifications: the analytical column was equipped with a pre-
column Security Guard Gemini-NX C18 4 × 2 mm I.D. cartridge (Phenomenex) and 5 
additional analytes were quantified, as well as AZT (internal standard). The LC system was 
controlled by Chromeleon software v6.80
n
, and chromatographic separation was achieved by 
injecting 10 μL onto a Gemini-NX C18 150 × 2 mm I.D., 3 μm 110 Å particle column 
(Phenomenex). The column oven temperature was controlled and maintained at 55°C 
throughout the acquisition and the mobile phases (adapted from Luo et al (2007)), were as 
follows: 7.5 mM aqueous tributylamine (puriss plus grade; Sigma-Aldrich) adjusted to pH 
4.95 (±0.05) with glacial AR-grade acetic acid (eluent A; Labscan) and LC-grade acetonitrile 
(eluent B; Labscan). The mobile phase flow rate was maintained at 300 μL/min throughout 
the gradient profile (Table 1), and was introduced directly into the mass spectrometer with no 
split. The MS was equipped with a TurboV electrospray source operated in negative 
ionisation mode, and data acquisition was controlled by Analyst v1.5.2 software (ABSciex). 
The following optimised parameters were used to acquire scheduled Multiple Reaction 
Monitoring (sMRM) data: ion spray voltage −4500V, nebulizer (GS1), auxiliary (GS2), 
curtain (CUR) and collision (CAD) gases were 60, 60, 20 and medium (arbitrary units), 
respectively, generated in a N300DR nitrogen generator (Peak Scientific). The auxiliary gas 
temperature was maintained at 350°C. A total of 44 analytes were quantified using HPLC-
MS/MS; the analytes and analyte-dependent parameters for the detection of central carbon 
metabolites are presented in Supplementary Table 1. For all analytes the entrance potential 
(EP) was -10 volts. Samples were run with sample- and analyte-relevant calibration standards 
and pooled quality control samples (Hodson et al., 2009; Sangster et al., 2006) to control for 
reproducibility of data acquisition and to ensure data integrity. The order of acquisition of the 
samples was randomised to remove/minimise any bias or batch effects related to sample type 
or, if applicable, treatment regimes. Analyte stock solutions were prepared in purified water, 
and aliquots of each solution were mixed to achieve a final calibrant solution at 200 μM. This 
calibrant solution was diluted to provide a total of 20 calibration standards at 200; 150; 100; 
90; 70; 50; 40; 25; 12.5 and 1:1 serial dilutions to 0.006 μM, constituting 7 ≤ x ≤ 20 
calibration points for all analytes to account for differential responses in the mass 
spectrometer. 
 
Data processing and statistical analysis 
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Data acquired by HPLC-MS/MS were processed using MultiQuant v2.1.1 software 
(ABSciex). Multivariate analysis (MVA) of the data was performed using SIMCA v13.0.3.0 
software (MKS Umetrics AB). Two MVA methods were applied, namely principal 
component analysis (PCA) and orthogonal projection to latent structures-discriminant 
analysis (OPLS-DA). For more information relating to these methods see Trygg et al (2007) 
and Bylesjö et al (2006). 
 
In normal horses, results were compared between lamellar and skin dermis dialysate, 
and between lamellar dialysate samples and tissue sections. In the OF study animals, results 
were compared between lamellar dialysate from OFT and CON groups, between time points 
within each sample group, and between lamellar dialysate and plasma. Using GraphPad Prism 
v6.00 for Windows (GraphPad Software), univariate analysis was then performed on selected 
metabolites identified by MVA. The data were tested for normality using D‟Agostino-Pearson 
omnibus K2 normality tests; non-parametric tests were applied if the data failed this test. 
Metabolite concentrations in lamellar dialysate and plasma were compared at each time point 
between OFT vs CON horses. Significance was set at P < 0.05. 
 
Results 
There was no evidence to suggest that, in comparison to a water-based calibration, the 
T1 solution with 40 g/L dextran-70 matrix caused any overt suppression or enhancement of 
the mass spectrometric detection of analytes from CCM. Lamellar and skin microdialysis 
samples were subsequently measured successfully after extraction, so no further processing of 
the samples was required. The metabolite composition of both lamellar and skin tissue 
sections was also successfully determined; without extensive testing of multiple methods the 
extraction protocol was thus deemed suitable for characterisation of intracellular CCM 
analytes in these two tissues. 
 
Skin vs lamellar dialysate 
Multivariate analysis was used to compare the data obtained from lamellar and skin 
dialysate, initially using PCA to summarise the major sources of variance in the data. Figure 
1a shows the PCA scores plot for this comparison and it is clear from this plot that the 
distributions of the samples from the skin and the lamellae were similar and approximately 
overlap each other. When applying alternative colouring to the PCA (Figure 1b) based upon 
horse (subject), some structure to the variance can be observed relating to the horse from 
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which the samples were taken. Supervision of the MVA using OPLS-DA was also unable to 
clearly separate skin and lamellar samples based upon their detectable metabolome in this 
experiment (Figure 1c). 
 
Lamellar dialysate vs plasma 
PCA of the metabolome of these samples showed clear differences, as observed in 
Figure 2a. In general the plasma metabolome appeared more variable than that of the 
dialysate. This was driven by central carbon metabolites such as malate, where clear 
differences were not only observed between plasma and lamellar dialysate but also between 
the control and treated groups. Marked increases in malate where seen, particularly at the 6 
hour time point in the plasma of OFT-treated subjects (Figure 2c). Figure 2b shows the 
loadings relating to the scores plot in Figure 2a and highlights the variables and therefore the 
metabolites that are influential in the differentiation between plasma and lamellar dialysate. 
Clearly observable group- and time-dependent metabolite profile differences were also noted 
for metabolic intermediates such as aconitate (Figure 2d), pyruvate (Figure 2e) and glycolate 
(Figure 2f). 
 
Univariate analysis of the lamellar dialysate revealed significantly (P<0.05) higher 
malate at the 6-hour time point and lower malate and aconitate at the 24-hour time point in 
OFT horses compared with CON (Figure 3). Pyruvate and glycolate concentrations were not 
found to be significantly different between OFT and CON, however a decrease in the 
concentrations of all four metabolites was apparent in the OFT group at the later time points, 
while concentrations remained stable in the CON group (Figure 3). Plasma malate 
concentrations increased significantly at the 6-hour time point in OFT compared to CON 
horses (Figure 4). 
 
OFT vs CON 
After investigating the overall differences between metabolite concentrations in lamellar 
and plasma samples, a more directed analysis was performed to look specifically at the 
comparison between lamellar microdialysate samples from CON and OFT subjects, as well as 
comparing the same for plasma extracts. In the case of plasma extract samples, PCA and 
OPLS-DA models highlighted malate as the only major difference between the metabolome 
of the CON and OFT horses in plasma. In the case of the lamellar dialysate, models were 
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generated for all time points other than the zero time point (i.e. before treatment) and 
therefore metabolomic differences were observed based upon OF treatment (Figure 5 a-f).  
 
Lamellar tissue extracts vs skin tissue extracts 
A comparison of tissue extracts from lamellae and skin was also performed in an 
attempt to assess the central carbon metabolomic differences between these tissues. Figures 
6a-f show the supervised (OPLS-DA) separation of the two tissue extracts and highlights a 
number of clear differences in the central carbon metabolite content of these tissues. It should 
be noted that the extraction procedure was controlled with a generalised internal standard 
(AZT) to account for losses/reduced recovery, and that the differences observed are not due to 
a consistent increase of metabolites in one tissue after extraction, since metabolite levels are 
both higher and lower in one tissue compared to the other. The lamellar extracts were found 
to be more variable in metabolite content than the skin extracts, as can be observed by the 
tighter distribution of the skin samples in the scores plot (Fig 6a). 
 
Lamellar tissue extracts vs lamellar dialysate 
 The central carbon metabolome of lamellar tissue extracts was compared with that of 
the lamellar dialysate to ascertain how well the microdialysate metabolite profile reflects the 
lamellar tissue. Figure 7a&b show the loadings from unsupervised (PCA) and supervised 
(OPLS-DA) analyses of the samples (n=6/group), with a separation in 7a clearly resolved by 
supervision in 7b. Column plots of four metabolites are shown in figs 7c-f to highlight the 
differences in profile for many of the metabolites, the vast majority of which have much 
greater concentration in lamellar tissue with the exception of malate (figure 7f), succinate and 
glucose 1-phosphate. A summary of the concentrations of all analytes for the various biofluid 
and tissue extracts are detailed in Table 2. 
 
Discussion 
A method for metabolomic analysis of equine lamellar and skin dialysate and tissue 
extracts was successfully developed and enabled measurement of the CCM in microdialysate, 
plasma and tissue extract samples. 
 
Principal component analysis of the data from the lamellar and skin tissue of healthy 
adult horses demonstrated that by comparison, lamellar and skin dialysate had a similar 
metabolite composition (Figure 1a). When the PCA was coloured by subject (Figure 1b) a 
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pattern of variance related to the sample source (i.e. the horse) was observed. In general this 
means that the site of sampling (skin versus lamellae) was not a major discriminating factor 
when considering possible differences in metabolome, whereas inter-subject variability 
showed a degree of influence on the metabolomic content of the tissues. Furthermore, OPLS-
DA supervision of the MVA also failed to separate lamellar and skin dialysate samples based 
upon their CCM (Figure 1c), meaning there was a degree of similarity in the metabolomic 
content of microdialysis samples obtained from these two collection sites. As the dialysate 
from both sites can be expected to contain metabolites that diffuse freely across the 
membrane, the similarities in dialysate composition demonstrates that in the normal (healthy) 
horse the interstitial fluid composition of the lamellar tissue is similar to that of the skin. 
 
Clear differences between the metabolome of lamellar dialysate and plasma from CON 
and OFT subjects were observed with PCA (Figure 2a). Unexpectedly, the metabolome of the 
plasma samples was found to be more variable than that of the lamellar dialysate. This finding 
may seem surprising given the homeostatic control of plasma metabolite concentrations in 
particular but could possibly be explained by two factors; firstly the plasma sample is a 
snapshot in time whereas the microdialysate sample is collected over a longer period and as 
such provides a more “averaged signal” of metabolite concentrations; secondly, and linked to 
the first, the plasma sample is more likely to be affected by external influences such as 
feeding immediately prior to sample collection. The variability in plasma was driven by four 
central carbon metabolites (i.e. malate, aconitate, pyruvate and glycolate; Figure 2b-f), which 
were not only influential in the differentiation between the two tissue sample types, but also 
provided differentiation between the CON and OFT groups (e.g. significant increase in malate 
at the 6 h time point in OFT plasma). However, when looking specifically at the comparison 
between plasma extracts from CON and OFT subjects in isolation, only malate was indicated 
as a discriminatory metabolite. The time-related profile for malate suggests that the 
determination of plasma concentrations for this metabolite may be a suitable early predictor 
of laminitis development (at least in laminitis due to alimentary oligofructose overload), 
although further investigations with larger subject numbers would be required to confirm its 
utility. Furthermore, determination of plasma malate concentrations at intermediate time 
points (e.g. hourly sampling from 0 – 12 h after OF administration) would be necessary to 
identify the evolution of this rise in malate, the time point when the maximum concentration 
(peak) is reached, and its duration (i.e. the potential diagnostic window). However, as malate 
is an intermediate metabolite with important roles in energy producing pathways such as the 
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tricarboxylic acid cycle (TCA) in animals (Alberts et al., 2008) as well as the glyoxylate cycle 
in bacteria (Kornberg and Krebs, 1957), and the naturally occurring malate molecule (i.e. L-
malate) is identical in bacteria and mammals (Alberts et al., 2008), the source of plasma 
malate in the present study cannot be determined; it could be a by-product of bacterial 
fermentation of OF in the gastrointestinal tract, which would be consistent with the timing of 
the increase in plasma in this experiment. If this is the case, the use of malate as a predictor of 
laminitis in naturally occurring laminitis might be precluded. Contrary to malate, two 
different isoforms of lactate occur naturally: L-lactate in mammals and D-lactate in bacteria 
(Alberts et al., 2008). Thus, determining the plasma D-lactate concentration could help 
establish if this and other intermediate metabolites such as malate have originated in the 
intestinal lumen as a result of the bacterial disbiosis known to occur after OF administration 
(Millinovich et al., 2006). However, the LC-MS/MS method used in this study could not 
distinguish between these two lactate isoforms, and other means of differentiation were not 
attempted. Furthermore, plasma lactate was not a discriminatory metabolite between the CON 
and OFT groups. Though the absence of a discriminatory shift in plasma lactate 
concentrations might indicate that the source of other measured metabolites including malate 
may be other than the intestinal intraluminal bacteria, this cannot be established with the 
findings of the present study. Thus, whether the discrimination between the CON and OFT 
groups observed with malate is attributable to an influx of bacterial metabolites from the 
intestine or a consequence of metabolic disruption attributable to the development of sepsis-
associated laminitis in the horse remains to be determined. It could be an important future step 
in the understanding of the pathophysiology of sepsis-associated laminitis and in the 
identification of potential biomarkers for early disease diagnosis. 
 
Metabolomic analysis of lamellar dialysate was capable of differentiating between OFT 
and CON groups. This analysis highlighted two metabolites (malate and aconitate) as clear 
discriminators between OFT and CON horses. These results suggest that changes in energy 
metabolism do occur locally in the lamellar tissue during laminitis development and warrant 
further investigation using the lamellar microdialysis technique. However, these changes may 
not be biologically significant as they occurred in the later time points, coinciding with the 
onset of lameness (18–22 h), and after the developmental phase of the disease. This is further 
confounded by the fact that microdialysis is an interstitial sample, where the observed 
changes may not represent the true intracellular metabolic status and could be affected by 
other processes such as inflammation. 
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In general lamellar tissue was found to have higher metabolite concentrations in 
comparison to lamellar dialysate, with the exception of malate, succinate and glucose 1-
phosphate . The extracellular origin of the dialysate dictates that concentrations are likely to 
be lower than the intracellular pools, as the content of the dialysate consists for the most part 
of TCA intermediates and pyruvate, all of which are produced in the cellular cytoplasm. 
Assessing a more comprehensive dialysate metabolome using a larger microdialysis probe 
pore size and with the inclusion of amino acids, fatty acids and carbohydrates would be 
recommended for future studies in order to comprehensively examine lamellar metabolism 
during laminitis development. A similar approach was utilised recently for trapezius myalgia 
in humans (Hadrevi et al., 2013). Furthermore, concurrent assessment of regulatory enzymes 
of energy metabolism (glycolytic and oxidative) could help determine if lamellar energy 
failure is a feature of laminitis in the horse. Phosphofructokinase, a rate limiting enzyme of 
the glycolytic pathway, as well as electron transport chain components were genetically 
downregulated in muscle from a rodent sepsis model (Callahan and Supinski, 2005). 
 
The main limitations of this study were the low number of subjects included and that 
only four of the thirteen time points collected were assessed in OFT and CON horses (due to 
financial and logistical restrictions). However, despite these limitations, targeted metabolomic 
analysis and MVA was successful in differentiating OFT and CON horses and potential 
plasma/lamellar dialysate biomarkers were identified. 
 
Conclusion 
Metabolomic analysis of the lamellar dialysate samples for central carbon metabolites 
was found to be capable of differentiating horses developing experimental sepsis-associated 
laminitis from controls in the OF model. Malate, pyruvate, aconitate and glycolate in lamellar 
dialysate, and malate alone in plasma, were identified as the source of differentiation  between 
OFT and CON groups. The origin and clinical usefulness of these potential biomarkers for 
early identification of naturally occurring laminitis remains to be determined. These 
significant changes in energy metabolism intermediates in the lamellar interstitium occurred 
during laminitis development and were not present in plasma samples, suggesting that further 
investigation of local bioenergetic failure as a cause of laminitis due to sepsis is warranted. 
Having established the central carbon metabolome in these samples the next step would most 
127 
 
likely be an open profiling approach to further assess the changes to the metabolome elicited 
by experimentally-induced laminitis. 
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Table 5.5.1: Liquid chromatography mobile phase gradient profile. 
 
Time (minutes) Eluent A (%) 
0 100 
8 100 
20 80 
30 73 
31 0 
33 0 
34 100 
50 100 
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Table 5.5.2: Concentrations of central carbon metabolites in lamellar dialysate samples, lamellar tissue extracts and plasma extracts. Sample sets are composed of the 
following: lamellar dialysate (6) – 6 samples of 8 OFT vs CON horses at 0 hours; lamellar tissue extract (6) – 6 samples; lamellar dialysate (15) – 15 samples of 16 CON 
horses at 0-24 hours; plasma extract (16) – 16 samples of 16 CON horses at 0-24 hours. 
CCM 
Analyte 
LLOQ 
(µM) 
CAL 
Points 
Lamellar Dialysate (6) Lamellar Tissue Extract (6) Lamellar Dialysate (15) Plasma Extract (16) 
Mean ± SD (Min; Max) N Mean ± SD (Min; Max) N Mean ± SD (Min; Max) N Mean ± SD (Min; Max) N 
3PG/2PG 0,39 12     93.536 ± 32.209 (48.237; 143.842) 6         
6PG 0,39 14     95.635 ± 21.877 (72.985; 136.987) 6         
ACO 0,012 10 0.769 ± 0.529 (0.308; 1.599) 6 24.31 ± 4.76 (19.073; 30.985) 6 0.561 ± 0.366 (0.289; 1.599) 15 2.313 ± 0.783 (0.311; 3.754) 16 
ACoA 0,006 13     0.607 ± 0.218 (0.441; 0.918) 4         
ADP 0,195 14     130.906 ± 49.668 (64.332; 193.748) 6         
AMP 0,024 16     33.26 ± 11.646 (18.075; 47.56) 6 0.103 ± 0.056 (0.046; 0.168) 4     
ATP 1,56 12     86.99 ± 29.057 (56.876; 131.328) 5         
cAMP 0,006 14     0.915 ± 0.841 (0.071; 2.235) 5 0.018 ± 0.003 (0.016; 0.02) 2 0.032 ±  (0.032; 0.032) 1 
CIT 1,56 10 8.9 ± 4.708 (3.425; 14.397) 6 344.694 ± 113.25 (252.421; 567.967) 6 5.325 ± 4.272 (1.812; 14.397) 10 12.174 ± 6.598 (2.174; 23.296) 13 
CMP 0,006 16     10.348 ± 2.056 (7.827; 13.921) 6         
Cre-PO4 0,006 20 0.09 ± 0.069 (0.038; 0.169) 3 439.457 ± 221.901 (228.128; 856.008) 6 0.077 ± 0.08 (0.024; 0.169) 3 0.268 ± 0.145 (0.141; 0.462) 4 
CTP 1,56 12             4.801 ±  (4.801; 4.801) 1 
DHAP 0,006 19     291.201 ± 138.372 (59.098; 483.138) 6         
F16DP 0,195 13     79.038 ± 20.983 (55.446; 110.9) 6         
F6P 0,006 15                 
FUM 0,048 14 0.402 ± 0.213 (0.168; 0.77) 6 465.756 ± 159.579 (273.031; 631.034) 4 0.547 ± 0.659 (0.139; 2.298) 11     
G1P 0,024 18 0.253 ± 0.09 (0.145; 0.403) 6     0.289 ± 0.073 (0.193; 0.403) 15 0.618 ± 0.298 (0.082; 1.209) 15 
G6P 0,024 16     86.699 ± 25.903 (58.624; 122.459) 6         
GA3P 0,006 18                 
GDP 0,39 12     76.572 ± 30.815 (40.384; 128.042) 6         
Glycol 0,39 14 3.496 ± 0.488 (2.92; 4.185) 6 38.532 ± 15.27 (10.553; 57.545) 6 3.811 ± 0.83 (2.37; 5.534) 15 10.114 ± 5.063 (1.431; 17.253) 16 
Glyox 1,56 12                 
GMP 0,024 17     15.883 ± 12.339 (4.328; 37.418) 6 0.038 ±  (0.038; 0.038) 1     
GTP 1,56 12     24.55 ± 7.166 (17.88; 36.665) 5         
KGA 0,39 12 1.781 ± 0.928 (0.784; 3.142) 6 56.512 ± 13.409 (32.329; 69.199) 6 1.816 ± 0.926 (0.943; 3.574) 15 2.697 ± 1.021 (0.465; 5.091) 15 
LAC 0,781 11         151.716 ± 38.495 (102.814; 213.017) 11 748.567 ± 443.412 (84.453; 998.31) 4 
MAL 0,195 14 1.526 ± 0.632 (0.648; 2.354) 6     1.205 ± 1.078 (0.396; 4.045) 15 2.183 ± 0.787 (0.387; 3.697) 16 
NAD 0,006 14     206.75 ± 76.268 (102.872; 304.763) 6 0.054 ± 0.042 (0.011; 0.118) 7     
NADH 0,024 18     38.337 ± 57.554 (0.888; 141.875) 6         
NADP 0,024 14     50.541 ± 13.586 (36.07; 67.304) 6         
NADPH 0,195 15                 
PEP 0,195 14     89.441 ± 31.918 (42.096; 125.295) 6         
PYR 0,097 16 44.382 ± 11.886 (33.904; 67.325) 6 382.238 ± 124.48 (220.813; 577.669) 6 39.718 ± 21.832 (16.637; 81.237) 15 8.677 ± 5.559 (1.15; 21.721) 16 
R5P 0,012 14                 
RL5P 0,006 20     223.048 ± 121.148 (51.235; 398.422) 6         
SUC 0,024 7 0.187 ± 0.069 (0.122; 0.259) 3     2.903 ± 2.557 (0.214; 5.303) 3 3.739 ± 2.721 (0.671; 7.897) 16 
UDP 0,097 15     3.924 ± 1.485 (2.483; 6.191) 6         
UDPG 0,024 16     280.588 ± 93.616 (142.012; 361.328) 6 0.089 ± 0.062 (0.035; 0.204) 8     
UDPGA 0,006 20     77.508 ± 34.411 (26.933; 116.619) 6         
UDPNAG 0,024 17     143.429 ± 80.746 (30.81; 252.865) 6         
UMP 0,006 16     8.38 ± 5.164 (3.149; 15.573) 6 0.028 ± 0.003 (0.024; 0.031) 3     
UTP 0,781 13     9.285 ± 1.007 (8.388; 10.683) 4         
Key: CCM – central carbon metabolism; LLOQ – lower limit of quantitation by LC-MS/MS; CAL – calibration; SD – standard deviation of the mean; N – number of 
samples measured above LLOQ.  
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Figure 5.5.1: MVA of skin and lamellar dialysate samples: (a) PCA scores plot of skin (S - blue) 
and lamellar (L - green) microdialysate showing similar data distributions for each tissue type. 
Numbers represent time points of collection; (b) PCA scores plot coloured by horse to show that 
some of the variance explained by the MV model is due to inter-subject (horse) variability; (c) 
OPLS-DA scores plot to show incomplete supervised separation between the sample metabolomes; 
(d) bar charts showing selected metabolites fumarate, glycolate, glyoxylate and α-ketoglutarate as 
an example of similar distributions in skin and lamellar microdialysate. 
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Figure 5.5.2: MVA of lamellar dialysate and plasma samples: (a) PCA scores plot of lamellar 
dialysate (D - green) and plasma (P – blue) showing different data distributions for each tissue type. 
Letters next to each point represent the subject from which the sample was collected (A-D = 
oligofructose-treated horses; E-H = controls). (b) loadings plot for (a), highlighting the four 
variables (red points = metabolites; MAL: malate; PYR: pyruvate; ACO: aconitate; Glycol: 
glycolate shown in 2 c-f) that were influential in the differentiation between the two tissue sample 
types. Profiles for (c) malate, (d) aconitate, (e) pyruvate, and (f) glycolate for each horse (X-axis: A 
– H) at each successive time point (0, 6, 12, 24 h = respectively, green and blue bars from left to 
right for each horse). 
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Figure 5.5.3: Bar charts of the medians and interquartile ranges (error bars) of the concentrations of 
malate (a), pyruvate (b), aconitate (c), and glycolate (d) in the lamellar dialysate of oligofructose-
treated (OFT) and sham-treated control (CON) horses. *Statistically significant difference at the 5% 
level. 
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Figure 5.5.4: Bar chart for the concentrations of malate in plasma from each individual horse in 
oligofructose-treated (OFT) and sham-treated control (CON) horses at each time point. 
*Statistically significant difference at the 5% level. 
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Figure 5.5.5: Differences in the lamellar dialysate metabolome after oligofructose treatment; OFT – 
red, CON – green; (a) PCA at the 6 hour time point; (b) profile of malate at the 6 hour time point; 
(c) PCA at the 12 hour time point; (d) profile of pyruvate at the 12 hour time point; (e) PCA at the 
24 hour time point; (f) profile of aconitate at the 24 hour time point. 
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Figure 5.5.6: Differences in the metabolome of lamellar extracts (green) and skin extracts (blue); (a) 
OPLS-DA scores plot of the extracts; (b) loadings plot of the metabolites with 4 highlighted 
variables (metabolites) in red, each shown in detail in c-f as column plots of (c) citrate; (d) 
glycolate; (e) UDP-glucose and (f) dihydroxyacetone phosphate. The four highlighted metabolites 
show a clear difference in central carbon metabolite content, which results in separation of the two 
tissue extracts. 
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Figure 5.5.7: Differences in the metabolome of lamellar dialysate (green) and lamellar tissue 
extracts (blue); (a) PCA scores plot of the comparison of lamellar dialysate vs tissue extract; (b) 
OPLS-DA scores plot of lamellar dialysate vs tissue extract; c-f column plots of (c) a-ketoglutarate; 
(d) aconitate; (e) dihydroxyacetone phosphate and (f) malate. 
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Supplementary Table 5.5.1: Analyte-dependent parameters for the transitions used in scheduled 
Multiple Reaction Monitoring data acquisition. 
 
Analyte 
Q1 Mass 
(Daltons) 
Q3 Mass 
(Daltons) 
RT 
(Minutes) 
DP 
(Volts) 
CE 
(Volts) 
CXP 
(Volts) 
Pyruvate 87.02 43.0 12.5 -45 -12 -1 
Lactate 88.95 42.9 9.0 -45 -18 -5 
Fumarate 115.01 70.9 21.4 -45 -12 -1 
Succinate 117.00 73.0 19.0 -45 -16 -3 
Malate 133.00 70.8 20.1 -40 -22 -3 
Alpha-ketoglutarate 144.95 100.8 20.9 -40 -12 -5 
Phosphoenolpyruvate 166.83 79.0 22.3 -40 -18 -5 
Glyceraldehyde 3-phosphate 168.84 97.1 10.2 -40 -10 -5 
Dihydroxyacetone phosphate 168.84 97.0 12.7 -50 -14 -5 
Aconitate 172.94 84.9 22.7 -30 -18 -5 
2 & 3-Phosphoglycerate 184.91 97.0 21.7 -50 -20 -5 
Isocitrate 190.93 111.1 22.5 -45 -20 -7 
Citrate 190.96 110.9 22.5 -50 -18 -7 
Ribose 5-phosphate 228.94 96.9 9.9 -65 -18 -5 
Ribulose 5-phosphate 228.92 96.9 11.6 -55 -16 -5 
Glucose 1-phosphate 259.02 78.8 10.9 -65 -48 -3 
Glucose 6-phosphate 258.89 96.7 8.9 -75 -22 -5 
Fructose 1-phosphate 259.02 96.8 10.5 -55 -22 -5 
6-Phosphogluconate 274.93 97.1 21.5 -60 -24 -5 
Cytidine monophosphate 322.07 78.8 12.4 -65 -66 -3 
Uridine monophosphate 323.01 78.8 14.1 -60 -64 -3 
Fructose 1,6-bisphosphate 339.08 96.9 22.1 -35 -30 -5 
Adenosine monophosphate 346.02 78.6 16.5 -70 -62 -3 
Guanosine monophosphate 362.05 78.9 14.7 -60 -62 -3 
Uridine diphosphate 403.03 78.8 22.0 -60 -74 -3 
Adenosine diphosphate 426.07 78.8 22.5 -85 -74 -3 
Guanosine diphosphate 442.06 78.9 21.9 -70 -76 -3 
Cytidine triphosphate 481.97 158.6 29.3 -75 -36 -11 
Uridine triphosphate 483.06 158.8 30.4 -65 -42 -7 
Adenosine triphosphate 506.10 158.7 30.5 -85 -40 -11 
Guanosine triphosphate 522.00 158.7 30.0 -80 -42 -11 
UDP glucose 565.18 323.0 21.3 -90 -34 -7 
UDP glucuronate 579.14 79.1 29.7 -90 -108 -1 
NAD 662.25 540.0 13.6 -50 -20 -9 
NADH 664.20 78.8 22.7 -110 -98 -1 
NADP 742.20 620.0 21.7 -45 -24 -11 
NADPH 744.10 79.1 30.3 -120 -116 -1 
Acetyl CoA 808.17 79.1 32.3 -125 -54 -5 
Cyclic AMP 328.09 134.0 17.4 -80 -36 -9 
Glyoxylate 72.82 45.2 6.0 -45 -12 -1 
Glycolate 74.80 46.9 6.3 -35 -14 -3 
Creatine phosphate 209.74 78.8 19.7 -35 -16 -3 
UDP N-acetylglucosamine 605.86 78.7 21.4 -95 -106 -1 
Azidothymidine (AZT) 265.8 223.0 14.1 -70 -16 -1 
 
Key: Q: quadrupole; RT: retention time; DP: declustering potential; CE: collision energy; CXP: 
collision cell exit potential. 
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6. General Discussion 
 
A technique for microdialysis probe placement and for sampling of the lamellar interstitium was 
developed. Lamellar microdialysis allowed consistent recovery of dialysate samples and was well 
tolerated by all horses, with no adverse clinical effects of probe implantation. Fluid recovery from 
lamellar and skin probes was consistent throughout the studies reported here. The minor disruption 
of the distal hoof wall and sole that was required for probe insertion was remote from the sampling 
site (microdialysis membrane), which was important to maintain tissue integrity around the 
membrane in order to be able to study the effects of weight bearing and limb load cycling on 
lamellar perfusion and bioenergetics, as mechanical forces operating on the soft tissue between hoof 
wall and distal phalanx may affect perfusion (Redden, 2003; van Eps et al., 2010). The stable 
metabolite concentrations in normal horses and minimal histological response to the probes 
suggested that analyte recovery was unlikely to be affected by the host response to the probe. In 
addition, the previously described (van Eps et al., 2012; van Eps et al., 2014) placement of digital 
pedometers over the antebrachium as a means to objectively assess limb load cycling (weight 
shifting) activity in the horse was evaluated (Appendix). An adequate correlation between 
pedometer count readings and a custom-made weigh-scale platform system for determination of 
weight bearing on each individual limb was identified. Findings of that study support the use of 
pedometers to monitor and quantitate limb load cycling frequency in the horse.   
Findings of the initial study (Section 5.1) suggested that microdialysis was suitable for 
evaluating disturbances in lamellar energy metabolism over time. A lower glucose and endogenous 
urea concentration in lamellar tissue compared with the skin, suggested lower blood flow in 
lamellar tissue and/or an increased glucose uptake by surrounding cells. As both glucose and urea 
must be delivered to the lamellae and skin haematogenously (Hall, 2011; Sorg et al., 2005), but 
only glucose is consumed, the lower endogenous urea concentration compared with skin supported 
the existence of comparatively lower lamellar perfusion. Furthermore, a high rate of glucose 
consumption has been demonstrated in the equine digit (Wattle and Pollitt, 2004). With a high L:G 
in normal lamellar tissue driven by low glucose (rather than higher lactate concentrations), the 
initial findings were suggestive of the presence of a high glycolytic rate in the lamellae (glucose 
consumption with production of lactate), which is typical of epidermal tissues (Ronquist et al., 
2003; Wattle and Pollitt, 2004). The lack of lactate accumulation (also observed in all subsequent 
studies; Sections 5.2, 5.3 and 5.4) suggested an adaptation to a high glycolytic rate in the lamellar 
tissue, with produced lactate being either utilised as an energy source via lactate dehydrogenase 
(LDH; richly present in lamellar epidermis (Wattle and Pollitt, 2004)) or removed efficiently via a 
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lactate shuttle (Gladden, 2004). Furthermore, because L:P is indicative of tissue redox status and is 
considered a sensitive marker of cellular metabolic dysfunction (Vespa et al., 2005) used in the 
diagnostic evaluation of disorders of energy metabolism in a range of tissues (Marcoux et al., 2008; 
Zhang and Natowicz, 2013), with lamellar L:P resembling values recorded in skin and previously 
reported for brain (Zhang and Natowicz, 2013) and muscle (Edner et al., 2005), lamellar dialysate 
L:P was considered to have potential for detecting the presence of bioenergetic failure during 
laminitis development. 
In the lamellar perfusion modification and limb activity/weight bearing studies (Sections 5.2 
and 5.3), tissue microdialysis was capable of detecting rapid transient perfusion and metabolite 
changes in equine lamellar tissue. The expected and typical metabolic pattern attributed to 
ischaemia in other tissues (Schulz et al., 2000) was recorded in lamellar samples during tourniquet 
application. This was accompanied and corroborated by a significant increase in dialysate urea 
concentration (decreased urea clearance) (Farnebo et al., 2010)., which demonstrated that the urea 
clearance method can detect lamellar hypoperfusion during an ischaemic episode. Walking, 
compared with standing in stocks, was associated with an increase in urea clearance (decreased urea 
dialysate concentration) and a concurrent dramatic shift in metabolite concentrations consistent with 
increased lamellar perfusion (Farnebo et al., 2010). The increase in lamellar urea clearance in 
horses during walking confirms increased lamellar perfusion during ambulation (Farnebo et al., 
2010; Farnebo et al., 2011) and the profound increase in dialysate glucose concentration is also an 
expected consequence of increased local perfusion (Hlatky et al., 2004). The fact that these changes 
were not present in the control (tail head skin dermis) dialysate indicates that they were not simply a 
generalised effect of increased cardiac output or altered systemic vascular resistance. A less 
profound but similar metabolic effect was noted when the instrumented limb was lifted repeatedly 
in the static horse. While these findings support a relationship between limb load cycling activity 
and lamellar perfusion, no statistically significant changes in lamellar metabolite concentrations or 
urea clearance were detected during a period of unilateral weight bearing.  However, the method 
used to induce unilateral weight bearing resulted in frequent loading and unloading of the 
instrumented limb (hopping); the model was therefore not appropriate for producing the 
combination of increased limb load and concurrently reduced load cycling frequency that might be 
expected in clinical cases at risk of SLL. Other interventions expected to alter lamellar perfusion in 
this study did not significantly alter urea clearance, but did cause marked metabolite changes that 
reflected alterations in local tissue energy balance. Furthermore, though detomidine sedation was 
successful in reducing the apparent limb load cycling activity as determined by pedometer count 
frequencies significantly lower than baseline, a significant change in energy metabolite 
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concentrations and urea clearance compared to baseline was not observed. This appears to 
contradict the hypotheses that compromised lamellar blood flow occurs secondary to decreased load 
cycling (van Eps et al., 2010b), and that intermittent unloading (limb load cycling) of the equine 
foot is required for adequate blood flow through the digit (Redden, 2003b; van Kraayenburg et al., 
1983). However, α2-adrenergic agonist such as detomidine are known to have dramatic 
cardiovascular effects in the horse (Short et al., 1986), including the induction of a transient, but 
severe systemic hypertension (Clarke and Taylor, 1986; Short et al., 1986) and constriction of 
arteriovenous anastomoses (AVA) (Hales et al., 1982), of which a large number is present in the 
lamellae (Hood, 1979; Molyneux et al., 1994). Furthermore, a transient induction of 
hyperglycaemia has also been shown to occur in horses after detomidine administration at the dose 
rate used in this study (0.01 mg/Kg IV) (Kullmann et al., 2014). Thus, detomidine-induced 
hyperglycaemia could have confounded the expected decline in dialysate glucose concentrations 
that would result from a reduction in llamellar perfusion secondary to decreased load cycling.  
Closure of AVA as a result of detomidine administration could have favoured capillary blood flow 
in the lamellar circulation. It is plausible that lamellar AVA constriction together with systemic 
hypertension, reported to last >20 min at the dose rate used in this study (0.01 mg/Kg IV) (Clarke 
and Taylor, 1986), may have prevented the decrease in lamellar perfusion that was expected as a 
result of decreased limb load cycling, particularly considering the rapid return of pedometer count 
frequency to baseline values. In addition, the confinement of horses to stocks may also have 
hampered the detection of decreases in perfusion after detomidine sedation, and could have 
exacerbated the observed changes during walking. Nevertheless, results of these studies suggested 
that lamellar perfusion and energy balance are related to limb load cycling and are particularly 
affected by walking.  
Furthermore, while previous studies have demonstrated increases in palmar digital arterial blood 
flow (Adair et al., 1994; Ingle-Fehr and Baxter, 1999) and lamellar microvascular perfusion ((Adair 
et al., 1994) after intravenous ACP administration, in the study reported in Section 5.3, there was no 
significant change in urea clearance after ACP. However, a marked decrease in glucose 
concentrations in the lamellar (but not skin) dialysate similar to that seen during tourniquet 
application was observed. This is a change that would be expected with hypoperfusion rather than 
hyperaemia. A plausible explanation for the apparently contradictory results is that the α-adrenergic 
inhibitory effects of ACP (Posner and Burns, 2009), may cause opening of AVA, which would 
increase net blood flow to lamellar tissue, as previously observed (Adair et al., 1994), but may not 
affect capillary flow (Molyneux and Bryden, 1978) and therefore would not affect measurements of 
urea clearance or nutrient delivery. Furthermore, AVA have a temperature-regulating function 
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(Pollitt, 1992), rapidly increasing local tissue temperature on opening in order to increase heat 
dissipation (Hales et al., 1978; Hales, 1985). Any increase in lamellar tissue temperature could be 
expected to increase metabolic rate (Zachariassen, 1991) and therefore cellular glucose uptake, 
which could account for the marked significant decrease in dialysate (interstitial) glucose 
concentrations after ACP. This mechanism is supported by the increase in pyruvate and decrease in 
L:P in lamellar dialysate after ACP administration, a pattern consistent with increased uptake and 
metabolism of glucose rather than decreased supply (Zhang and Natowicz, 2013). However, 
phenothiazine derivatives such as ACP have been shown to induce a decrease in glucose uptake as a 
result of alteration in cell membrane permeability (Rogers, 1966) in other tissues including rat 
diaphragm and spinal cord (Rafaelsen, 1961), and even in Protozoa (Rogers, 1966). This effect was 
not apparent in lamellar tissue, which could be also due to the unique feature of a high number of 
AVA in this tissue (Hood, 1979; Molyneux et al., 1994). Thus, changes in metabolic rate, 
modulated by the thermoregulatory effects of AVA, may override the decrease in glucose uptake 
observed in other tissues in response to phenothiazine derivatives (Rafaelsen, 1961; Rogers, 1966), 
and may have a profound influence on lamellar energy metabolism and this requires further study. 
Overall only tourniquet application and walking caused significant changes in lamellar urea 
clearance. Since microdialysis perfusion rate can affect the sensitivity and resolution of the urea 
clearance technique (Farnebo et al., 2010), the use of a relatively high perfusion rate (1 µL·min
-1
) in 
these studies may have reduced the likelihood of significant changes. The use of a lower perfusion 
rate (≤ 0.5 µL·min-1) may be appropriate for future studies, but must be balanced with the 
requirement for adequate sample volume to enable analysis, which dictates sampling intervals. 
From these findings, it appears that microdialysis urea clearance and metabolite analysis may not be 
sensitive enough to detect mild reductions in perfusion over relatively short periods when compared 
with baseline values obtained in the static horse confined to stocks.  
Together, findings of these studies support the hypothesis that reduced limb load cycling 
frequency, but not increased weight bearing, may be associated with reduced lamellar perfusion. 
However, further studies are required to determine if lamellar hypoperfusion and energy failure are 
key contributors to SLL. If they are, results from this thesis indicate that the development of 
strategies to increase limb load cycling activity in patients at risk of SLL may be important for 
preventing the disease. Studies examining the effect of reduced load cycling frequency over longer 
periods are required, and a better model which combines increased weight load and decreased limb 
cycling are needed. 
The ability to document changes in energy metabolism and the effects of any detected perfusion 
changes on lamellar energy balance was subsequently used to study the potential role of 
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bioenergetic failure and of perfusion changes in the development of experimental (OF-induced) 
laminitis. There were marked and significant decreases in glucose concentrations in both skin and 
lamellar dialysates during the development of laminitis that were not observed in simultaneous 
plasma samples nor in the lamellar dialysate from control horses. The decreased glucose in lamellar 
dialysate occurred in the face of significantly increased urea clearance (increased local perfusion) at 
the lamellar probe site, indicating that it was not due to reduced glucose delivery as a result of 
hypoperfusion (Hlatky et al., 2004). An increase in local cellular uptake and utilisation of glucose is 
therefore the most likely cause. Increases in glucose utilisation have been observed in various 
organs during sepsis (Chew et al., 2008; Chew et al., 2013; Meszaros et al., 1988). Increased 
aerobic glycolysis in muscle during septic shock occurs through β2 adrenergic stimulation due to 
catecholamine release (Levy et al., 2008), a mechanism that could affect multiple cell types in a 
tissue.  However, sepsis-related increases in glucose utilisation are most profound in tissues rich in 
resident macrophages (Meszaros et al., 1988), suggesting that metabolic activation of resident 
inflammatory cells may make an important contribution. Since a resident macrophage population is 
present in lamellar (Faleiros et al., 2011) and skin (Tay et al., 2014) dermis, and lamellar 
inflammation has been well documented during the development of laminitis in carbohydrate 
models (Belknap et al., 2007b; Leise et al., 2011; van Eps et al., 2012), early increases in 
inflammatory cell metabolism may have contributed to the decreased OFT dialysate glucose 
concentrations. 
Although there were clearly marked disturbances of energy metabolism in the lamellar tissue, 
there was no definitive evidence of lamellar bioenergetic failure during laminitis development in 
this model. Marked and sustained increases in L:P occurred in skin, indicative of oxidative energy 
failure (Nordmark et al., 2009; Schulz et al., 2000); however, although there were significant 
increases in L:P in lamellar dialysate compared with baseline, values were not significantly 
different from control horses. The peak median L:P in the treatment group was almost identical to 
controls and below that which would be considered consistent with failure of oxidative energy 
metabolism (L:P > 30) in other tissues such as brain (Nordmark et al., 2009; Schulz et al., 2000). A 
lack of lactate accumulation in lamellar tissue was also observed in this study (Section 5.4).  
The significant decrease in lamellar urea concentrations (increased urea clearance) from 6-18 h 
in OF-treated horses indicated increased microvascular perfusion (Farnebo et al., 2010) and, 
together with the dialysate metabolite pattern, confirmed that lamellar ischaemia did not occur 
during the developmental phase of laminitis in this study. Limb load cycling is thought to enhance 
lamellar perfusion (Redden, 2001b; van Eps et al., 2010a) and a correlation between urea clearance 
and pedometer count frequency was identified in control horses in the current study. Increases in 
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pedometer count frequency in OFT horses were noted from 6 h onwards, which coincides with the 
time-point when urea clearance increased, offering a potential explanation for lamellar hyperaemia 
as a result of the frequent weight shifting that characterises the onset of laminitis. Furthermore, 
pedometer count frequency monitoring in the horse appears to be not only adequate for assessment 
of limb load cycling activity (Appendix), but capable of detecting the onset of weight shifting 
during laminitis development earlier than clinical monitoring through visual assessment. Thus, 
pedometer count frequency monitoring could be a non-invasive and inexpensive method for 
detection of laminitis-associated foot pain before it becomes clinically apparent. 
Further evaluation of energy metabolism was undertaken using metabolomic analysis of 
samples from normal horses and during OF induction (Section 5.5). A method for metabolomic 
analysis of equine lamellar and skin dialysate and tissue extracts was developed, and the metabolite 
composition subsequently determined. Principal component analysis (PCA) of the data from the 
lamellar and skin tissue of normal adult horses demonstrated that lamellar and skin dialysate had a 
similar metabolite composition. However, during experimental laminitis induction with OF, clear 
differences between the metabolome of lamellar dialysate and plasma from control and OF-treated 
subjects were observed with PCA. Decreases in dialysate concentrations of additional central 
carbon metabolism (CCM) intermediates (as well as pyruvate) was also noted during OF induced 
lamintis, which likely represent evidence of disturbances in oxidative metabolism. Interestingly, as 
previously observed in all other studies presented in this thesis, lactate was not increased as 
determined by metabolomic analysis, likely due to the independent or combined effect of the above 
mentioned utilisation as an energy source via LDH or its efficient removal via a lactate shuttle 
(Gladden, 2004). Overall, the metabolomic assessment of lamellar and plasma samples from OF-
treated horses compared to healthy controls demonstrated that the tissue environment is markedly 
different from the plasma environment/composition. More studies at the tissue level in order to 
assess these differences might be warranted. Using a similar approach as the one recently reported 
in a study of trapezius myalgia in humans (Hadrevi et al., 2013), the use of a larger microdialysis 
probe pore size in future studies would allow measurement of amino acids, fatty acids and 
carbohydrates, resulting in a more comprehensive assessment of the lamellar metabolome during 
laminitis development. Furthermore, concurrent assessment of regulatory enzymes of energy 
metabolism (glycolytic and oxidative) could help determine if lamellar energy failure is a feature of 
laminitis in the horse. 
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Conclusion 
In conclusion, the investigations reported in this thesis demonstrate that lamellar microdialysis 
was suitable for evaluating lamellar energy metabolism over time. Together with urea clearance, the 
technique for lamellar microdialysis was also capable of detecting rapid transient perfusion and 
metabolite changes/disturbances in equine lamellar tissue. Combined with induced modifications in 
weight bearing and limb load cycling activity, the results suggested that lamellar perfusion and 
energy balance are related to limb load cycling and are particularly affected by walking.  The results 
support the hypothesis that reduced limb load cycling frequency, but not increased weight bearing, 
may compromise lamellar perfusion in supporting limb laminitis, but confirmation of this 
relationship with a more suitable SLL model is required. Furthermore, medications like ACP, 
thought to increase lamellar blood flow, had no effect on perfusion but did dramatically alter the 
metabolite patterns in one of these studies. Therefore, medications commonly used in practice may 
not have the expected effects on lamellar perfusion, and should be used with caution until further 
and clear evidence on the true effects of these medications on the lamellar vasculature and energy 
metabolism is obtained. 
These investigations also demonstrated that hyperaemia (and not ischaemia) occurs during the 
developmental phase of laminitis in the OF model. However, despite increased perfusion, glucose 
concentrations in the lamellar interstitium were markedly reduced, apparently due to increased 
glucose uptake and metabolism. There was no definitive evidence of lamellar bioenergetic failure; 
however there were changes in energy metabolites (decreased pyruvate in particular) that 
demonstrated alterations in lamellar energy metabolism during the development of laminitis 
induced with OF. Metabolomic analysis confirmed decreases in particular TCA cycle intermediates 
(pyruvate and others) in lamellar dialysates that also supported an alteration in energy metabolism 
during laminitis development that warrants further investigation. 
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Reasons for performing study: Decreased limb load cycling activity (weight shifting) may be 
important in the pathophysiology of supporting limb laminitis, and increases are the earliest clinical 
sign of laminitis.  A practical and simple means of measuring load cycling activity would be useful. 
Objectives: To document limb load cycling activity patterns in healthy adult horses, and compare 
these patterns to pedometer count frequencies recorded at various placement sites in the fore and 
hind limbs. 
Study Design: Experimental trial. 
Methods: Individual limb load cycling activity patterns from 6 geldings were simultaneously 
recorded for 1 hour on a custom built weigh-scale platform and with pedometers placed at various 
locations on the fore and hindlimbs (experiment 1). The number of limb load cycles per minute was 
compared over time, and the pedometer counts compared to the limb‟s weigh-scale counts. The 
correlation between pedometer counts and weigh-scale traces was examined. In a second 
experiment, pedometers were placed on the antebrachium of both forelimbs in 6 horses and the 
number of counts per minute during periods of confinement to stocks, stall rest, and hand walking 
were compared. Data were analysed non-parametrically. 
Results: There was no significant variation of limb load cycling activity over time. In experiment 1, 
the median ± interquartile range [IQR] limb load cycling activity per minute, and percentage of 
weight load carried on the forelimbs and hindlimbs were 0.56 [0.35; 1.05] and 0.53 [0.35; 0.83], 
and 58.23%  [57.63; 58.94] and 41.77% [41.06; 42.37], respectively. A high correlation between 
pedometer counts and weigh-scale counts was identified for all placement sites. In experiment 2, 
pedometer counts were significantly higher during walking (50.8 [41.3-56.6]) compared to free 
ambulation in a stall (3.8 [2.4-6.3]), which was in turn significantly higher compared to being 
restrained in stocks (1.13 [0.24-1.69]). 
Conclusions: The findings of this study support the use of pedometers as an easy, inexpensive way 
to monitor limb load cycling activity for detection of increases in weight shifting in horses. 
Potential relevance: pedometer count frequency monitoring in horses could allow earlier 
recognition of laminitis development. 
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Introduction 
The appearance of clinical signs of foot pain marks the end of the developmental phase and the 
initiation of the acute phase of equine laminitis [1]. This transition is marked by varying degrees of 
a characteristic lameness, the severity of which is the basis of the Obel grading system [2]. 
Incessant, frequent weight shifting is regarded as the first manifestation of foot pain associated with 
the onset of the acute phase, and corresponds to grade 1 on the Obel scale (OG1): “Weight shifting 
between the forelimbs, while still ambulating freely” [2]. It is one of the earliest clinically 
detectable signs, preceded only by increased digital pulses during the developmental phase. 
Hitherto, the identification of early signs of laminitis has been subjective. The recognition of 
weight shifting is thus subject to observer interpretation and bias, influenced and dependent upon 
personal opinion and clinical expertise; i.e. subtle weight shifting activity can be easily overlooked, 
or normal limb load cycling activity can be over-interpreted, even by the experienced clinician. In 
an attempt to reduce this potential bias during experimental work in the authors‟ laboratory, the 
placement of digital pedometers in the forelimbs of research subjects has been described [3; 4]. In 
those studies, pedometer counts significantly increased 2 to 4 h before the earliest visual recognition 
of clinical signs associated with the onset of frequent, incessant weight shifting (OG1). These 
findings suggest that recording pedometer count frequency in the forelimbs of horses at risk of 
laminitis could aid in the early detection of pain, before OG1. Thus, placement of pedometers on 
the forelimbs of high risk equine patients (i.e. horses with limb injuries or sepsis) could allow for 
earlier and more targeted initiation of prophylactic interventions such as digital cryotherapy [4; 5] 
that might ameliorate the devastating effects of laminitis [4; 6] .  Furthermore, since decreased 
weight shifting frequency may be important in the pathophysiology of supporting limb laminitis 
(SLL) in patients with a painful condition of the contralateral limb [7], a reliable means of 
quantifying weight shifting in the clinical patient would be useful. 
The hypothesis of the present study was that pedometer count frequency can objectively and 
quantitatively determine limb load cycling activity (weight shifting) in adult horses. The objectives 
of this study were: 1) to document normal limb load cycling activity patterns in healthy adult 
horses; 2) to compare this limb load cycling pattern to pedometer count frequencies recorded with 
pedometers placed at various sites in the fore and hind limbs; and 3) to determine the most reliable 
pedometer placement site for potential clinical use. 
 
Materials and Methods 
Animals 
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Six mature geldings (5 Standardbreds and 1 Thoroughbred; mean age 9.5 years, range 4-13; 
mean body weight 458 Kg, range 440-480 Kg), with no lameness and no gross nor radiographic 
foot abnormalities were used for experiment 1 , comparing weight shifting events to pedometer 
counts during restraint in stocks. Horses were trained and accustomed to entering and standing in 
stocks for a period > 3 h prior to the experiment.  An additional 6 normal adult Standardbred 
geldings (mean age 6.5 years, range 3-10; mean body weight 463 Kg, range 413-530) were used in 
experiment 2 which compared pedometer counts during periods of confinement to stocks, stall rest, 
and hand walking. 
 
Weight shifting measurements 
In experiment 1, six horses were restrained in stocks with a floor that was comprised of a 
custom built weigh-scale platform capable of recording individual load on each limb over time. The 
weigh-scale platform was connected to a system that logged weight data from each of the four 
scales at a frequency of 20 Hz. Data was downloaded with a computer, recorded and converted to a 
trace with data points at 0.05 second intervals using commercial software (LabChart 7)
a
. Weigh-
scale readings were recorded for one hour in each horse. 
For every limb of each individual subject, the computer-generated trace was assessed visually 
by one of the authors (CEMT) and a sudden decrease in the weight recording (> 10 Kg decrease 
occurring over < 10 seconds) for an individual limb was considered a weight shifting event for that 
limb (Figure 1). The 1 h trace was divided into 15 min long segments and the number of events for 
each segment was recorded. 
 
Pedometer placement and data collection 
In each of the six horses in experiment 1, three pedometer devices intended for human use 
(Azuni Multifunction)
b
 were attached to each forelimb and two devices were attached to each 
hindlimb using adhesive tape (wrapped around the circumference of the limb), in the following 
locations: 1) distal antebrachium, 10 cm above the accessory carpal bone; 2) middle of 3
rd
 
metacarpal bone; 3) proximal phalanx of the forelimbs; 4) middle tibia, 10 cm above the medial 
malleolus; and 5) middle 3
rd
 metatarsal bone. At each location the pedometer was placed on the 
lateral aspect of the limb. Pedometer count data was collected for 1 h, simultaneously with weigh-
scale data collection. Pedometer counts were read and recorded every 15 min then the pedometer 
was reset. 
In experiment 2, the 6 horses were fitted with a different type of pedometer (Digiwalker 
sw700)
c
 attached with adhesive tape over the distal antebrachium of both forelimbs and recordings 
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were obtained every 2 hours whilst the horses were restrained in stocks for 24 h and then every 2 
hours whilst they were allowed to ambulate freely in a stall for 24 hours.  Recordings were also 
obtained over a 30 minute period whilst the horses were walked continuously (hand-led) over hard 
(paved) ground. 
 
Statistical analysis 
The data failed normality testing (D‟Agostino-Pearson omnibus K2) and therefore were 
analysed non-parametrically. The number of weight shifting events per minute in experiment 1, 
identified by visual inspection of the weigh-scale trace, was compared between 15 minute recording 
points using Friedman analysis with Dunn‟s post-tests. Spearman‟s rank correlation coefficients (rs) 
were calculated to examine the correlation between pedometer counts and weight shifting events for 
each pedometer site in each limb over each 15 minute segment of the 1 h evaluation period in 
experiment 1. The overall median pedometer count frequencies from experiment 2 were compared 
between periods of confinement in stocks, stall rest and hand-walking using Friedman analysis with 
Dunn‟s post-tests. Significance was set at P<0.05. Data were analysed using GraphPad Prism 
v6.00
d
. Data are expressed as median [interquartile range: IQR].  
 
Results 
Weight shifting events (stocks) 
The weight shifting events per 15 minute period for fore and hind limbs (horses restrained in 
stocks) as determined by the weigh-scale platform are presented in figure 2. There was no 
significant variation in limb load cycling activity over time for the 1 h study period. The overall 
median [IQR] limb load cycling activity per minute during the entire 1 h recording period for the 
forelimbs was 0.56 [0.35; 1.05] and for the hindlimbs was 0.53 [0.35; 0.83]. The median [IQR] 
weight distribution over the entire recording period for the forelimbs (combined) was 270.8 [258.8; 
280.9] kg and for the hindlimbs 191.5 [187.4; 201.0] kg, equivalent to a percentage weight 
distribution of 58.23 [57.63; 58.94] % on forelimbs and 41.77 [41.06; 42.37] % on hindlimbs. 
Visual inspection of the weigh-scale traces also revealed that during a weight shifting event, weight 
was apparently always transferred completely to the contralateral limb (i.e. forelimb to forelimb and 
hindlimb to hindlimb), resulting in the generation of a mirror image trace for the contralateral limb 
(Fig. 1). 
 
Pedometer counts and correlations (stocks) 
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The median [IQR] pedometer count frequencies at each pedometer placement site for the entire 
hour were 0.25 [0.17; 0.57] for the antebrachium, 0.28 [0.12; 0.62] for the metacarpus, 0.18 [0.05; 
0.35] for the pastern, 0.31 [0.13; 0.52] for the tibia, and 0.49 [0.20; 0.75] for the metatarsus. The 
pedometer counts at each site compared to the recorded weight shifting events on the weigh-scale 
platform are presented in figure 2. Pedometer counts at all sites were lower than weight shifting 
recorded on the weigh-scale platform (Fig. 3). Overall the median pedometer count values were 
between a minimum of 32.1 % (pastern) and maximum of 92.5% (metatarsus) of the number of 
weight shifting episodes for the same period as determined by the weigh scale trace.   
The correlation coefficients (rs) between pedometer count frequencies and weight shifting 
events for each limb are presented in table 1. A high correlation between pedometer counts and 
weight shifting events, unlikely to be due to chance (P < 0.05), was identified for all pedometer 
placement sites (Fig. 4). 
 
Pedometer counts: stocks vs stall vs hand walking 
Hand walking had a significantly (P<0.05) higher pedometer count frequency per minute (50.8 
[41,3-56,6]) compared with free ambulation in a stall (3.8 [2.4-6.3]) and compared to being 
restrained in stocks (1.13 [0.24-1.69]). Pedometer count frequency in the stall was also significantly 
(P<0.05) higher compared to being restrained in stocks (Fig. 5). 
 
Discussion 
The results of this study indicate that pedometer count frequencies are a reliable estimate of 
limb load cycling activity in static horses confined to stocks. The median pedometer counts at each 
placement site in all four limbs were lower (approximately 50% across sites) compared to the 
median weight shifting events recorded on the scales (Fig. 2). Thus, pedometer counts 
underestimated the limb load cycling activity as measured by weight shifting events. However, 
pedometer count frequencies measured at every placement site correlated highly with weight 
shifting events. Therefore, despite the existence of differences in the total counts detected by the 
pedometers and the weigh-scale platform, the existing significant correlation indicates that 
pedometer count frequency monitoring in horses offers a reliable estimate of differences in limb 
load cycling activity over time. As expected, pedometer count frequency (measured at the 
antebrachium) was higher in horses that were free in stalls and highest during hand-led walking. 
The findings suggest that recording pedometer count frequencies could offer a simple, non-invasive 
and inexpensive method for estimation of limb weight shifting events in clinical and research 
settings. The correlation between pedometer count frequency and weight shifting events was 
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highest for pedometers placed over the antebrachium and the proximal phalanx. For ease of 
placement and reading and also to minimise the chance of damage to or loss of the pedometer in the 
stall bedding, the antebrachium may be the preferable site for clinical use, particularly if the horse is 
free in a stall. 
Reduced limb load cycling activity is thought to be a key contributor to SLL [7], as constant 
weight bearing on the limb inhibits perfusion through the digit [8]. In this study a weight shifting 
event was defined as a rapid decrease of more than 10 kg in weight measured for a single limb and 
this encompassed events that involved lifting the limb completely off the ground as well as more 
subtle weight shifts. These subtle weight shifts in the static horse were likely not measured by the 
pedometer devices, which rely upon a rapid acceleration/deceleration event to trigger the count.  It 
is not clear as to what amount of weight shift off a limb might be required to influence perfusion 
within the digit, however the findings of the present study suggest that pedometers may be a 
valuable monitoring tool for measuring limb load cycling activity in clinical patients at risk of SLL.  
In addition to pain and loss of function in a limb affected by a primary injury, individual patient 
behaviour and analgesics with sedative effects (e.g. butorphanol or ketamine) could also affect load 
cycling on the supporting limb in clinical patients. Thus, determining pedometer count frequencies 
to assess load cycling activity in the supporting limb of patients being treated for contralateral limb 
injuries could help adjust treatment strategies in order to decrease the risk of SLL. Further studies 
are required to determine if lamellar hypoperfusion and energy failure are key contributors to SLL, 
however research examining the relationship between limb load cycling activity and the 
development of SLL could be performed readily in clinical patients with the use of pedometers. 
The limb load cycling frequency in normal horses under different conditions has not been 
previously documented to the authors‟ knowledge. In the present study, the average limb load 
cycles for the forelimbs was similar to that of the hindlimbs (i.e. 0.56 [0.35; 1.05] and 0.53 [0.35; 
0.83] per min, respectively). Compared to a previous study using a similar method for the 
determination of voluntary weight load distribution on all limbs [9], the values for fore and 
hindlimb weight distribution identified in the present study (medians: 58.23 and 41.77 %, 
respectively) are nearly identical to those previously reported during a control period in 10 horses 
prior to experimental laminitis induction (i.e. 57.5 and 42.42 %, respectively) and in 20 healthy 
adult horses (58.09 and 41.91 %, respectively) [9]. In that study less that 700 data points/limb were 
collected for a total of 5 min, and previous studies used single and averaged multiple measurements 
of a shorter duration [9]. In the study reported here over 70,000 data points per limb per horse were 
collected for 1 h at an interval of 0.05 seconds.   
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A major limitation of this study was that weight shifting events were only able to be recorded in 
horses confined to stocks, due to the nature of the weigh-scale platform. When compared to 
pedometer counts recorded in horses ambulating freely in a stall, limb load cycling activity in 
stocks was markedly decreased (Fig. 4). In the ambulatory horse, each stride should equate to one 
limb load cycle, which would correspond to a weight shift if walking on a weigh-scale or a pressure 
mat.  It should also equate to one pedometer count, based on human usage where pedometer 
accuracy is reported to increase at faster walking speeds [10]. Hence, if pedometer counts had a 
strong correlation with weight shifting in the static horse, the correlation and accuracy whilst 
ambulating could be higher. It thus seems reasonable to suggest the use of pedometers for 
quantification and monitoring of limb load cycling activity in the freely moving horse. Further 
studies on freely moving horses are required to confirm the validity of this statement. Another 
limitation of this study was the small number of horses enrolled which necessitated the use of non-
parametric analyses, potentially decreasing the power of the findings. In addition, only healthy 
horses representing two breeds (Standardbreds and Thoroughbred) were used. A clinical trial would 
be required to confirm the usefulness of pedometer count monitoring in the hospitalized patient at 
risk of laminitis. The pedometer type appeared to affect the pedometer count frequency: median 
pedometer count frequency (measured at the antebrachium) in horses restrained in stocks was 
higher with the Digiwalker sw700 pedometers (1.13 [0.24; 1.68]) compared with the Azuni 
Multifunction pedometers (0.25 [0.17; 0.57]). This difference could be attributed to variable 
sensitivity of the pedometers due to differences in the internal mechanism of the devices. This has 
been identified as a problem when using pedometers for physical activity monitoring in humans, 
with under or overestimation of the step counts [11]. Lastly, the effect of flies, other insects or any 
skin stimulation that triggers cutaneous muscle contractions in the horse whilst pedometer count 
frequencies are being recorded must be acknowledged as a potential confounding factor that should 
be taken into account when interpreting the results during research or clinical monitoring. 
In conclusion, the findings of this study support the use of pedometers as an easy, inexpensive 
way to monitor limb load cycling activity for early, objective detection of changes in weight 
shifting frequency. Measurement of changes in weight shifting frequency may be useful for the 
identification of horses at risk of SLL, or in the early detection of clinical laminitis; however more 
research is needed. 
 
 
 
Manufacturers: 
a. ADInstruments Pty Ltd, Bella Vista, NSW, Australia 
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b. Azuni International Co, Taipei, Taiwan 
c. Yamax, Tokyo, Japan 
d. Graphpad Prism 6.0, GraphPad Software Inc, La Jolla, CA, USA 
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Table 1: Results of Spearman’s rank correlation coefficients (rs) between pedometer counts at 
each placement location and weight shifting events (derived from the weigh scale trace) over a 1 h 
period with horses confined to stocks. 
 
Pedometer site Limb rs P value 
Antebrachium 
Left 0.77 0.00001 
Right 0.70 0.0002 
Metacarpus 
Left 0.64 0.001 
Right 0.80 0.000003 
Proximal phalanx 
Left 0.72 0.00007 
Right 0.79 0.00004 
Tibia 
Left 0.66 0.0005 
Right 0.78 0.000007 
Metatarsus 
Left 0.64 0.0007 
Right 0.76 0.00001 
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Figure A.1: Sample traces of the weigh-scale platform readings from one of the study subjects 
(horse 2) during a 5-minute period (41.5 – 46.5 min). A sudden deflection (decrease) in the trace > 
10 Kg (Y axis) for the right fore (RF; red), left fore (LF; blue), left hind (LH; green) and right hind 
(RH; magenta) limbs was considered a weight shifting event (red arrows). Note that during a 
weight shifting event, weight was transferred completely to the contralateral limb (i.e. RF to LF 
and RH to LH), resulting in inverse mirror traces between contralateral limbs. 
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Figure A.2: Median ± [IQR] (error bars) pedometer counts and weight shifting events per minute 
for each limb during a 1 h period restrained in stocks.  Weight shifting events (weigh-scale system) 
= blue trace.  Pedometer counts at different sites: in panels a and b, distal antebrachium 10 cm 
above the accessory carpal bone (grey),  mid-3rd metacarpal bone (black), and proximal phalanx of 
the forelimbs (red); in panel c and d, mid tibia 10 cm above the medial malleolus (grey) and mid-
3rd metatarsal bone. 
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Figure A.3: Median (black horizontal line) and interquartile range (error bars) of limb load cycling 
activity patterns per minute during each 15 min period (open circles) for six individual healthy 
adult horses restrained in stocks, determined with a custom-made weigh-scale system.  
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Figure A.4: Scatter plots of limb load cycling activity patterns per minute for 6 adult horses 
restrained in stocks during a 1 h recording period as determined by pedometers at each 
placement site (x-axis) and compared to weight shifting events detected using a custom-made 
weigh-scale system (y-axis). 
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Figure A.5: Median and interquartile range (error bars) pedometer count frequency recorded with 
pedometers placed on the antebrachium (10 cm above the accessory carpal bone) of 6 horses 
standing static restrained in stocks for 24 h, ambulating freely in a stall for 24 h and walking 
uninterruptedly for 30 min. A significant difference (P<0.05) between the pedometer count 
frequencies recorded during each period was identified (a: significantly different from the stocks 
period; and b: significantly different from the stall period. 
 
 
 
